MedPharmIA Manufacturer App Nov2017

MedPharm Iowa, LLC | 1
Iowa Department of Public Health

^ I D P H ^ ) Protecting and Improving the Health of lowans

Medical Cannabidiol Manufacturer L i c e n s e Application
Request for Proposal #58818014
Cover Page
Applicant Entity Information:
Legal Name include d/b/a MedPharm Iowa, LLC

(doing business as) if
applicable:
" "
Last Four Digits of the xx-xxx8360

Federal Tax ID Number:
Address: 1953 East Market Street
Phone: 515-707-8092
Email Address: MedPharmlA@gmail.com
I hereby affirm and certify that:
1. The information in this application is accurate, to the best of my knowledge.

2. The applicant has the resources to meet the requirements included in this
application.
3. If a license is awarded, based on my authority, the organization is committed to
fulfilling the statutory requirements and rules.
4. I have read and understood the applicable requirements.
Name - S i a n a t u r e ^ ^ ^ ^ t ^ C ^ , / ^ ^ / ^
Name - Printed: Christopher J L / l e l s o n , PhD, Manager
Title - Printed: Manager
Date: October 30, 2017

MedPharm Iowa, L L C | 2
~~ \ Iowa Department of Public Health
V I D P n ) Protecting and Improving the Health of lowans

Statutory Requirements Certification Form
Applicant B u s i n e s s Name: MedPharm Iowa, LLC
Name of Person Completing Form: Christopher E. Nelson, PhD, Manager
1. I certify that I have read the provisions of the Medical Cannabidiol Act and
applicable proposed administrative rules and that this application complies with
all statutory and proposed administrative regulation requirements. I understand
the administrative rules regarding manufacturers will be published in the Iowa
Administrative Bulletin on October 25, 2017, with a first possible effective date of
February 7, 2018. I agree to monitor any changes to the noticed version of the
rules attached to this RFP, and to comply with any amendments to these rules.
2. I certify that the application details a plan that will enable the applicant
manufacturer to supply medical cannabidiol to licensed dispensaries by
December 1, 2018.
3. I certify that the applicant manufacturer will participate in the Department's

secure sales and inventory tracking system.
4. Prohibited Activities - I certify that the applicant manufacturer will not, in the state
of Iowa:
a. Own or operate a medical cannabidiol manufacturing facility unless the

manufacturer is licensed by the Department pursuant to Iowa Code 124E
and proposed administrative rules.
b. Produce or manufacture medical cannabidiol in any location except in
those areas approved by the Department.
c. Sell, deliver, transport, or distribute medical cannabidiol from any location
except its manufacturing facility or a dispensary facility.
d. Produce or manufacture medical cannabidiol in Iowa for sales or
distribution outside of Iowa.
e. Sell or distribute medical cannabidiol to any person or business other than
a dispensary licensed in the state of Iowa.
f. Refuse to sell, deliver, transport, or distribute medical cannabidiol in any
form or quantify produced by the manufacturer to a dispensary, unless
deemed appropriate in the manufacturer's reasonable business judgment
and approved by the Department in writing.
g. Transport or deliver medical cannabidiol to any location except as allowed

I Iowa Department of Public Health
V I D P H ; Protecting and Improving the Health of lowans
in proposed administrative subrule 154.22.

h. Sell medical cannabidiol that is not packaged and labeled in accordance
with proposed administrative rule 154.21.
i. Sell medical cannabidiol in any form or quantity other than those approved
by the Department subject to recommendation by the Medical Cannabidiol
Board and approval by the Board of Medicine.
j. Permit any person to consume medical cannabidiol on the property of the
manufacturer.
k. Employ a person who is under 18 years of age or who has been convicted
of a disqualifying felony offense.
I. Manufacture edible medical cannabidiol products.
5. I certify that no owners of the applicant manufacturer business have been

convicted of a disqualifying felony offense and understand all applicant
manufacturer business owners will be subject to a background investigation and
a national criminal history background check conducted by the Department of
Public Safety.
6. I certify that no employees of an applicant manufacturer have been convicted of

a disqualifying felony offense and all employees of a licensed manufacturer will
be subject to a background investigation and a national criminal history
background check conducted by the Department of Public Safety.
7. I certify the applicant manufacturer does not and will not share office space with,
refer patients to, or have any financial relationship with a health care practitioner.
8. I certify that all of the applicant manufacturer's manufacturing, cultivating,

harvesting, packaging, processing, and storage of medical cannabidiol will take
place in one secured manufacturing facility location at the physical address
provided to the Department during the application process.
9. I certify that the applicant manufacturer will not operate a manufacturing facility at
the same physical location as a medical cannabidiol dispensary.
10. I certify that the applicant manufacturer will not operate a manufacturing facility in
any location within 1,000 feet of a public or private school existing before the
date of the manufacturer's licensure by the Department.
11. I certify that the applicant manufacturer will contract with a laboratory as defined
in and consistent with the proposed administrative rules.
12. I acknowledge that the applicant manufacturer is subject to reasonable

inspection by the Department, a Department-approved consultant, or other
agency, including the Iowa Department of Public Safety, pursuant to Iowa law,
including but not limited to, Iowa Code chapter 124E and all applicable
i V I D P H } Protecting and Improving the Health of lowans
administrative rules.
13. I acknowledge that the Department may assess a manufacturer a civil penalty of
up to $1,000 per violation of Iowa Code chapter 124E or proposed administrative
rules in addition to other applicable penalties.
14. I acknowledge the Department may suspend or revoke a manufacturer license in

accordance with proposed administrative rules.
Name - Signature
Name - Printed: Christopher E/Nelson, PhD, Manager

Protecting and Improving the Health of lowans

Licensing/Regulatory Authority R e l e a s e Form
1. Yes or No. Has the applicant manufacturer applied for, is currently, or has
previously been, licensed, authorized, or registered to produce or otherwise
distribute cannabis and/or cannabidiol products in any form, in any other states or
jurisdictions?
No, the applicant manufacturer has not applied for, is not currently, and
has not previously been licensed, authorized, or registered to produce or
otherwise distribute cannabis and/or cannabidiol products in any form, in
any other states or jurisdictions.
2. If the answer to question #1 is yes, complete this form for each license,
authorization, and registration, for each state and jurisdiction:
a. State or Jurisdiction:
b. State Licensing/ Regulatory Authority:
c. State Agency or Authority Contact Name, Phone, and Email:
d. License, Authorization, or Registration Number:

e. Name of Applicant's Business Licensed, Authorized or Registered in the
other state/jurisdiction:
I hereby specifically grant the Iowa Department of Public Health permission to contact
the above listed state or jurisdiction and licensing/ regulatory authority to confirm the
accuracy of information contained in this application.
I hereby specifically grant permission to the above listed state or jurisdiction and its
licensing/ regulatory authority to release to the Iowa Department of Public Health any
and all information relating to the application, licensure, authorization, or registration to
produce or otherwise distribute cannabis and/or cannabidiol products in any form. Such
information includes but may not be limited to the following:
P ~\ Iowa Department of Public Health
\ V I D P H j Protecting and Improving the Health of lowans
Any denial, suspension, revocation or other sanction of the application, license,

or authorization, and
A copy of documentation so indicating; or
a statement that the applicant was so licensed, authorized, or registered and was
never sanctione
Name - Signature,
Name - Printed: C h r i s t o p h e / t . Nelson, PhD, Manager

1 Iowa Department of Public Health
V I D P H ) Protecting and Improving the Health of lowans

Proper Zoning Form
1. Business address of business applying for a manufacturer license:
1953 E. Market Street, Des Moines, Iowa 50317
2. Proposed physical address of manufacturing facility, including county name:
1953 E. Market Street, Des Moines, Polk County, Iowa 50317
3. Yes or No: Local zoning ordinances allow for a manufacturing facility at the
proposed physical address.
Yes, the property is zoned M2 (Heavy Industrial Zone), which is adequate for
manufacturing at the proposed physical address.
4. Yes or No: The business has confirmed with the local zoning office the zoning
classification and regulations applicable to the property identified in #2 above.
Yes, MedPharm Iowa's consultant team met with both the Assistant Planner
and'the Plans Examiner on September 27, 2017 and confirmed that the
property is adequately zoned M2.
6. Yes or No: The business has obtained a certificate of occupancy, or its

equivalent, which certifies that the property identified in #2 above will be used
as permitted under the zoning ordinance.
No. MedPharm Iowa's consultant team met with the both the Assistant Planner
and the Plans Examiner on September 27, 2017 and again on September 29,
2017 to review the anticipated code and occupancy requirements. The final
certificate of occupancy will only be issued after construction renovations to
MedPharm Iowa's facility are completed.
7. If the answer to question #6 is no, has one been requested?
As noted in the response to question #6 above, MedPharm Iowa's consultant

team has met with the Assistant Planner and the Plans Examiner, but a final
* V | D P H ^ Protecting and Improving the Health of lowans
certificate of occupancy will only be issued after construction renovations to

MedPharm Iowa's facility are completed.
Yes or No: The business has filed a request for rezoning with the local zoning
authority.
No. Rezoning is not necessary.
9. If the answer to question #8 is yes, what is the anticipated date of the decision
on the rezoning request?
N/A
Name - Signatur
Name - Printed: Christophers/Nelson, PhD, Manager
The section below must be completed by an authorized representative of

the local zoning authority and a n o t a ^ p u b l i c :
Signature of Authorized Zoning Representative
Printed Name of Authorized Zoning Representative: EVUi A A P QF.UMPU=-.LAP
<
Local Zoning Authority: c i v V >F 0& r> A A O I L M ^ . > 6 u A
0
Phone Number of Authorized Zoning Representative: R*n - Z ^ - H r r ? ) )
Date of Signature: to ^ t o t T .
State of ^ W r
County of fciK
Signed before me on ^_ ^C/ lr)kdl? (date) by

~^ (name^ of individual).
(SEft
TYLER J. HALL
COMMISSION NO. 806 I 94
MY COMMISSION EXPIRES
<ew
Notary Public
/ I D P H P ) Protecting and Improving the Health of lowans

Owner Certification Form
Note: Each applicant manufacturer owner must complete and submit a separate form.
For any statement for which the answer is no, answer no immediately after that
statement and provide a brief explanation.
1. I certify that I do not and have not held an ownership interest in a cannabis
manufacturer or its equivalent in another state or territory of the United States
that has had the registration or license suspended, revoked, placed on
probationary status or subject to disciplinary action.
2. | certify that I have not managed or served on the board of any business or not-
for-profit that was convicted, fined, censured, or had a registration suspended or
revoked in an administrative or judicial proceeding.
3. I certify that I am not a party to any legal proceeding where damages, fines, or
civil penalties may reasonably be expected to exceed insurance coverage
available to cover the claim by $500,000 or more.
4. I certify that I am not delinquent on the filing of state or federal taxes.
5. I certify that I have not held a cannabis, medical cannabis, or medical marijuana
license or registration in another State for which I have been disciplined by the
State, including, but not limited to, restriction, suspension, or termination.
6. I certify that I have not been denied a professional license or privilege of taking
an examination or had a professional license or permit disciplined by a licensing
authority in any State.
7. I certify that I have not been convicted of a disqualifying felony offense defined as
a violation under federal or state law of a felony under federal or state law, which
has an element the possession, use, or distribution of a controlled substance, as
defined in 21 U.S.C. 8 0 ; "
Name - Signature:
Name - Printed: Christopher E. Nelson, PhD, Manager

^ I D P H P ) Protecting and Improving the Health of lowans
I further acknowledge I have actual notice that, notwithstanding any state law, Cannabis
is a prohibited Schedule I controlled substance under Federal law; any activity not
sanctioned by Iowa Code chapter 124E and proposed administrative rules may be a
violation of state or federal law and could result in arrest, prosecution, conviction, or
incarceration and that the $7,500 license application fee is non-refundable.
Name - Signature
Name - Printed: Christopher^. Nelson, PhD, Manager

Note to Reviewer: In response to the Iowa Department of Public Health's answer distributed on
October 26, 2017 to a question posed in the second round of RFP questions, MedPharm Iowa has
incorporated its exhibits following each narrative section. Because this approach was required by
the Department, the length of this document exceeds two hundred (200) pages. The narrative
sections subject to the page limit described in the RFP, however, number less than two hundred
(200) pages, as required.
S E C T I O N 3.02. P A R T C . S U B P A R T 1: B U S I N E S S O V E R V I E W AND P L A N
a. Provide a brief summary of the applicant manufacturer's qualification, experience, and
industry knowledge relevant to the development and operation of a medical cannabidiol
manufacturing business in Iowa.
MedPharm Iowa, L L C , an Iowa limited liability company ("MedPharm Iowa") has
extensive experience and industry knowledge to the development and operation o f a medical
cannabidiol manufacturing business. This experience and industry knowledge stems from a
combination of MedPharm Iowa's owner, Christopher E. Nelson, PhD ("Dr. Nelson"), and its
relationships with Kemin Industries, Inc., an Iowa corporation and Kemin Foods LC, an Iowa
limited lability company (collectively, "Kemin"); MedPharm Holdings LLC, a Colorado limited
liability company ("MedPharm Holdings"); and MedCara, L L C , an Iowa limited liability
company ("MedCara"). A diagram of MedPharm Iowa's structure is attached hereto and
incorporated herein as Part C , Subpart la., Exhibit A .
Dr. Nelson, the owner of MedPharm Iowa and the President and CEO of Kemin, brings to
MedPharm Iowa substantial experience in the strategic and operational aspects of a botanical-
based company. He has been responsible for creating the botanical strategy for Kemin and keenly
understands the biology and chemistry associated with growing, extracting, formulating and
selling plant extracts. He w i l l transfer this knowledge and experience to MedPharm Iowa's
operation as one of its key strategic planners.
MedPharm Iowa also intends to contract with Kemin, a privately held, family-owned and
operated global nutritional ingredient company headquartered in Des Moines, Iowa, to serve as its
medical cannabidiol consultant. For more than f i f t y years, Kemin has used applied science to
provide products and services that help improve the quality, safety and efficacy of food, feed and
health-related products.
Among its areas of strategic expertise, Kemin has invested heavily in its Specialty Crops
program, which consists of a global team of plant breeders, horticulturists, agronomists, analytical
chemists and extraction chemists. This program includes more than three thousand (3,000) acres
of specialty crop production, including rosemary, oregano, mint, and potato, in the United States
and more than fifteen thousand (15,000) acres o f production, including marigolds, outside the
United States. Kemin's Specialty Crops program also grows crops over more than two (2) acres
of controlled environments, such as greenhouses. Due to the investment and focus on this program,
more than forty percent (40%) of Kemin's finished products are now derived from plants. In
addition, Kemin's crops are vertically integrated from the first breeding lines planted to the
finished products that leave its manufacturing facilities

Through this Specialty Crops program, Kemin targets key molecules produced by its
unique plants, including antioxidants, antimicrobials, carotenoids, saponins and bioactive proteins.
Once these molecules are isolated, Kemin processes these plants by utilizing the safest and most
efficient methods of extraction, while meeting or often exceeding regulatory requirements for the
final product. Kemin's team members are experts at researching, designing, and executing
extraction processes in both small and large-scale systems. These extraction processes utilize a
variety of technologies, including organic solvent-based and water-based extractions and
supercritical fluid extraction. Kemin scientists are also experts in analytic chemistry and quality
control/assurance, routinely developing and executing methods for determining homogeneity,
shelf life stability, and overall quality of its plant extracts. Kemin turns these key extracted
molecules into products that serve the world's glowing population, and it is this expertise that w i l l
provide MedPharm Iowa with invaluable information regarding growing, extracting and
manufacturing ingredients, such as medical cannabidiol, from plants.
MedPharm Holdings, another of MedPharm Iowa's consultants, lends expertise i n the
Cannabis industry to MedPharm Iowa's operations. MedPharm Holdings has successfully
obtained a medical marijuana-infused product license under Colorado law and is finalizing
construction of a new facility that w i l l soon begin growing, extracting and developing final
delivery formulations of Cannabis. MedPharm Holdings has access to high quality Cannabis
germplasm, and MedPharm Holdings w i l l provide this knowledge for MedPharm Iowa's
operations.
MedPharm Iowa also has established a relationship with MedCara, an Iowa-based
company that specializes in formulations. The ability to create dosage forms that are both
consistent and efficacious is critical to the medical Cannabis industry, and the process involves
exhaustive analytical chemistry to isolate the exact compounds needed. Relying on MedCara's
experience, MedPharm Iowa w i l l provide customers with consistent and high-quality medical
cannabidiol.
MedCara's majority owner is TJ Johnsmd, BSPh ("Mr. Johnsrud"). Mr. Johnsrud, who
is also the founder and president of NuCara Management Group, LLC, which oversees pharmacies
throughout the Midwest, has been honored for his commitment to excellence in pharmacy in Iowa
with the 1991 Bowl o f Hygiea, the 2001 Robert G. Gibbs Distinguished Pharmacist Award, the
2003 Distinguished Alumni Award from the University of Iowa College of Pharmacy and the 2014
Osterhaus Medal for Lifetime Achievement. He has served as Past President and remains a current
member of the Iowa Pharmacy Association where he is Chairman of the Task Force on the Iowa
Pharmacists New Practice Model, and he is a member of the National Community Pharmacists
Association, the American Pharmaceutical Association, the National Association of Chain
Drugstores, and a lifetime member of the University of Iowa Alumni Association.
Dr. Nelson's strategic botanical knowledge, combined with Kemin's deep knowledge of
plant breeding, growing, manufacturing, and extracting, MedPharm Holding's proficiency in
developing a medical Cannabis business, and MedCara's formulation expertise, MedPharm Iowa
is well positioned to become the Iowa's leader in the medical cannabidiol industry.
b. Business Plan
(1) Describe the steps and anticipated timeframes for becoming operational as a
manufacturer and having medical cannabidiol available at dispensaries by
December 1, 2018.
MedPharm Iowa and its consulting team have extensive experience in the design and build
of successful Cannabis facilities, including the growth of Cannabis plants for extraction and
formulation. Meanwhile, Kemin, MedPharm Iowa's consultant, has become an expert in plant
science, from breeding and planting to manufacturing and distributing final products. MedPharm
Iowa has leveraged this knowledge, experience, and technical expertise to develop a construction
and production schedule that w i l l allow it to provide medical cannabidiol to dispensaries by
December 1,2018. MedPharm Iowa's m i l construction and production schedule is attached hereto
and incorporated herein as Part C , Subpart \b.(l), Exhibit A.
For ease of reference, the grow schedule from propagation and growth of the mother plants
through MedPharm Iowa's first harvest is described in Figure lb.(I) below. Note that
manufacturing and packaging of the final products includes, without limitation, equipment
validation, formulation, quality testing, labeling, packaging, and delivery to dispensaries.
Figure 1/>.(1) - Grow Schedule.
Growing 150 days Mori 3/26/18 Fri 10/19/18
52 Validate & Optimize Mothers days Mori 3/26/18 rri 3/30/18

Plant Equip Parameters
Propogate & Grow Mother 45 days Mon 4/2/18 f r i 6/1/18

Plants
S3 Validate & Optimize Grow ;10days Mon 5/21/lBjFri 6/1/18

Room Equip Parameters
Propogate & Grow ;50days :Mon 6/4/18 |Fri 8/10/18

Vegetative State
56 Flowering & Harvest ;50days ;Mon 8/13/18|Fri 10/19/18
Crop 1 Harvest Complete :0 days Tri 10/19/18 Fn 10/19/18
S8 Manufacturing 20 days Mon 10/22/l;Fri 11/16/18
Validation Runs 5 days |Mon 10/22/l;|Fri 10/26/18
60 Manufacture, Formulation 10 days jMon f r i 11/9/18

S & Packaging !l0/29/18 j
61 Certified External ilO days M o n 11/5/lS Fri 11/16/18

Laboratory Testing
62 Initial production complete ;0 days f r i 11/16/18 f r i 11/16/18

MedPhaim Iowa, LLC | 15
(2) Describe the proposed production capacity by December 1, 2018, and in the second
and third year of operation. Include a description of the ability to expand capacity in
the future.
MedPharm Iowa has established its production capacity based on the volume of product it
estimates w i l l be sold in Iowa during the first three years of operation. I n establishing this estimate,
MedPharm Iowa relied on key assumptions derived from market research and the experience of
its consultants. Figure 16.(2) below highlights these assumptions. This set of assumptions assumes
that MedPharm Iowa w i l l initially supply f i f t y percent (50%) o f market demand.
Figure 16.(2) - Production Capacity

2018 2019 2020 2021
Number of Licenses Issued 6,381 7,338 8,439 9,705
(15% growth rate)
Percent of Licensed Users
50% 50% 50% 50%
Purchasing (assumed 50% due to
limited offerings)
Square Feet of Growing Space 49* 287 330 379
(needed for 50% o f market) .
* accounts for one month of sales in 2018
Based on the above, MedPharm Iowa's growth chambers have been designed with four
hundred (400) square feet of growing space. This amount of growing space provides MedPharm
Iowa with the ability to grow up to ninety-six (96) plants at one time, which MedPharm Iowa
believes w i l l provide enough harvestable biomass yield to meet demand. While remaining
confident that it w i l l meet demand through 2021, MedPharm Iowa is also prepared to expand its
capacity in the event demand outpaces its estimates. As described in the Commitment Letter
attached hereto as Part C , Subpart lb{2) Exhibit A and in the Lease (as defined in Section 3.02,
Part C , Subpart 2e) attached hereto and incorporated herein as Part C , Subpart \b.(2) Exhibit B ,
MedPharm Iowa holds a right of first refusal on approximately thirty thousand (30,000) square
feet of expansion space in the same building as its Proposed Facility, which allows it the ability to
increase production capacity at its licensed physical location.

(3) Give a summary of the business continuity plan should there be a loss of power or
other natural or man-made event that precludes manufacturing at the site for a
period of time.
MedPharm Iowa is adequately prepared should it experience a loss of power or other event
that precludes manufacturing at its site for a period of time. First, MedPhann Iowa's facility
includes a backup generator that w i l l power the grow rooms (among other systems) should a short-
term loss of power occur. In addition, MedPharm Iowa's production includes plans to begin
stocking inventory to equal three (3) months of demand, at minimum. This additional stock w i l l
be stored in fire-resistant safes attached to the floor of a secured room. MedPharm Iowa w i l l also
work with any other manufacturer licensed by the Iowa Department of Public Health (the
"Department ") to maintain enough medical cannabidiol supply to the market in the event one
manufacturer experiences a catastrophic or total loss.

(4) Describe the forms and quantity of medical cannabidiol (i.e., products) that will be
manufactured during the first year of operation (i.e., available December 1, 2018),
and any forms and quantities of products that are likely to be developed in the second
and third year of operation.

MedPharm Iowa's formulation goal is to develop and provide innovative medical
cannabidiol products in forms and doses that are consistent and efficacious for customers. This
process includes pre-fomiulation, formulation development, small-scale manufacturing, analytical
method development and validation, routine quality control analysis, and stability studies. As
described in more detail i n Section 3.02, Part C , Subpart 5 below, MedPharm Iowa has developed
a label for each of the products it proposes. Please see that Section for more information.
MedPharm Iowa understands that cannabinoids and other plant constituents can undergo
various chemical and biological reactions during growing, processing, formulating, and
consuming and that these reactions may result in an alteration of the effects for the customer. To
combat this, MedPharm Iowa has designed its processes to construct a chemical fingerprint for the
plants so that their contents are better associated with customer outcomes. Constructing this
fingerprint requires standardizing the production of Cannabis, using reliable analytical methods
for detection and quantification of plant components that comprise the fingerprint.
Although MedPharm Iowa w i l l have various forms and quantities available during the first
year of operation (as described below), it continues to look towards the future, while recognizing
that it must at all times comply with 2017 Iowa Acts, House File 524 and Iowa Administrative
Code 641154.15(124E) to 641154.65(124E) (collectively, "Annlicable Law"). MedPharm
Iowa recognizes that current delivery technologies could be vastly improved. For example, oral
MedPhann Iowa, L L C | 17
absorption of Cannabis is usually low and bioavailability is highly variable. Methods such as
lipophilic enhanced absorption formulation ("L.E.A.F."), however, can overcome these issues
and may allow for new formulations that use the delivery technology as one of the components of
efficacy. Other opportunities include a topical cream for neuropathies and the development o f a
multi-dosed powdered inhaler for a standardized intrapulmonary delivery of cannabinoids.
MedPhann Iowa plans to introduce multiple forms, including oral and transdermal, each
with specific dosage categories. A l l forms utilize MedPhann Iowa's L.E.A.F. system. Each
formulation has been designed to be used for any debilitating medical condition (as defined in
Applicable Law); each customer's choice will be based on need and preference. It is important to
note that research has shown that tetrahydrocannabinol ("THC") is more effective when combined
with camiabidiol ("CBD"). CBD can be used alone or combined with THC. Generally, there are
three (3) dosing strategies: elevated THC, low THC, balanced THC/CBD (1:1) and elevated CBD.
CBD improves the effectiveness of THC while decreasing potential adverse effects, such as
psychoactive activity.
MedPhann Iowa proposes to manufacture and offer for sale the following fonnulations and
quantities of medical cannabidiol during the first year of operation:
1. Tincture - concentrated solution.

O i l dosed by a dropper
One ounce bottle (30ml) with a 0.3ml dropper
Alcohol dilutions of Cannabis extracts, containing surfactants to enhance
absorption
Excipients: ethanol, M C T oil, caprylic/capric triglycerides
Available in four varieties:

i. Elevated THC - THC 3% and CBD 0.3% (delivers lOmg THC and l m g
CBD)
ii. Balanced THC/CBD - THC 3% and CBD 3% (delivers lOmg THC and
lOmg CBD)
i i i . Low THC - THC 0.3% and CBD 3% (delivers l m g THC and lOrng CBD)
iv. Elevated CBD - CBD 10% (delivers lOOmg CBD, l m g THC per l m l
dropper)
MedPhann Iowa, LLC | 18
2. Nano Tincture (emulsion) - alcohol-free, enhanced absorption oral susrjgjisioiL
concentrated.
Oil, dosed by a dropper

Nanosuspensions are colloidal dispersions of nano-sized particles stabilized by
surfactants. As a delivery system, nanosuspensions enhance the therapeutic
efficacy of the dose.

Excipients: caprylic /capric triglycerides, veegum, acacia

CBD)
lOmg CBD)
i i i . Low THC - THC 0.3% and CBD 3% (delivers l m g THC and lOmg CBD)
dropper)
3. Soft Gels - enhanced absorption, concentrated
Available: 30 capsules per bottle

Formulated to achieve enhanced bioavailability and immediate release.
Excipients: phosphatidylcholine, coconut oil, caprylic/capric triglycerides
Available in three varieties:

CBD)
lOmg CBD)
i i i . Low THC - THC 0.3% and CBD 3% (delivers l m g THC and lOmg CBD)
4. Transdermal Liposome Cream: targeted for pain.

Liposomal creams/ointments/salves, utilizing L.E.A.F.
Available in a 30gm and 60gm metered dose applicator manufactured by Topi-
CLICK.
MedPharm Iowa, L L C ] 19
Excipients: acrylates copolymer, butyiospermum parkii (shea butter),
caprylic/capric triglycerides, carthamus tinctorius
Available in one variety:

i. Elevated CBD - 10% CBD and 1% THC (delivers lOOmg CBD and l m g
THC per gram)
5. Suppository - enhanced absorption.
Available i n both rectal and vaginal forms
1:1 ratio of THC/CBD, 1 gm suppository
Excipients: phosphatidyl choline, coconut oil, cetearyl alcohol
Available i n one variety:

i. Balanced THC/CBD - 1% THC and 1% CBD (each suppository delivers
lOmg THC and lOmg CBD)
In the second and third year of operation, MedPharm Iowa would consider the following
formulations and quantities of medical cannabidiol, subject to revisions in Applicable Law and
information obtained during the first year of operation:
1. Sublingual Oral Strips - self-micro emulsifying delivery system.
Emulsified, dissolvable strips, utilizing the saliva as the natural water source,
delivering Cannabis extracts. For oral use, these may be formulated as liquids or
solids. Solids would be packaged in capsules or tablets
Excipients: M C T oil, tween 80, PEG 400

2. Bio-Adhesive Strips.
Patch-like delivery system utilizing bio-adhesive strip technology, enhancing
mucosal absorption with micro-emulsion technology, resulting in a sustained
release effect of Cannabis extracts
Excipients: M C T oil, tween 80, carboxymethylcellulose
3. Inhalation - powdered inhalation and vaping.
The coating of standardized oil with an emulsion comprising a wax/lipid, an
emulsifying agent, and water. The emulsion can be spray dried to form a powder,
which can subsequently be dispersed i n water and coated onto the surface of
medicaments to form a protective, enteric and/or controlled release of Cannabis-
containing granules, pellets and tablets.

Excipients: caprylic/capric triglycerides, veegum, poloxamer 407, beeswax
4. Bath Salts.
. Powdered oil extract formulated with L.E.A.F, allowing Cannabis extracts and
essential oils to be absorbed foil-body while taking a warm bath or soak.
Excipients: tween 80, poloxamer 407, veegum, M C T oil

(5) Describe planned product pricing for each of the first three years of operation.
MedPharm Iowa has based its pricing on the manufacturing costs for each finished product
offered. The chart below provides the manufacturer's suggested retail pricing, which is based on
evaluation of comparable products from multiple states. The below chart remains subject to change
at MedPharm Iowa's discretion; however, MedPharm Iowa intends to remain at all a times a
competitive manufacturer.
MSRP,
FORM SIZE/QUANTITY DOSE
Each
lOmgTHC, l m g CBD $ 70.00
lOmgTHC, lOmg CBD $ 70.00
Tincture Oil 1 m l bottle, 0.3ml dropper l m g THC, lOmg CBD $ 70.00
lOOmg CBD, l m g $ 70.00
l O m g T H C , l m g CBD $ 85.00
lOmgTHC, lOmg CBD $ 85.00
Nano Tincture
1 m l bottle, 0.3ml dropper l m g THC, lOmg CBD $ 85.00
(Emulsion) Oil
lOOmg CBD, l m g $ 85.00
lOmgTHC, l m g CBD $ 90.00

30 capsules per bottle lOmgTHC, lOmg CBD $ 90.00
Soft Gel
l m g THC, lOmg CBD $ 90.00
lOmg THC, lOmg CBD - Vaginal $ 40.00

Suppository 10 per blister pack $ 40.00
lOmg THC, lOmg CBD - Rectal
30gm Topi-CLICK l m g THC, lOOmgCBD $ 40.00

Transdermal
60gm Topi-CLICK l m g THC, lOOmgCBD $ 60.00
Cream
MedPharm Iowa, L L C
Part C , Subpart la
Exhibit A
Puitfess* /iîeenwil of asiS&f

Service Af rc-iSffit
Sssv! Mi me at
lit e r&s Ajj f mfc?A
Purchase AgfCfi-muAl of Order
Scrk'kd Agreement
Variola M-ricc agree m t

Part C , Subpart 16.(1)
Exhibit A
[Please see the following pages.]

EXHIBIT
JStfets FriE/U/II tot U / l / 1 8

! o J
11 f l OH f'iaf.,-r'if^ Mi 0 day! frte/11/17 frlif/H/U
:e lrf:**i'.''g Vnt 7 days
C f w i fci fMY*&aw 1 *y4 Wed 5/1 W17 tue S/1S/17
Art*srt S<1 to Hdaji Wd 9/1 S/l 7 t fl S/7J/1 7
Lo!*.*:iof !*!ertk.n M (Ssy* Wl 9/11/11 fri ltt/70/17
D*i*nCevtfKt to 0 dip Mc* 9/74/1 7 Wan 9/75/1
M 9 T u o 9 J f 1 1 1 1 1 C ;
Insist D t i f l U r a * ' / -^ ' W
HeJ'wa for ^^seattwA daft McMD/9/17 f*i I P / U / l 7
App&CMSaa Prep 5. d** Mfl 10/9/17 Ifl 10/1 J/17
Gro*ltaao*i 0 to,! rf 17/1/17 Ml7/1/17

âffi^â l^p*f H^&tt
DaaJ>e lafcjf*?**Presort 0<S*ys SJt 17/1/18 M U 7 / I / U
feS^l^^â^rtowiwesam'dEVi Itea l / i l / W 7/17/18
CowKCu&a tevertifslle^ & 77 days It*** E/S1/I7 Ifl 10/6/1'
flns!iI*-6'Owt<S^s>*'< IS tifi Man 10/5/17 HI 10/77/17
Orfr FropafJUo* 0-a!> 10 diy f r i 17/1/17 f r i 17/1/17
Oi*HG*rl<sutpfw Odap (ril7/l/l7 ffll7/i/17
0<tJe Vtg t flcwtrGrow OiJiyi f r i 17/1/17 fri 17/1/17
rrcâgîian Oaasfew 33daf* fvten 17/4/17 ft! 1/17/18

[^present Froajremirl
Ad*y Men 11/4/17 M
CfcwfWfJS* Frooatwicrat SOttey* Man 17/*/17 fri4/t/lS
fjrcitt; f (cUfîg Iqu^PfcsM 0 dayi T'rM 1/1I/1B IKu 1 / i l / H
pir* b j i t ^ w n l liOdap Ffll/U/18 Tr*j7/I?/lS
Or&M UtrartSonlâfpsMfs*0dip It!u7/a/lB 1huI/e/U
tnHiMOl l ^ j n M R t 99 d i p friJ/S/18 T*& 1/14/1B
Mjaaftdorinf FKHY - H t u I M top Tet J/14/17 111 J / W / i l

1 {S&e.lfeea,SsrtSY.frBfit
Otf&c, Matter HM fenl
Frt*j?jWtat/*KI 4dip T o9/i{/17 fri 9/79/17

u
Detisfcd FrBfraasisIr* l*d ISdlyt IM9/76/17 fri 10/20/17
fcisi^jllsl tuition of'

10/73/17
75 dap Man ) 0/71/1 I f l 11/74/11
l i dap fAsii 11/77/1 fri I7/1S/17
FlFK-rrattlng jadip Mon 11/77/1 fri 17/77/17
fcejs-iFr.sw 1 CDrstnadfci Odap f r i 17/17/17 Ifl 17/77/17
;sdap Mon 17/7S/1 FrU/71/lB
l-j&lfrofOfat.yiE. IS d t p MsfiS/S/lS fit 3/73/18

UotKw Hart Grew t <pj^>
1 l u l
EXHIBIT
i I.
~UioJ/J*/J8f. 3/JO/18
M3/33/IB Iri3/J0/Ifi
fc^/l/lfi
lG/il/17
PJ Deiî DQurl""^ ManlS/W/t H1 IJ/Kf/"I*
pi'f&idi.-iSB.G^ ( t o l / l / l B tril/19/lH
f l pîr^niffl 1/1/18" | r i l / I * / I S
E!-A P t J 1 CGPitTXtfli ff|]/I*/ta Ml/K/W
p! conrtructlart i?3 Man 1/13/18 HU/1S/1B
P3. hfta'' Giros* ftâ^ Mî/9/18 fitS/IB/lS
PI final liSjpetfllC* $/Il/lBPrlf/1/)fi
irit/i/ifl i n e/i/iB
M i P ^ i f i w ^ g f wist* r t * w we i W Msa Frie/W/IB

10/U/W
ttSrirtton, P s t t a ^ , l i b . M
n D*n 90 b p Moo S0/J3/1 frii/?3/>B
M MM*, KCW lS&rp Mon J/16/JH F-13/H/1B
F3 i W s l t o g M, J/JtyiB MUVWIB
i ^ M * 3 C o t r u r t t o ' i Odyl Pfl3/iJVlB t U / / 1 8
Pjceî^t!^ loody MO" i / H / m n s / i o / i f l
lore,t i ^ / K t ^ l ^ w M io Ki/iyi8 Th/iVi8
inn UpfcHCB* Jtwl/S/ll
:
I'Kttt Pii*3t(i'r li? ?iter* lOdsyi rl7/13/lS XtiJ/M/iB
upfcu^ id.** ifi///i8 iêfl/ii
K,ti*isctb* iota* Mcyn/tBfrt^*/iB

it HOuc?^< lt^
fftlMJCWlrfOctcap^V 0 ^ lrtB/74/lB
6 r e w t e J U O t y i M < l / K / l l 111 10/11/II
J
" V i M l t . 1 OptlmU< Matfct* S d i p MO" >// W
p/opo^sSfl ft B(on M*tKw <fcrp M4/;/IB Wt/l/1*
VifaUt.lOpttalMOrow lOdap Mon S/J1/1BM 6/1/18

Room (âSjt Pf w r t m
Propefito I.Grow iodip M i t f i t / ' / l B myio/lB
HwrtiiAflKiiMrt dp M<x./lVlB Fri lD/W/18

trap 1 H a n d CtBMjJata ,
C/OfllH^WCfi*^. Od.p rilO/lS/18ffilO/19/lB
U . - f * ^ , *T* MH0W1M"/A8
V.MiUapbM M^lO/U/lFrilO/lWlB
M h
Mi-JKtur F0fTKd3Hcn 10d*p Moo 1(111/9/1B
tain r.V U teitsKa

Part C , Subpart lb.(2)
Exhibit A
j Kemin Industries, Inc.
MIIM INSPIRED MOLECULAR SOLUTIDHS J D^ S %t u

7
toll free: 800.777.8307
www.kemin.com
October 30, 2017
RE: Request for Proposals to License Medical Cannabidiol Manufacturers

REQUEST FOR PROPOSAL #58818014
Dear Reader:
Please be advised that Kemin Holdings LC is the owner of property locally known as
1953 East Market Street, Des Moines, Iowa 50317 (Property). The building located at
that address contains 43,650 square feet of rentable space. Kemin Holdings LC certifies
as follows:
1. It has agreed to lease 13,650 square feet of the Property to MedPharm Iowa LLC with the
understanding that MedPharm Iowa intends to grow, harvest, grind, extract, blend,
package and ship medical cannabis to dispensaries in Iowa. MedPharm Iowa's space w i l l
be separated from the remainder of the building by a demesne wall.
2. The space leased to MedPharm Iowa w i l l be built out and fully equipped with state o f the
art equipment to grow and manufacture medical cannabis.
3. Kemin Holdings and MedPharm Iowa have agreed to enter into a ten (10) year lease with
an option to expand into the remaining portion of the building as the business matures.
The entire rentable space i n the building totals 43,650 square feet.
Additionally, the parties w i l l have the option to continue the leasehold after the initial
term. I f you have any questions, please advise.
Sincerely,
K E M I N HOLDINGS, LC
/s/ Christopher E. Nelson PhD, Manager
Christopher E. Nelson PhD, Manager

Exhibit B
L E A S E - BUSINESS PROPERTY
CONFIDENTIAL pursuant to Iowa Code Sec. 22.7(6)
Co
<3
b
Kemin Holdings, L.C. Landlord MedPharm Iowa L L C Tenant
By: By:
Name: Name:
Title: Title:
Date Date:
^2,
e
a
to
CONFIDENTIAL pursuant to Iowa Code Sec. 22.7(6}
S E C T I O N 3.02. P A R T C , S U B P A R T 2: M A N U F A C T U R E R F A C I L I T Y
a. Specify the physical location of the proposed manufacturing facility.

MedPhann Iowa's proposed manufacturing facility w i l l be located at 1953 East Market
Street, Des Moines, Iowa 50317 (the "Proposed Facility "). The Proposed Facility is an
approximately 13,650 square foot build-out of the northernmost portion of an existing building on
the property. As more fully described below, the portion of the building that is not used for
MedPharm Iowa's operations w i l l be separated by a full height demising wall.

b. Provide documentation sufficient to establish that the applicant is authorized to conduct
business in the State of Iowa; and that state and local building, fire, and zoning
requirements and all applicable local ordinances are or will be met for the proposed
location of the manufacturing facility.
MedPhann Iowa filed its Certificate of Formation under the laws of the State of Iowa on
September 18, 2017. MedPharm Iowa was also issued a Certificate of Existence on October 11,
2017 by the Iowa Secretary of State. This Certificate of Existence is attached hereto and
incorporated herein as Part C , Subpart 2b., Exhibit A.
The design and construction of MedPhann Iowa's Proposed Facility w i l l be reviewed,
approved, and inspected by local authorities having jurisdiction to ensure that all state and local
building, fire, and zoning requirements and all applicable local ordinances w i l l be met. Upon
completion of its construction renovations, MedPharm Iowa w i l l obtain a certificate of occupancy
that evidences the satisfaction of each o f these requirements.
c. Provide documentation of any support by a local government authority for the proposed
manufacturing facility location.
MedPharm Iowa has reached out to local officials to discuss support by local govermnent
of the Proposed Facility. Unfortunately, due to the time constraints between the issuance o f the
Request for Proposal and its due date, these officials were not able to add this discussion to their
meeting agendas in time.
d. Describe how the manufacturer will inform the Department of potential new hires to
initiate required background investigation and national criminal history background
checks.
MedPharm Iowa's standard operating procedure for hiring new employees w i l l include a
step that requires MedPhann Iowa to notify the Department to initiate its background investigation
and national criminal history background checks. This process would occur immediately after the
potential new employee progresses past the initial phase of the interview but before an offer of
employment could be made. Unless directed otherwise by the Department, MedPhaim Iowa w i l l
inform the Department of each potential new hire by email or by certified letter in a manner
reasonably satisfactory to the Department, and MedPharm Iowa w i l l include all relevant
information necessary for the Department to perform fully its background investigation and
national criminal history background checks. MedPharm Iowa w i l l also submit the fees to the
Department (or the Iowa Department of Public Safety, as applicable) as prescribed by applicable
Iowa law and regulations.

MedPhann Iowa w i l l also inform all potential new employees in writing that it must submit
this information to the Department and confnm with the Department the satisfactory results o f the
background investigation and national criminal histoiy background checks before an offer of
employment could be made. Potential new employees who refuse to acknowledge and agree to
this provision would not be considered for employment with MedPharm Iowa.
e. Provide documentation that the proposed manufacturing facility location is owned by
the applicant. If not owned by the applicant, provide a written statement from the
property owner certifying that the property owner has consented to the applicant
operating a manufacturing facility at that location and the duration of the actual or
planned lease.
MedPhann Iowa's Proposed Facility is owned by Kemin Holdings, L . C , an Iowa limited
liability company r'Kemin Holdings"). Kemin Holdings is a related entity to Kemin, and it is
under common control with Kemin. MedPharm Iowa has secured a right to lease the Proposed
Facility pursuant to that certain Lease - Business Property by and between MedPharm Iowa and
Kemin Holdings (the "Lease"). A copy of the Lease is attached hereto and incorporated herein as
Part C , Subpart 2e. Exhibit A.
A written statement from Kemin Holdings certifying that Kemin Holdings has consented
to MedPhann Iowa operating a manufacturing facility at the Proposed Facility is attached hereto
and incorporated herein as Part C , Subpart 2e. Exhibit B . The duration of the Lease is ten (10)
years, with MedPhaim Iowa holding an option to renew each calendar year upon notice to Kemin
Holdings.
/. Describe signage, lettering, text and graphic materials that will be shown on the exterior
of the manufacturing facility.
MedPharm Iowa's signage and graphic materials w i l l comply with Iowa law and
regulations. MedPharm Iowa has elected to not display its name on the Proposed Facility's
exterior; however, it w i l l display its address, pursuant to fire code regulations, in simple block
lettering. Pursuant to proposed administrative submle 154.18(3)/:, however, the exterior of the
Proposed Facility w i l l display signage in a conspicuous location at every entrance to the Proposed
Facility that reads in capital letters "THESE PREMISES ARE UNDER CONSTANT VIDEO
SURVEILLANCE". These yellow signs with bold black type w i l l be made of weatherproof metal
and contain a single image of a surveillance camera along with the text noted above. A n example
of this sign is attached hereto and incorporated herein as Part C , Subpart 2 f , Exhibit A.
In addition, all exterior doors, except the main visitor and employee entrance, w i l l display
signs that state "Do Not Enter - Restricted Access Area - Access Limited to Authorized Personnel
Only". A n example of this sign is attached hereto and incorporated herein as Part C , Subpart 2 f ,
Exhibit B. Certain standard safety signage may also be shown on the exterior of the Proposed
Felicity, such as "No Smoking" signage. MedPharm Iowa also anticipates erecting simple signage
properly identifying the parking areas as the "Visitor Parking Area" and the "Employee Parking
Area".
g. Provide a site plan, drawn to scale, of the proposed manufacturing facility showing
perimeter fencing as well as all streets, property lines, buildings, parking areas, and
outdoor areas, if applicable, that are within a 500-foot radius of the manufacturing
facility.
MedPharm Iowa, in conjunction with its architects, has developed a site plan for the
Proposed Facility, which is attached hereto and incorporated herein as Part C , Subpart 2g., Exhibit
A (the "Site Plan"). Below, selected portions of the Site Plan are discussed in further detail.
With respect to perimeter fencing, nearly the entire Proposed Facility is enclosed with
seven (7) foot black vinyl chain link fence, topped with one (1) foot of barbed wire. The only area
not enclosed with fencing is the overhead receiving door situated on the northeast corner o f the
Proposed Facility, which is manufactured of steel. Bollards spaced five (5) feet apart w i l l be
installed to prevent vehicles from ramming the door, while still allowing forklift traffic access to
the receiving area. In addition to the Proposed Facility's fencing, the adjacent Kemin property is
also fully enclosed with seven (7) foot black vinyl chain link fence, topped with one (1) foot of
barbed wire.
Employees, consultants, and visitors w i l l access the Proposed Facility via a private
entrance o f f East Market Street. A visitor parking lot w i l l be accessible during normal business
hours, and w i l l allow visitors and consultants to enter the Proposed Facility through the main
entrance. A separate, fenced employee parking lot w i l l be accessible to employees only via card
access.
The Proposed Facility is bordered by East Market Street to the north and Martin Luther
King, Jr. Parkway to the south, although the latter is not directly accessible from the Proposed
Facility. There are relatively few businesses within a five hundred (500) foot radius of the Proposed
Facility. Kemin Holdings owns the vacant land to the east of the Proposed Facility, along with the
manufacturing and maintenance buildings south of the Proposed Facility. Waste Management of
Iowa, Inc. (""Waste Management") owns the property to the west. To the north, beyond the train
tracks owned by Norfolk Southern, are properties owned by Siegwerk USA and Greenstar M i d -
America, LLC.
h. Provide a blueprint or floor plan, drawn to scale, of the proposed manufacturing facility,
which shows and identifies the following information:
MedPharm Iowa and its architects have also developed a floor plan that both ensures it w i l l
be able to produce its finished products efficiently and effectively and that complies with all
Applicable Law. The floor plan for the Proposed Facility is attached hereto and incorporated herein
as Part C , Subpart 2/?., Exhibit A (the "Floor Plan"). Below, selected portions of the Floor Plan K
are discussed in further detail. U

(1) The square footage of the overall manufacturing facility. to
"a

k5
Wis,
a
(2) The locations and square footage of all areas that may contain Cannabis or medical "a*
a
cannabidiol with descriptions of the activities to occur in the spaces. The diagram
should include walls, partitions, counters and all areas of ingress and egress. Said
S
o
u
diagram must also reflect all cultivation, propagation, harvest, extraction,
refinement, testing, storage, packaging and labeling, and transportation areas.
(3) The square footage and location of areas to be used as storerooms or stockrooms, if
K
not included above.
0
A l l storage areas have been noted above i n Section 3.02, Part C , Subpart 2, h.(2).
(4) The location of pesticide, fungicide, and fertilizer storage, mixing, and cleanup
U
areas, including equipment storage and cleanup.
(5) The location of all break rooms, employee lockers, and employee shower facilities
(for those applying pesticides or other crop inputs).
8
(6) The locations of any business operations on the property that will not be related to
the production and distribution of medical cannabidiol.
The Site Plan also shows Kemin's greenhouse to the southeast of the Proposed Facility.
Kemin utilizes this greenhouse to grow certain crops, but these operations are unrelated to the
production and distribution of medical cannabidiol and no Cannabis or Cannabis-rdated activities
w i l l take place in this greenhouse. As previously noted, these operations are completely separated
from MedPhann Iowa's operations by fencing.

(7) All points of entrance and exit at the manufacturing facility.
;. Provide a site development and construction (or conversion) plan identifying the
construction start date, duration, and completion date.
Please review the Site Plan and Floor Plan. In addition, the construction schedule, which
describes the phased approach MedPharm Iowa has developed for its buildout, is attached as Part
C , Subpart 2/'., Exhibit A.
A construction phasing diagram is attached hereto as Part C , Subpart 2/., Exhibit B.
j. Describe any air treatment system or other means to reduce odors released from the
tig
facility.
Exhaust air from the Proposed Facility w i l l be treated for odor mitigation via HEPA filters,
carbon Filters and photohydroionization units ("PHI Units"). Cannabis grow operations across
o
the country utilize PHI Units because of their effectiveness in significantly reducing odor. Not
only w i l l exhaust air flow through these PHI Units, return air recycled back through the Proposed
Facility w i l l also flow through PHI Units, which w i l l mitigate odor within the Proposed Facility.
More information regarding the PHI Units is attached hereto and incorporated herein as Part C ,
Subpart 2j., Exhibit A.

k. Explain previous experience with developing new manufacturing facilities.
MedPhann Iowa's consultant, Kemin, brings a wealth of experience in developing new
manufacturing facilities to MedPhann Iowa's operation. Kemin has developed manufacturing
facilities in nine (9) countries, and it employs a corporate engineering department, a global
construction manager, and process engineers. These team members have been involved in
developing multiple greenfield, renovation, pilot scale, scale-up manufacturing, and process
improvement projects. Around the globe, Kemin team members coordinate preliminary planning
and programming; conceptual design and detailed design development; and construction and
startup of each manufacturing facility. Currently, Kemin's engineering team manages eighty-four
(84) projects and another fifty (50) projects in scope development, at a cost of approximately $160
million. These projects include manufacturing facilities, research and development facilities,
warehouses, and laboratories.

In addition, MedPharm Iowa has designed its Proposed Facility with the assistance of MerJ
Architecture, a firm that has helped design multiple Cannabis facilities in Colorado.
Part C , Subpart 2b.
Exhibit A
10/11/2017
IOWA S E C R E T A R Y OF S T A T E
PAUL D. PATE
CERTIFICATE OF EXISTENCE
Certificate VsMdarioa
The following certificate was issued by the Iowa Secretary of State
Certificate ID: CS140810 Validation Date: 10/11/2017
Date: 1011/2017
Name: MEDPHARM IOWA, L L C (4S9DLC - 554002)

Date of Incorporation: 9/18/2017
Duration: PERPETUAL
I, Paul D, Pate, Secretary of State of the State of Iowa, custodian of the records of incorporations, certify the
following for the limited liability company named on this certificate;
a. The entity is in existence and duly incorporated under the laws of Iowa,
b. All fees, taxes and penalties required under the Revised Uniform Limited Liability Company Act and other
laws due the Secretary of State have been paid.
c. The most recent biennial report required has been filed with the Secretary of State,
d. The Secretary of State has not administratively dissolved the limited liability company.
e. The Secretary of State has not filed either a statement of dissolution or statement of termination.
Paul D. Pate, Iowa Secretary of Stale
1/1
Part C , Subpart le.
Exhibit A
L E A S E - BUSINESS P R O P E R T Y
Kemin Holdings, L.C. Landlord MedPharm Iowa L L C Tenant
By: By:
Name: Name:
Title: Title:
Date Date:
a
Exhibit 1
1953 East Market

Des Moines, I A 50317
\
Part C , Subpart 2e.

Exhibit B
Kemin Industries, Inc.
2100 Maury Street
JÊMIN) INSPIRED MOLECULAR SOLUTIONS Des Moines, IA 50317, USA
toll free: 800.777.8307
www.kemin.com
October 30, 2017
RE: Request for Proposals to License Medical Cannabidiol Manufacturers

REQUEST FOR PROPOSAL #58818014
Dear Reader:
Please be advised that Kemin Holdings LC is the owner of property locally known as
1953 East Market Street, Des Moines, Iowa 50317 (Property). The building located at
that address contains 43,650 square feet of rentable space. Kemin Holdings LC certifies
as follows:
1. It has agreed to lease 13,650 square feet of the Property to MedPharm Iowa LLC with the
understanding that MedPharm Iowa intends to grow, harvest, grind, extract, blend,
package and ship medical cannabis to dispensaries in Iowa. MedPharm Iowa's space w i l l
be separated from the remainder of the building by a demesne wall.
2. The space leased to MedPharm Iowa w i l l be built out and fully equipped with state o f the
art equipment to grow and manufacture medical cannabis.
3 Kemin Holdings and MedPharm Iowa have agreed to enter into a ten (10) year lease with
an option to expand into the remaining portion of the building as the business matures.
The entire rentable space i n the building totals 43,650 square feet.
Additionally, the parties w i l l have the option to continue the leasehold after the initial
term. I f you have any questions, please advise.
Sincerely,
KEMTN HOLDINGS, LC
/s/ Christopher E. Nelson PhD, Manager
Christopher E. Nelson PhD, Manager

Part C , Subpart I f .
Exhibit A
THESE PREMISF-
ARE UNDER
CONSTANT VIDEO
SURVEILLANCE
MedPhaim Iowa, L L C | 49
Part C , Subpart 2/.
Exhibit B
r ~ r r r ~ . " " " " ' " " " " " - ,
DO NOT ENTER
R E S T R I C T E D A C C E S S AREA
A c c e s s Limited to
Authorized Personnel Only
f
Part C , Subpart 2g.
Exhibit A
ease see the following page.]

CONFIDENTIAL pursuant to Iowa Code Sea 22.7(6)
Part C , Subpart 2h.
Exhibit A
ease see the following page.]
to
a
nM 0 1
(9)1 'cc S VJ I mvmmd 1VIIN30HM0D
Exhibit A

EXHIBIT
B&idaî Hie/U/17 SsiIl/l/lB
f ijj i t U OfJ tU-.-r-^ IM 0 dayi Ktfi/n/lf friS/ll/H
Saelr.^-5*n^Vi!-i 7 days Mw 9/11/1 I l u 3/17/17
D*attA*&i:itfoiV(!if*w Srfa^l W*d 9/18/17 los 9/1S/I7
Arc Meet S!*llix\ ai ft3 Wsd s/u/i; in e/77/17
Cortr jt M 5-t J tlo n 7.3 Is-fi Vm 9/13/17 f r i 10/20/U
DciîCoilr^thotValo Odi* I t e i 9 / ) S / I I t t o 9/1S/1 Kijfea lit. pfeHEd W I S
9days Tia>9/7C/17 Hiirj/6/17

Attrition
Rfrve t l j&vt for eaSdj-jl (,fcMO/9/l7 Hi 10/13/1*
((p^sfein Pre? S day* 1079/17 (r! 10/13/17
G'&w llcew* Awarded Ofe-,* f r i 17/1/17 f r t t l / l / l J
Dearfi-i* 1^ &o^V Odap SH12/1/18 J s t l l / l / l B
M-sês t t j ^ ^ i f ^ r i E i r ' ' s s a 2J.S iSs<(i ttsa B/ll/17 IfeJ 7/17/1K
G'CW K.-u Hv* 6 7 7 diyi I h i /31/17 III 10,'fr/l 7
Onfcr f r c ^ r t f e ^ O - j ^ . U r O r f i ^ frt 17/1/17 f r i l 7/1/1
rl 17/1/17 Fri 17/1/17
Ord<r Vtf t f lcicf Grd* odayi frt 17/1/1 f fri 11/1/17
0<Ur* Man 17/4/17 Irl 1/1J/18
Motr-un^6ro S da-|l 17/4/17 f r i W W
GrtsuHatise Frwtia5t SO <f 1 f1 Mo 17/1/17 f i f i / t / M
Orcfj-f Fj-tl-i^'eg !qi^!TsSM 0 djyt
Fad^** h)u^M>7( 1X3 di r<

ftsa 1/11/18 \hu 1/11/18
fri 1/11/18 T>* 7/17/11

Unj^j F^fa( Iqalfm'
r
Onto UtrKton E qaipmtnlOfaft Tfca 7/8/18 Ihu 2/1/IS
EjrKtS!W\ tifipww/tl 3 lyl fri 7/9/1B Irsi t/14/18

T
MBMfKteite( rm-y - Pfesw I M day* Tee S/H/17 f r i J/JO/1B

1 M i , teurity. Her*
Offset, UsOaf H i *t fcrri)
FTC Aff> M*t!flj/Wil 4diys TuaS/H/17 H i / / !
!
tMtiiieiiprcgO'8ra* a^ 19 ds yJ Iufi9/?i/17 fr". 10/20/17
feudf el f * tail l c of lOdaytMan f r i 11/1/17

Coiecpt liyout 10/23/17
PI CMsigTO-Jn.-'r p 7S <iiyi fto> 10/21/1 f r i 1t/74/17
f l t*id.-lGM? l i <Jl,l 11/77/1 fri J J/15/17
Fl P/mitilivf jaiayi Mî 11/27/1 f r i 17/17/17
Ddf frtl2/2?/17fril7/72/17
tS Arfi Uon 12/7S/1 Fri 3/73/1*
lSdiyi MwiB/S/lB tH3/71/ia
| C ltd
EXHIBIT
I " * *
Man S/2W1B rf. 3/3f/lS
F?ti5* I O?! DcctfJ.-vry iri3/3:>/is Msyso/is
u FJsa f(5t/l/ia
I (OfeiraJ KV&C ital tlM 10/11/1I
- u~
-. y i <teyi Mi.T 10/J3/1 Fd nmm
-w- ., F2 E^!*(g t G IS dat Mcfl)/l/ll fftl/13/lS
^ Fôn 1/1/1B ftl 1/K./1B
~u~ E--> Ffaia 2 Cort7\rt>r> tnimjlH Fril/WlS
-, P2 Gn!.1nsrtk!Ji fcton 1/23/18 FflS/lE/lB
-
-, Md.lyi Mm 4/3/18 f r l 5 / i a / l B
W
-1 10 diyi fct^S/Jl/lBFttfe/1/18
n Fllfc/1/1B Irl t/1/18
M^roaJcclErSisg Fwt*y Hs 219 iSty* MOA F18/24/11

t (tte"( & Tfisa ISOSIESS, lo/ii/n
t&rarttea. P u i s êig. Lab, All
"
-, FUtoidpOa^r^ I t e l 10/J3/1 Fri 7/73/1B
~lT~ , F3 l ^ ^ f t G l / P IS** M^J/7*/HM3/l/IB
~p~ ,d,
n fc*=A2/26/lM3/21/lfi
~M "
-. E*gH Fta M 3 Osritrutll<M D A x Fii3/23/lB F(13/23/18
, PJ CCflIir\srtii^ Mw3/7t/lBrrlE/10/ia
m
n PMOl l i t f i n b i K ^ r w r ** Frit/lS/lS Itwjt/28/lB
-, inn upftiKi^ FrI6/J9/lS 1^7/S/tB
IsiSta I FtiSuglfg tflitfff'W**'.* 10 dayj Fr17/t3/lB 1^7/M/lS
-ir- Start UpftI*n:n . (H7/27/IS Ir-jB/2/IB
--jg - FtoiE/13/18FriK/14/lB
F7 Flail lcif*rbf-5
* Ffeaia 3 Cert oi Oeupi/se FllH/24/18 FilJ/24/lB
-4 Grcwfef M l / H / 1 8 f ll 1 0 / l l / l t
VatyjaSa & Opt (ratal Ms* Mini/lf/18ffi3/30/lB

f"i*st Fqoip Fl *a rp>et!l
FfOpi>g)1e Cren Mot hi* 4Sdays MM 4/2/18 Fr1/1/1B
Vacate t-OplWieGrow lOdjyi Uan5/21/lBFrit/l/L8

ttzom l^j({i F a i raiitn
-i3 FfOSSjriia 11 Grow tO ttjyt MSJ16/4/1B FrlE/10/18

Vtgetwve Statu
FWtffrg&HaiYtit Kl d i ,1 ManE/U/lBFfiia/19/lS
-ir- Crop 1 Huyeit Ccwsiet< irl 10/I9/1S Fri 10/19/18

n
-ta HaearfactorfeiJ Uo 10/22/1 Fil 1 1 / l l / U
n
-- n Vif>)tlcii FajiU Sdiyl M< 10/72/1 frUB/76/lB
MifHifiitufl (fe-RiuJiltei Mon lrlll/9/18

t FKIJÎ-J 10/29/U
-. Z&X&ai tdcma)
Ute-Jtefy luting
10 iayi fctofin/s/lBrHll/16/lS
Frill/li/lS i r l l l / W l s at fr*4t!=a u n M r i i "^Siyl
Uttzuti ftjRVTM
I l/lMf l^fM4 y I
MedPhami Iowa, LLC | 58
Part C , Subpart 2j.
Exhibit A
I
Fig'
ENVIRONMENTAL GROUP, INC.
mwmmmm m imi
A Photohydroionization'' (PHI) Technology
The CommercW PHI Unit by RGF* is

designed to reduce o d o r s , air pollutants,
jit VOCs (chemical odors), smoke, moid
bacteria and viruses. Tha unit is easily
mounted into sir conditioning and heating
system air duds where most sic* build-
ing problems start. W h e n the HVAC sys-
tem is in operation the CoitrmmciM PHI
Unit creates an Advanced Oxidation
Process consisting of: Hy*o-jroxides,
ozanide ions, super oxide ions and
hydroxide ions. All are friendly oxidizers.
By friendly oxidizers We mean oxidizers
thatrevertback to o x y g e n and hydrogen
after the axidaiori of the pollutant T h e
Patent Pending system is available fully assembled for
easy installation.
Why Use ROf 'a Phctor^dratonMen'Techrmtofflr ?

femlddai UV light rays have been usedfordecades by the medical industry a s a methodfordestroying rrfcro-organlsns {germs, viruses,
bacteria}. UV light is dependable and. cm to easly installed in HVAC duds or a plenum. GBcmlodat UV BgM is effectiveto!redug *y
the airborne micromanias that pass directy through the light rays. Howver, germicidal UV light has f e to no effect or, gases, vapors
or odors. Photohydroionization Advanced Oxidation, on tie other hand, is very effective on gases, vapors, VOCs and cdors.
Actai lab tests showing upto<il% reductions of

airborne bacteria and moid
The combination of safe low level ozone ( 0 3 > and UV light enhanced by a hydraled quad-metallic compound target develops an advanced
oxidation reaction that creates as well as reduces ozonetosafeto*levels. This process also produces hydro-peroxides, super oxde ions,
ozonide Ions and hydroxides. By engisneering; the proper U V light wavetengtii, in combination w a triple talon, nomaintenanceunit.The
P H I Cei provides safe hydro-peroxides, super oxidetons,ozwvide ions and rryd'oxdes to puMy the air.
W * the R6F HVAC PHI CeiP Advanced Oxidation System, m e r e - o r g a n * can be reduced up to 93.S9%. Gases, VOCs and odors can
aiso be reduced signifcanty, and the room w haw ozonide ions, hydto-pwoxldes, super oxidetonand hydroxides which wiB help g i you-
room fresh, dean and odorfreeair.
MedPhaim Iowa, LLC
Engineered to fit specific cfm applications in large commercial and industrial environments

Commercial 2 0 - Housing i s 20" L U of oeiis Lengtfi of ceB C F M Coverage Tonnage
CML-25 1 14" 9,730 25 0.25A 30W
CML-50 2 14* 19,460 50 0.55A 72W
CML-75 3 14" 29,120 75 0.90A 108W
CML-100 4 14" 38,920 100 1.10A 132W
C D T T I T I I - ' - : a j 5 - h j j i "ig -.= i 5 ft of 35" e e l s # o f 14" celts C F M Coverage Tonnage

CML-65 1 0 25,020 65 0.60A 72W
1 1 34,750 90 0.87A 104W

CML-90
1 2 44,480 115 1.20A 144W
CML-125 2 0 50,040 125 1.10A 132W
CML-140 1 3 54,210 140 1.10A 192W
CML-150 2 1 59,770 150 1.10A 132W
CML-180 2 2 69,500 180 1.80A 216W
CML-190 3 0 75,060 190 1.70A 204W
CML-215 3 1 84,790 215 Z05A 246W
CML-250 4 0 100,080 250 Z15A 258W
RGF Environmental Group, inc.

1101 West 13lh Street (Port of Palm B e a c h Enterprise Zone) Riviera Beach, Florida 33404
800 842-7771 fax 561 848-9454 www.rgf.com
S E C T I O N 3.02, P A R T C , SUBPART 3: S E C U R I T Y R E Q U I R E M E N T S
a. Provide a plan to meet the restricted access requirements of proposed administrative
subrule 154.18(1) to 154.18(2).
MedPhann Iowa has designed the Proposed Facility with security features that w i l l meet
or even exceed the requirements of proposed administrative subrale 154.18. Both the Site Plan,
Part C , Subpart 3a., Exhibit A and the Floor Plan, Part C , Subpart 3a., Exhibit B, provide
information with respect to the type and location of security devices. These exhibits are referred
to throughout this Subpart 3.

b. Provide a plan to meet the perimeter intrusion detection system requirement of proposed
administrative subrule 154.18(3), including a floor plan noting location of all cameras,
and including a description of the storage capabilities for the onsite retention of
historical recordings.
MedPhann Iowa w i l l also invest considerable resources into its computer-controlled video
surveillance system (collectively, the "Surveillance System").

As noted in Section 3.02, Part C , Subpart 2 / , the exterior of the Proposed Facility w i l l
display signage in a conspicuous location at every entrance to the Proposed Facility that reads i n
capital letters "THESE PREMISES ARE UNDER CONSTANT VIDEO SURVEILLANCE". A n
example of this signage is attached hereto and incorporated herein as Part C , Subpart 3b., Exhibit
B.
c. Provide a plan to meet the security alarm system requirements of proposed
administrative subrule 154.18(4).

With respect to fire detection, the Proposed Facility w i l l be fully protected by a standard
fire alarm system and fire sprinkler system, as required by applicable building codes. The fire
alarm system w i l l include horns, strobes, and smoke detectors. The fire alann system w i l l
immediately notify emergency personnel in the event of an alarm. As required by applicable
building codes, the fire alarm system w i l l be on generator backup and w i l l have an additional
battery backup to ensure operability during a power outage. MedPharm Iowa w i l l contract with
Midwest Alarms to service and inspect on a routine basis the fire alarm system and the fire
sprinklers.
d. Provide a plan to meet the personnel identification system requirements of proposed

e. Provide the names and addresses of any contractors hired or planned to provide security.
MedPharm Iowa w i l l contiact with US Security Associates, Inc. to provide on-site security
personnel twenty-four (24) hours a day, seven (7) days a week. US Security Associates, Inc.'s
address is 4357 Czech Lane NE, Suite C-5, Cedar Rapids, Iowa 52402.
Part C , Subpart 3a.
Exhibit A
[Please see the following page.]

CONFIDENTIAL pursuant to. Iowa Code Sec. 22.7(6)
Exhibit B
[Please see following page.]
a
MedPhann Iowa, L L C I 72
Exhibit C

52 SECURITY
S2 NetBox Exlieme Is a full-featured, web-based access control and Access Control

event monitoring system that supports up to 128 portals. Optional i S u p p o r t s up to 12* doors or other access points
system partitioning allows the entire databaseto be separated into
Vionr<( i iiio: Includes comprehensive
multiple smaller systems for entities such as fiefcf offices or tenants
event logging, notificationand escalation
Features such as person record and cardholder management,event
mtt Provides configurable system
a r d alarm monitoring, threat level escalation a n d reportIng are
status and response acttans such a s system k x k d o w n s
accessible from any w e b browser.There is no softwaneto Install.
i i i i Maintains detailed,
credential-driven user records a n d access history
A solid-state appliance, 52 Netfkse Extreme Is fast and reliable.
i insOffers pre-defined a n d c u s t c m reports
T h e system works whir existing Infrastructure and peripheral oV/fces,
making It easy to cteploy. 52 Net Box Extreme Is flexible a n d scalable,

System
supporting upto6<S2 Nodes. In addition, S2 Net Box Extreme tightly
Web intei fate; Delivers browser-based, unified system
integrates with S2 MetVB* series video management systems, providing
management a n d administration
unified system management a n d administration, Integratkfiwiththlid
Solid- State Design! Extends product lifecycle, lowering total
party video management systems Is also supported.
cost of ownership
Video Integral lore Vforks with 52 NetVR series video

S2 NetBox Extreme Is well suited for mid-scale deployments. As
management systems and other third party video systems
organizations grow, migration to 52 NetBox Enterprise Is seamless,
11 Support: Integrates with third party products such as
targe, distributed enterprises can also centrally manage multiple
human resource databases via an open source API
S2 Netfiox Extreme controllers with S2 Global*.
a Automated Systeiri.Vi,)ii,!.;|.?riv;ra:Automatically discovers
52 Ifodes and handles system backups
Viobili' (Sf. pi Allows for mobile security management using

S2 Mobile Security Officer'
System PwtKtonlng 0 ptiom Allows t h e entire database to be

separated Into multiple smaller systems
MedPhann Iowa, LLC
Cardholders 40,000 Operating TempeJ ature 32" - 95'F (0 - 35=0
Access Levels unlimited Storage Temperature -4'- 158'?l.-20'-7Q't)

Unique User Roles 16 O p e r a t i n g Environment Humidity 85%,
S J m i t a n e c m s Useis non-condensing 35'C
10
Time Specifications 5' A C Input 86 - 264VAC, 47/440 Hz, 15A
r',j!lilCLp.2:ity 128 , ..., BTU M a x i m u m 256 per hour
S 2 Node C a p a c i t y 1
64 Regulatory Approvals l l L , CE, K C R o H S ' ^ r I T
M a x i m u m Inputs / O u t p u t s Warranty 2 years, hardware;
I year, software
Online Transactions Up to 4 0 million records
Video M a n a g e m e n t S2 NetVR series VMS and other

O p e r a t i n g System Any; for badcjing use Windows 7
major VMS manufacturers
Browser 1
Chrome, Internet Expbrer, firefox
52NWtCipK>ty It
a n d Safari
S2 NetVR C a m e r a Capacity U24
Processor Intel Core i3 or higher
M e m o r y (RAM) 8GB minimum C o n c u r r e n t S2 Client 10
C o n n e c t i o n s (S2 NetBox,
H a r d Drive 1O0GEn ' I ' I I in.
S2 Magic Monitor*, S2 MobUe
Security Officer)
Storage Capacity 20GB Third Party V M S C a m e r a C a p a d t y 256
Processor Intel Atom N2800 Access Control Allegion, ASSA ABLOY, DMP
and Mercury
MemojifjRAJfU 4GB total
^jOger^ngSêm Ubmtu Linux
Ethernet Ports 1 S2-EXT-16-WM Indudes 16 portal license,

MTBF 213,447 wall mount
Chassis Wall mount or standard S2-EXT-16-RM Indudes 16 portal license,

2U rack mount rack mount
Dimensions <H,W,D) Wall Mount I3in x toînx 3J7in Portal licenses expandable to 128 portals.
33j02cm x 26.67cm x 9.07cm
' 5 2 f M v r o r l c r f c K t e o p a c r t y msfYî d a p s n d l t v g H I s y s t e m das&jEi.
Rack Mount: 3.5n x 17.2in x 11 in 1
R d ' e r I D E f t s t&sst R d e a s a N a l a s r o e t r c w s a r V E n S n n csxzQ&Mtftf-
a .89cm x 43.69cnv^274cm ' t o a i s t l o n s l IntegaUon lifixmalfcH* m r f e t 5 3 J e 3 # 5 2 j y t o m
Weight 9.7 lbs (4.4 kg) maximum
E>2fllSS2 Ssojrt>Ccrpoofem-AI itj^s m'J^rmL S3 ScciFfty,S2rtefeK,S2 NstVft,

S2 Gtatiat 52fctoblteSseurny Oftoif 2nd S2 Magk; Monitor im rKjt&sfSil tiaSimjrtiol
52 Ssoarty CDrpxailoa mn^sKtytrademates amUK property or tret ra^jectweowraas. S2 SECURITY
Data i i ^ t I D ctra>g2 vflti&k notte.
ss>ri4
MedPhami Iowa, L L C
S2 SECURITY
D a t a r e t e n t i o n r e f e r s t o h o w a n d h o w l o n g d a t a is s t o r e d for f u t u r e r e f e r e n c e , allowing data to be

s e a r c h e d a n d a c c e s s e d a t a l a t e r d a t e , a n d a l s o t o d i s p o s e o f i n f o r m a t i o n t h a t is n o l o n g e r n e e d e d . It is
r e c o m m e n d e d that e a c h organization establish a data retention policy to d e t e r m i n e w h a t data n e e d s to

b e a r c h i v e d , a n d h o w l o n g t h e d a t a is t o b e k e p t . A s p a r t o f a n e f f e c t i v e d a t a r e t e n t i o n p o l i c y it is
i m p o r t a n t t o e n s u r e r e q u i r e d d a t a is b e i n g r e t a i n e d , a n d p r o p e r l y b a c k e d u p , a n d a l s o p e r m a n e n t l y
d e l e t e d after the specified retention period has expired.
System Ba<kups
S2 N e t b o x a n d S 2 E n t e r p r i s e s y s t e m s , k n o w n a s c o n t r o l l e r s , are regularly b a c k e d u p at 0 O : I S h o u r s daily.
T h e S u n d a y b a c k u p is a f u l l b a c k u p , a n d b a c k u p s p e r f o r m e d M o n d a y t h r o u g h S a t u r d a y a r e d i f f e r e n t i a l
backups. T h e s e backups are automatically written a n d s a v e d locally to t h e S 2 n e t w o r k controller. T h e y
w i l l a l s o b e s a v e d t o a n e t w o r k a t t a c h e d s t o r a g e { N A S ) a n d / o r F T P s e r v e r if c o n f i g u r e d a n d a v a i l a b l e .
W o r e : You must configure a NAS or FTP device in order to have a backup copy of the system backup pies
available in case of a controller hardware failure. Additional backups m a y be performed on d e m a n d as
required. In t h e e v e n t o f a c o n t r o l l e r f a i l u r e , s y s t e m b a c k u p s c a n b e r e s t o r e d t o a n o t h e r c o n t r o l l e r .
T h e f o l l o w i n g d a t a o b j e c t s a r e c a p t u r e d in a b a c k u p file:
S e c u r i t y d a t a b a s e w i t h all c o n f i g u r a t i o n i n f o r m a t i o n .
Photos and badge designs
Floorplans
U s e r c r e a t e d s o u n d files
R e c e n t s y s t e m activity a n d log d a t a
:
"f item Arcmves
T h e S 2 N e t b o x a u t o m a t i c a l l y c r e a t e s a r c h i v e files c o n t a i n i n g o p e r a t i o n a l t r a n s a c t i o n d a t a f r o m t h e
N e t b o x activity log in o r d e r t o o p t i m i z e t h e p e r f o r m a n c e o f t h e S 2 N e t b o x d a t a b a s e b y r e m o v i n g o l d e r
d a t a . E a c h S u n d a y a f t e r t h e full b a c k u p a t 0 0 : 1 5 h o u r s , t h e s y s t e m c h e c k s t h e n u m b e r of A c t i v i t y L o g
r e c o r d s . If t h i s n u m b e r e x c e e d s 1 5 0 , 0 0 0 t h e n a l l r e c o r d s i n e x c e s s o f 1 0 0 , 0 0 0 a r e z i p p e d i n t o a n a r c h i v e
file a n d r e m o v e d f r o m t h e a c t i v e S 2 N e t b o x d a t a b a s e . T h e S 2 N e t b o x s t o r e s t h e 2 0 m o s t r e c e n t a r c h i v e
files locally o n t h e S 2 N e t b o x c o n t r o l l e r , a n d will a l s o s t o r e u p to 1 0 0 of t h e m o s t r e c e n t a r c h i v e s o n a
N A S o r F T P s e r v e r if c o n f i g u r e d . W h e n c u s t o m r e p o r t s a r e r e q u e s t e d w i t h d a t e s w e e k s o r m o n t h s in t h e
p a s t , it is l i k e l y t h a t s o m e o f t h e r e l e v a n t d a t a m u s t b e r e t r i e v e d f r o m a r c h i v e f i l e s . T h e a r c h i v e f l i e s m a y
contain data for any of t h e following reports: G e n e r a l E v e n t History reports, C u s t o m History reports.
MedPharm Iowa, LLC
C u s t o m P e o p l e r e p o r t s , a n d A u d i t Trail R e p o r t s . T h e S2 controller will r e t r i e v e a p p r o p r i a t e d a t a f r o m
t h e a r c h i v e files a u t o m a t i c a l l y .
1. P l a n ( p r i o r t o implementation):
D e f i n e d a t a retention period (e.g., 6 - m o n t h s , 1-year, etc.).
Figure h o w o f t e n a r c h i v e files will b e g e n e r a t e d . N o t e : S 2 N e t b o x will only
s t o r e 2 0 a r c h i v e files locally. Additional a r c h i v e s 2 1 - 1 0 0 are s t o r e d o n N A S

o r F T P / S F T P , if c o n f i g u r e d . Y o u w i l l n e e d t o a l l o c a t e a d e q u a t e s p a c e
depending on your retention requirements.

Plan network attached storage (NAS) or F T P / S F T P server configuration with a
network administrator.
Remote Storage Recommendations:

o 8 0 G B of available storage or greater.
o Network storage locations should have RAID redundancy, and
preferably an off-site b a c k u p solution,
o Network share n a m e s should not include spaces,
o Create a dedicated user account and grant the user account
r e a d / w r i t e p e r m i s s i o n s for t h e n e t w o r k s h a r e ,
o M a n a g e p e r m i s s i o n s for t h e n e t w o r k s h a r e to only allow access
for authorized s y s t e m administrators and network administrators
as required.
o S 2 s y s t e m s are b a c k e d u p daily at 0 0 : 1 5 h o u r s , a n d s h o u l d be
t a k e n into c o n s i d e r a t i o n for s c h e d u l e d n e t w o r k or s e r v e r o u t a g e s .
2. Execute (Implement remote backups):

C o n f i g u r e n e t w o r k a t t a c h e d s t o r a g e ( N A S ) o r F T P / S F T P s t o r a g e l o c a t i o n s in t h e S 2
software.
Network Storage Configuration (Configuration : Network Resources :
Network Storage).
o Insert r e q u i r e d n e t w o r k s h a r e i n f o r m a t i o n a n d click s a v e . Click
T e s t C o n n e c t i o n t o e n s u r e t h e N A S m o u n t is s u c c e s s f u l .
FTP/SFTP Configuration (Configuration : Network Resources : FTP Backup):

o Click e n a b l e a n d insert required FTP s e r v e r information a n d d i c k
s a v e . C l i c k T e s t C o n n e c t i o n t o e n s u r e t h e F T P s e r v e r is v a l i d .
3.Review:
C h e c k r e m o t e b a c k u p s o n a w e e k l y or m o n t h l y basis to c o n f i r m b a c k u p and
a r c h i v e files a r e b e i n g w r i t t e n f r o m t h e S 2 c o n t r o l l e r .
M a n a g e BscV.jjp and Arch'-ve Fi'e:
Periodically delete old backup and archive files from the remote
storage location in accordance with company retention policies.
Please contact S2 Application Engineering if you would like assistance in estimating or adjusting
your retention period.

Exhibit D
DO NOT ENTER
R E S T R I C T E D A C C E S S AREA
A c c e s s Limited to
Authorized Personnel Only
MedPhami Iowa, L L C | 78
Exhibit A
[Please see the attached pages.]

DS ControlPoint Client User Interface
FUTURE-PROOF CLIENT MONITORING APPLICATION
Supports All Digital Sentry Digital Video Management Systems

(DVMS), and MasterControl/DVX
Supports Pelco's DX4100, DX4500, DX4600, DX4700, DX4800,
DX8000, and DX8100 Series DVRs
Supports Pelco NET5300T Series and NET5400T Series Video Servers
(Encoders)
Supports Pelco IP Cameras with Sarix HD Technology
Supports the Display of iVEX; MJPEG; MPEG-4; and H.264 Baseline,
Main, and High Profiles Encoded Streams from IP Cameras
Compatible with Workstations Running Microsoft Windows
Server 2003, Windows Server 2008, Windows XP, Windows Vista,
Windows 7, or Windows 8
Unified Interface that Seamlessly Supports Analog and IP Video Audio Monitoring and Playback from Analog and IP Sources
Inputs * Video Export Wizard
Organizes Cameras into Logical Groups and System Groups " Video Authentication
Quick Sort by Device Name, IP Address, or Custom Definition * Video Analytics Support (Through Optional Active Alert)
"- Tear Offs Allow for Extended Camera Viewing Across Multiple * Tabbed Work Area with Context-Sensitive Icons
Monitors*
* Right-Click Functionality from Secondary Navigation or Tabbed Work
* Instant Recording and Quick Review of Recorded Video Area
Multicamera Sequential Tours * Data from Third-Party Devices, Alarms, Events, and Audio Displayed
> Pan/Tilt/Zoom (PTZ) Camera Control in Any Window Pane
* Digital Zoom * Alarm Pop-Ups Automatically Alert Operators to Associated Cameras
DS ControlPoint is an intuitive, graphical user interface used to DS ControlPoint includes a video scrub bar to make finding the
monitor and operate a combination of analog and IP video capture right segment of video efficient and effortless. Built-in bandwidth
devices across an IP network, and through a single client. throttling, along with override capabilities on a client-by-client basis,
makes deploying IP video security nonintrusive over an existing
With support for Pelco, Integral, and Digital Sentrfrecording devices network topology. Operator alerting functions, such as video pop-up
and servers running DS NVs, DS ControlPoint provides a seamless on alarm, allow for effective monitoring of hundreds of cameras.
and progressive migration from analog to IP environments.
DS ControlPoint also provides investment protection for customers DS ControlPoint ships with all Digital Sentry systems. The
looking to benefit from today's HD and megapixel camera offerings. software can be downloaded at no cost separately or with DS NVs
from twvw.pefco.com. DS NVs includes four free licenses for Pelco IP
DS ControlPoint is easy to use with a tabbed environment, which
video capture devices.
allows operators to quickly switch between several work spaces.
Selecting live or recorded data from one or more locations is as simple
as a single click.
DS ControlPoint displays exceptional high-quality images captured

by any one of Pelco's robust line of standard resolution and
megapixel IP cameras, along with hundreds of IP video capture
devices from major industry providers. By using DS ControlPoint
and DS NVs video management system (VMS), you can extend your
plug and play capabilities with support for ONVIF version 1.02
specifications. This flexibility allows you to choose components that "The number of monitors that can be supported is limited by the
best satisfy your installation requirements. hardware configuration and is not a software limitation.
Ifltefmtioni^ StarvJsJtSs
Oi^sAiratiofl Ricjiitef FIFTH;
I M
ISO S80I QuaCty S/stem LIO01:
HHIH;
C3669 / REVISED 4-22-14
by S c h n e i d e r Electric
M u l i ' l u i u i Km.i I [ C SO
DigitrJSefrtry
Software Only
OS CeatiolPolit DSNVR
A user Is able lo monitor and manage any DSNVs
ot these systems through a single-user Interface. DS ReatVue
DX8100
DS100D o
o
DS X P r e s s o
o
ANALOG CAMERAS
IP CONVERTER
gJ||l.
ANALOG CAMERAS
ANALOG CAMS HAS
ANALOG CAMERAS
IMPORTANT NOTE. PLEASE READ. The network implementation is shown as a general representation only and is not intended to show a detailed network topology. Your actual
network w i l l differ, requiring changes or perhaps additional network equipment lo accommodate the system as illustrated. Please contact your local Pelco representative to discuss your
specific requirements.
PELCO D V R / H V R PRODUCT FEATURES

DS XPress DX8100
iVEX Compression MPEG-4 Compression
4,9,16,32,64,128 Channels 8,16,24,32 Channels
Analog Cameras Analog Cameras
IP Cameras/Encoders IP Cameras
Video Analytics (Through Optional Active Alert) DS RealVue
SNMP MPEG-4 Compression
Network Health Monitoring 4,8,16,32 Channels
Off Line Storage Archiving (Through Optional Archive Utility) 30 fps at D1 Resolution 720 x 480 per Camera
Analog Cameras
DX4100 IP Cameras/Encoders
H.264 Compression Video Analytics (Through Optional Active Alert)
4 Channels SNMP
Analog Cameras Network Health Monitoring
DX45OO/DX4G00
MPEG-4 Compression Off Line Storage Archiving (Through Optional Archive Utility)
8,16 Channels DS NVR
Analog Cameras
Server Bundled with DS NVs and Pre-Activated IP Camera Licenses
DX470O/DX4800 4,16,32 Channels
H.264 Compression IP Cameras/Encoders
8 or 16 Analog Channels Video Analytics (Through Optional Active Alert)
Plus 2 Megapixel IP Channels Storage Expansion Through SCSI Interface
DS 1000 SNMP
MPEG-4 Compression Network Health Monitoring
16,32 Channels Off Line Storage Archiving (Through Optional Archive Utility)
Analog Cameras
IP Cameras/Encoders DS NVs
SNMP Software-Only Network Video Solution on the Server of Your Choice
Network Health Monitoring 4,16,32,64 Channels Per Server
Off Line Storage Archiving (Through Optional Archive Utility) IP Cameras/Encoders
Video Analytics (Through Optional Active Alert)
Storage Expansion Through SCSI Interface
M t n i H i r u u i I own J l.t ! l
V
SUPPORTED FEATURE SET DS DX80O0/DX810O DX4700/DX4800 0X4500/0X4600 DX4100
Connections
Log on to single system @ m
Log on to multiple systems
Get camera names @ e @ 0
Same-user login from multiple clients

Live
Single and multiple cameras &
View OSD items (camera name, time,
and so forth)

PTZ (Speed setting does (Speed setting does (Speed setting does
not apply) not apply) not apply)
Digital zoom
Motion borders
Alarm borders
Manual record borders

Continuous lecord borders @
Audio playback

Support server local time &

Support GMT time e
Support client time e
Groups
e
Local groups
System groups
Tours

Tours
Search
Audio playback e
Multiple search tabs e
Motion borders 0
Alarm borders
Manual record borders e
Continuous record borders e
Authentication
Included samples filter
Smart search
View OSD items (camera name, time,
and so forth)
Quick review e e
Digital zoom e e e e
Play every frame
Multispeed playback 8X maximum 6X maximum 6X maximum 6X maximum

Support server local time 0 *
o e
Support GMT time
Support client time

Presearch grid
SUPPORTED FEATURE SET DS 0X800070X8100 DX4700/DX4800 DX460O/DX4G00 0X4100
Export
Native compression support
Audio playback

Standalone IMedia playback
AVIEXEXPA
Miscellaneous

Simultaneous live and search tabs
KBD300A

KBO5000
Pop-up on alarm DX8100 0nly
DSConneX
Manual recording
Recorder events
IMPORTANT NOTE.When DS ControlPoint is used with four monitors, there

are operational limitations that ate dependent on the following attributes:
Model of camera utilized
Processor Resolution and frame rate
Minimum Intel" Pentium 2.4 GHz with Number of camera layouts per monitor
Hyper-Threading Technology
Optimum Intel Core~2 Quad CPU, Q9400 at 2.66 GHz
(4 CPUs) Four Monitor Example
Internal Memory Cametas: IXE10LW 1280 x 720,30 fps, quality 49, in camera motion
Minimum 2 GB Monitor Configuration: Four PMCL532F monitors with resolution 1920 x 1080
Optimum >4 GB Monitor 1:6x5 camera layout
Operating System Monitor 2 : 5 x 5 camera layout
Minimum Windows XP Professional SP3
Monitor3:4x4camera layout
Optimum Windows Vista (32 or 64 bit),
Windows 7 (32 or 64 bit), Monitor 4 : 2 x 2 camera layout
Windows 8 (32 or 64 bit), Total: 70 cameras
Windows Server 2003, or
Windows Server 2008
OP"!
Video System
Minimum 128 MB RAM with DirectX 9.0 KBD300A Desktop keyboard with full switching and
Optimum Dual-head, 256 MB RAM with DirectX 9.0c programming capabilities and joystick control
of PTZ functions; requires a KBD300USBKIT
or a KBD300USBKIT-X
R E M O T E CLIENT P C R E Q U I R E M E N T S
KBD300USBKIT Remote keyboard wiring kit (120 VAC) for
( U T I L I Z I N G 3 OR 4 M O N I T O R S } KBD300A
Processor KB0300USBKIT-X Remote keyboard wiring kit (230 VAC) for
Minimum Intel Core i7-3930K CPU, at 3.20 GHz KBD300A
(6 CPUs) with Hyper-Threading KBD5000 Desktop keyboard configured with three
Internal Memory control modules (variable speed joystick, jog
Minimum 16 GB dial and shuttle ring for playback and menu
Optimum >16GB navigation, and a keypad for camera and
Operating System monitor control)
Minimum Windows XP Professional SP3
Optimum Windows Vista (64 bit),
Windows 7 (64 bit),
Windows 8 (64 bit),
Windows Server 2003, or
Windows Server 2008
Video System
Minimum Graphics Card, NVIDIA" GTX TITAN
6 GB RAM
Pelco, Hie Pelco logo, and other trademaiks associated with Pelco products referred
/ P e l c o by S c h n e i d e r E l e c t r i c
lo In this puofcatlon are trademarks of Pelco, Inc. or Its affiliates. ONW and the
3500 Pelco Way, Clovis, California 93612-5699 United States ONvTF logo are trademarks ol ONViP Inc. All other product names and
USA&Canada Tel(800)289-9100 Fax(800)289-9150 services are the properly of their respectr*e companies.
I n t e r n a t i o n a l Tel+1 (559)292-1981 Fax +1 (559)348-1120 Product specifications and availability are sat>|ect to change without notice.
www.pelco.com www.pelco.com/communily Copyright 2013, Pelco, Inc. All lights reserved.
.j.-.iPln.iii II. .!',*,
Digital Sentry DSSRV2 Network Video Recorder

H.264 CAPABILITY, FULLY SCALABLE HARDWARE/SOFTWARE SOLUTION

* Increased data rate of up to 350 Mbps (RAID) or 300 Mbps (JBOD)
total throughput, allowing the server to support more users and play
back more cameras simultaneously than previous DSSRV models
* 4TB stotage drives provide 33% more storage over DSSRV 3TB
models at no additional cost; systems previously utilizing two or
more servers can now be built on a single servei
SSO system drive, with increased read-write speeds and no moving
parts, increases overall system responsiveness and reliability
Supports up to 128 IP Camera Streams; up to 64 Analog Cameras*
* Records H.264, MJPEG, and MPEG-4 IP Stteams
Supports Pelco and Third-Party IP Cameras and Network Encoders
Compatible with the DS Archive Utility
* Compatible with DS ControlPoint for Simultaneous Monitoring of All
DS Series and DX Series Products in a Single Client Interface Recording Rate Configurable per Individual Camera
* Network Health and Event Monitoring Support Through SNMP and VideoXpert Ready. Migrate to VideoXpert, bringing your products
New Digital Sentry System Information (DSSI) Utility foiward into a next generation VMS
O p t i m i z e d For V i d e o S u r v e i l l a n c e
The Digital Sentry Network Video Recorder (DSSRV2 NVR) is Two gigabit network ports provide for convenient n e t w o r k
optimized by Pelco to deliver the essential hardware support for the architecture planning by allowing one port to be dedicated to
DS NVs video management software (VMS) without the extra cost or IP cameras, w h i l e the second network port is used for client
connections. Two DisplayPorts ports provide a convenient connection
risk of integrating hardware and software.
for high resolution digital monitors for use with HD cameras.
IM
Boosted by the 4th Generation Intel X e o n processor and 8 GB of
DSSRV2 models are available with DIACAP/DIARMF-ready software,
RAM, DSSRV2 NVR provides an optimal combination of processing
for use in secured environments implementing information assurance
power and reliability to meet the demands of HD video recording and security standards.
playback operations. The system is powered to support up to 128
Reliability
combined IP and analog video streams, with up to 64 analog cameras
supported via the optional ENC5516 direct-attached encoder. Analog DSSRV2 models incorporate an SSD system drive. With increased
streams are also supported using Pelco and third-party encoders. read-write speeds and no moving parts, the SSD system drive
increases the reliability, uptime, and responsiveness of the system.
The DSSRV2 NVR boasts total throughput of up to 350 Mbps DSSRV2 systems now support 4TB drives, increasing capacity by
(300 Mbps for JBOD models) for recording analog and IP video 33% over original DSSRV models without increasing cost. With front-
streams as well as playback and export through the DS ControlPoint available storage drives for easy servicing and upgrades, the DSSRV2
client. The increased data rate over original DSSRV models allows NVR is available with up to 20 TB storage for models without the
more users to play back video from the server simultaneously. When optional optical disk drive (ODD), or up to 16 TB for ODD models. The
determining the maximum number of cameras and the desired frame drives are hot-swappable when configured for internal RAID 5
rate to host on each system, the number of concurrent client storage.
connections, the number of streams played back per client, and the
bandwidth required for client connections must be considered. External storage is supported through USB attached storage or by
using the optional DSSRV-SCSI interface card to connect to external
The DSSRV2 NVR functions as a stand-alone system or as part of a SCSI storage targets such as the DX8100HDDI, providing additional
network of servers, monitored from the DS ControlPoint user storage of up to 24 TB. The external storage can be configured for
interface. The system can be deployed solely as a network video either JBOD storage or for software controlled RAID 5 storage.
recorder, as a digital video recorder (DVR), or as a hybrid NVR.
"Trie DS NVs database is limited to 128 cameras. The actual number of
cameras the server supports depends on camera settings, client activity,
network bandwidth, and the available throughput of the DSSRV2.
Intgmatkmal Standards
OrgaiuiatiGn R^sttred Firm;
ISO SOOI Quality Sjsiere
9001
CJA1U1
C4014/REVISED 2-25-16
by S c h n e i d e r E l e c t r i c
Mclrtiuui I m n I I ( M
)
The cornerstone of Digital Seriiry design, a fully Open Architecture, is Eliminate the risk of deferred support that comes with VMS software
provided through ONVIF compliance and support for a large number from one vendor and a general purpose hardware platform from
of IP-specific drivers. Users can choose specific IP cameras or another. Replace it with the assurance of an integrated platform built
encoders to fit their application. s p e c i f i c a l l y for t h e rigors of IP video recording. M a k e t h e
performance, reliability, and Open Architecture of DS NVs running on
In addition, the Digital Sentry platform supports the Pelco API and a
DSSRV2 NVR the core foundation of your video management
full suite of integration tools, allowing Digital Sentry to be integrated
solution.
into access control or physical security information management
(PSIM) systems.
ANALOG CAMERAS
M n r l i "
*4Wr\ pHI"
i d m i CfiS
OS CONTROLPOINT CLIENTS
IMPORTANT NOTE. PLEASE READ. The network implementation is shown as a general representation only
and is not intended to show a detailed network topology. Your actual network will differ, requiring changes or
perhaps additional network equipment to accommodate the system as illustrated. Please contact your local
Pelco representative to discuss your specific requirements.
IIIMIFIIMIJI Iowa. U < ! S5
Processor
8
Intel XeonE3-1275 v3 Interface Gigabit Ethernet (lOOOBase-T) ports (2x)
Operating System Windows 7 Ultimate 64-bit
Internal Memory 8 GB DDR3 non-ECC RAM; 16 GB DOR ECC
RAM for DSSRV2-RD models Power Input 100 to 240 VAC, 50/60 Hz, autoranging
User Interface DS ContiolPoint Power Supply Internal
Internal Storage (JBOD or RAID 5*) Power Consumption Operating Maximum
DSSRV2 BOO GB, 4 TB, 8 TB, 12 TB, 16 TB, 20 TB Watts Amperes BTU/H
DSSRV2-DVD 500 GB, 4 TB, 8 TB, 12 TB, or 16TB 100 VAC/50 Hz 222.0 2.22 758.0
DSSRV2-RD 12 TB, 16 TB, 20 TB, or 24 TB 110 VAC / 50 Hz 224.0 2.02 759.4
RAID Level Internal RAID 5 (requires DSSRV-RAID 110 VAC / 60 Hz 223.0 2.03 761.4
controller card for hot-swappable drives) 115VAC/50HZ 217.0 1.89 740.8
External Stotage Pelco's DX8100HDDI or third-party SCSI 115VAC/60HZ 215.5 1.87 735.7
targets (requires optional DSSRV-SCSI) 220 VAC / 50 Hz 213.0 0.97 727.2
System Drive SSD 220 VAC / 60 Hz 204.1 0.93 696.8
240 VAC/50 Hz 211.9 0.88 723.4
Storage Drives 207.6 0.86 708.8
240 VAC / 60 Hz
DSSRV2 6,3.5-inch hard drive bays
DSSRV2-DVD 4,3.5-inch hard drive bays
Optical Drive DVDRWwithDSSRV2-DVD Power
Buttons
USB Porte 3 USB 2.0 ports (1 front, 2 rear)
Indicators
2 USB 3.0 ports (rear) Unit Status Green, amber, red
"The minimum configuration for an internal RAID 5 is three hard disk drives. Primary Network Green, amber, red
One hard disk drive of the RAID 5 configuration is used for parity, reducing Secondary Netwoik Green, amber, red
net storage capacity by the stoiage capacity of one hard disk drive. For Software Status Green, amber, red (based on diagnostics)
example, an 18 TB RAID system provides net storage of 15 TB. Hard Disk Status Gieen, red, off (behind bezel)
VIDEO ENVIRONMENTS!
Video System Intel HD Graphics P4700 (shared memory) Operating Temperature 10to35C(50 to95F)
Maximum Resolution 3840 x 2160 per DisplayPort output (2x) Stotage Temperatute
0 0
- 4 0 t o 6 5 C H 0 t o 149 F)
1920 x 1200 @ 60 hz on DVI-D output
Operating Humidity 20% to 80%, noncondensing
1920 x 1200 @ 60 hz on VGA output
Video Outputs Supports up to 3 simultaneous displays using Maximum Humidity Gradient 10% pet hour
any combination of the four outputs' Operating Altitude -15 to 3,048 m (-50 to 10,000 ft|
Video Standards 60 Hz capable for NTSC Operating Vibration 0.25 Gat 3 Hz to 200 Hz at a tate of
75 Hz capable for PAL 0.5 octave/minute
Video Decoding Supported MPEG-4 ASP; H.264 Baseline, Main, and Note: The temperature at the unit air intake can be significantly higher than
High profiles room temperature. Temperature is affected by rack configuration, floor
Panoramic Motion Recording Supports up to 8 Oncam EV0-O5, or layout, air conditioning strategy, and other issues. To prevent performance
failure and unit damage, make sure the tempetature at the unit is
EVO-12 cameras continuously within the operating temperature range.
Panoramic Continuous Recording
Supports up to 8 Oncam EVO-05, or
PHYSICAL
EV0-12 cameras
Supports up to 6 Optera IMM Series cameras Dimensions 50.8 x 43.4 x 8.9 cm
(20"Dx17.1"W x3.5" H)
t Running client softwate on the server limits the server's performance. It is Weight Unit Shipping
recommended that you run DS ControlPoint on a separate client to ensure DSSRV2-005 11.8 kg (26 lb) 20.9 kg (46 lb)
optimal server and recording performance. DSSRV2-O40 11.8 kg (26 lb) 20.9 kg (46 lb)
DSSRV2-080 12.7 kg (28 lb) 21.8 kg (48 lb)
AUDIO DSSRV2-120 14.5 kg (32 lb) 23.6 kg (52 lb)
Audio Decoding G.711 speech codec DSSRV2-160 15.4 kg (34 lb) 24.5kg(54lb|
DSSRV2-200 16.3 kg (36 lb) 25.4 kg (56 lb)
Audio Bit-rate 64 kbps 12.7 kg (28 lb) 21.8 kg (48 lb)
DSSRV2-005DVD
Audio Levels DSSRV2-O40DVD 13.6 kg (30 lb) 22.7 kg (50 lb)
Input Electret microphone DSSRV2-080DVD 14.5 kg (32 lb) 23.6 kg (52 lb)
Output Up to 3 Vp-p, adjustable, minimum load of DSSRV2-120DVD 15.4 kg (34 lb) 24.5 kg (54 lb)
8 ohms DSSRV2-160DVO 16.3 kg (36 lb) 25.4 kg (56 lb)
Audio Connectors 2,3.5 mm stereo jacks DSSRV2-120RD 13.6 kg (30 lb) 23.6 kg (52 lb)
Connector Tip Signal left (input and output) DSSRV2-160RD 14.5 kg (32 lb) 24.3 kg (54 lb)
Connector Ring Signal right (input and output) DSSRV2-200RD 15.4 kg (34 lb) 25.2 kg (56 lb)
Connector Sleeve Common DSSRV2-240RD 16.3 kg (36 lb) 26.1 kg (58 lb)
Audio Inputs Microphone
Audio Outputs Speaker or line out
(
The following table describes model numbers for DSSRV2 products. For DS-SW-CAM DSSRV2 models include eight licenses for
example, the model number for a 12 TB, DSSRV2 device with a Pelco and third-party IP cameras; additional
United Kingdom power cord is DSSRV2-120-EUK. The model number for a 8 DS-SW-CAM licenses can be purchased
TB, DSSRV2-DVD device with an North American power cord is DSSRV2- separately
080DV-US. Models ending in D are for use in DIACAP/DIARMF security- ENC5516 Direct-attached analog encoder
enabled environments. ENC5400-4PORT 4-port host card; connects 4 ENC5416 or
Model Storage Country Code (optional) ENC5516 encoders
DSSRV2-RAID LSI 3Ware 9750-8i RAID controller card
NVR Without Optical Disk Drive
0SSRV2-SCSI Adaptec SCSI Card 29320LPE
DSSRV2-O05 500 GB DSHDD-005 500 GB upgrade/replacement drive
DSSRV2-040 4 TB DS-EN-HDD-4TB 4 TB upgrade/replacement drive
PWRCRD-S-AR Standard power cord, Argentina
DSSRV2-080 8 TB
PWRCRD-S-AU Standard power cord, Australia
DSSRV2-120 12 TB
PWRCRD-S-EU Standard power coid, Europe
DSSRV2-160 16 TB PWRCRD-S-UK Standard power cord, United Kingdom
DSSRV2-200 20 TB PWRCRD-S-US Standard power cord. United States
Note: Only joystick control is supported. Mouse operation is required to move
NVR With RAID Configuration
between tear-off tabs in DS ControlPoint. Enduia color-coded keys are not
DSSRV2-120RD 12 TB US = North America supported.
EUK = Europe/United Kingdom
DSSRV2-1G0RD 16 TB D = DIACAP/DIARMF
DSSRV2-200RD 20 TB
CE, Class A; meets EN5013O-4 standard requirements
DSSRV2-240RD 24 TB FCC, Class A
UL/cUL Listed
NVR With Optical Disk Drive C-Tick
DSSRV2-005DV 500 GB CCC
KCC
DSSRV2-04ODV 4 TB
DSSRV2-080DV 8 TB T A N D A R D S / O R G A N12 A TIO N S
DSSRV2-120DV 12 TB Pelco is a member of the MPEG-4 Industry Forum
Pelco is a member of the Universal Plug and Play (UPnP) Forum, Steering
DSSRV2-160DV 16 TB Committee
Pelco is a member of the Universal Serial Bus (USB) Implementers Forum
Pelco is a contributor to the Internal Standards for Organization/
SUPPLIED ACCESSORIES
Electrotechnical Commission (IS0/IEC) Joint Technical Committee 1
Power cord (for applicable models) (JTC1), Information Technology," Subcommittee 29, Working Group 11
USB Keyboard and Mouse 1 Compliance, ISO/IEC 14496 standard (also known as MPEG-4I
Compliance, International Telecommunication Union (ITU)
Bezel Key 2 Recommendation G.711, "Pulse Code Modulation (PCM)of Voice
Rack Mount Kit Brackets, rails, and hardware for mounting in Frequencies"
a 2 RU rack Pelco is a member of Hie ONVIF Open Industry Forum
DSSRV-LIT Documentation
USB-DS Imaged with DS NVs and includes resource
documentation
Notice: Judgment as to the suitability of the products for users'purposes is solely the
users' responsibility. Users should refer to the Operation manuals for cautionary
statements regarding user selected options and how Ihey might affect video quality.
Users shall determine the suitability of the pmducts for their own intended application,
picture rate andpidure quality. In the event users intendto use the video for evidentiary
purposes in a judicial proceeding or otherwise, users should consult with their attorney
regarding any particular requirements for such use.
I Pelco by Schneider Electric Pelco, Hie Pelco logo, and other trademarks associated ttlth Pelco products referred
to In this publication are trademarks of Pelco, Inc. or Its affiliates. ONVIF and the
1
3500 Pelco Way, Clovis, California 93612-5699 United Slates
ONW logo are trademarks of ONVIF Inc. All olrer product names and
USA&Canada Tel(800)289-9100 Fax(600)269-9)50 services are the property of their respective companies.
International T e M (559)292-1981 Fax+1 (559)348-1120 Ftodud specifications and availability are subject to change without notice.
www.pelco.com www.pelco.com/cornmuntty Copyright 2016, Pelco, Inc. All rights reserved.
V
MciSPhiHiti I i ( !/
The next step in 360 total situational awareness
BMP sensor
U p t o 3 0 fps video stream at 1 M P a n d !4 M P )nviF I

0.2 lux minimum illumination a n d electronic W D R
1 2 M P high-resolution sensor
U p to 3 0 fps at 2.0 M P
0.1 lux m i n i m u m illumination
Constant 3 6 0 " surveillance with n o blind spots
N o moving parts, n o maintenance a n d silent operation
PoE or 12 VDC p o w e r e d
3-years warranty
Local SD card slot for event recording
Configurable privacy regions
Polygonal video motion detection regions

Surface Mount EVO-05-SSK EVO-12-SSK
Local alarm digital Input a n d output
P e n d a n t Mount EVO-05-PSK EVO-12-PSK
Audio microphone Input
Electropollshed marine grade 3 1 6 stainless steel
Designed for d e m a n d i n g Industrial environments

Market leading O n c a m 3 D dewarping software
withstanding high pressure washes a n d corrosion
Full Live a n d retrospective dewarping available
IP69K rated for dust a n d water protection
Camera features are accessible through V M S platforms
IK10 rating for vandalism protection
Simultaneous multiple video streams
Two mounting options available, surface a n d pendant
10x digital z o o m capability through cllent-slde d e w a r p i n g
H.264 / MJPEG streaming w i t h multiple quality levels

Food a n d processing areas Optimizes b a n d w i d t h a n d storage utilization
Industrial a n d chemical plants Intuitive w e b - b a s e d interface for viewing a n d configuration
Vehicle w a s h stations Supported by major V M S / NVR systems Including
Ports a n d marine applications VideoXpert (version 1.6 or later) a n d
High e n d architecture Digital Sentry (version 7.8.90 or later)
ONVIF profile S conformant
.me!/
International Standards
Organization Registered Firm;
ISO 9001 Quality System
by S c h n e i d e r E l e c t r i c C 4 0 3 5 Revised 3.8.17
185-VF2.0
Minimum Illumination 0.2 lux = 50 IRE F/2.0 0.1 lux = 50 IRE F/2.0
30 fps for 1 MP and % MP resolution
Frame Rale 15 fps for 2 MP resolution 12 fpsformaximum resolution
10 fps tor 4 MP full resolution
Video Motion Detection 8 configurable regions
Externa) Input 1x contact input
External Output 1x contact output
Security Configurable password protection
Advanced Event Management Triggeied by motion, exter nal input or HTTP event, result configurable, external output,
FTP/SMTP upload and local recording
Networking TCP/IP, HTTP, DHCP, DNS, NTP, FTP, SMTP and RSTP
Privacy 10 configurable privacy regions
SD Card Built-in SD card slot. Supports cards up to 128 GB capacity. Speed class 10 or higher required.
Audio Connections Audio In through 3.5 mm jack, RTSP using G711 codec or ONVIF S
Analog Video Out Test port for production, not available in normal operation
While Balance Range Auto White Balance (Range = approximately 2500 K - 8000 K)
Video Stream 1 Codec H.264 High, Level 5 / MJPEG (streams configurable) H.264 in 9.6 MP, 6 MP, 4 MR 2 MP
Video Stream 1 Compression Level Multi-levels of compression and frame rate adjustment
Fisheyes at: 9.6 MP (3200 x 3000),
Fisheyesat; 4 MP (2144 x 1944), 2 MP (1488 x 1360), 6 MP (2528 x 2376), 4 MP (2080 x 1960),
Video Stream 1 Pixel Resolution
1 MP (1056 x 960), Vt MP (528 x 480) 2 MP (1472x1384)
Video Stream 2 Codec H.264 High, Level 5 / MJPEG (streams configurable) H.264 in 4 MP, 2 MP, 1 MP and MP
Video Stream 2 Compression Level Multi-levels of compression and frame rate adjustment
Fisheyes at: 4 MP (2144 x 1944), 2 MP (1488 x 1360), . Fisheyes at: 4 MP (2080 x 1960), 2 MP {1472 x 1384
Video Stream 2 Pixel Resolution
1 MP (1056 x 960), Vi MP (528 x 480) 1 MP (1056 x 992), % MP (544 x 512)
Video Stream 3 Codec MJPEG MJPEG in 4 MP, 2 MP, 1 MP and Id MP
Video Stream 3 Compression Level Multi-levels of compression andframerateadjustment
Fisheyes at: 2 MP (1472 x 1384), 1 MP (1056 x 992)
Video Stream 3 Pixel Resolution Fisheye at: % MP (528 x 480) Vi MP (544x512)
" VCam Stream 4,5, 6, 7 Codec N/A . . TL264 :

" VCam Stream 4,5,6, 7 Multi-levels of compression and
N/A frame rate adjustment
Compression Level
* VCam Stream 4, 5, 8, 7 . 4xindependenthoard'dewarpedVCamsat
N/A 1 MP (1280 x 720), VS MP (640 x 480)
P'rxe! Resolution
Maximum Frame Rate 30 fps
Settings: brightness / contrast / saturation / exposure compensation,
Image Control compression' quality and wall / ceiling / table mount'
image Enhancement Electronic WDR 60dB

10x zoom with Oncam 3D client-side dewarping software
PTZ Functionality
Contact Oncam Sales for the supported VMS / NVR list
VMS / NVR Support
Web Browser Compatibility Internet Explorer 9, Edge 25, Firefox 23 and Chrome 29 or above. Plug-in required for full functionality
Unicast Up to 20 simultaneous users depending on the resolution settings
Multicast Supported for H.264 main camera stream

Options include Variable Bit Rate Controls, Options include Constant Bit Rate Control and
Bit Rate Control
Constant Bit Rate Control and Constant Quality Control Constant Quality Control
* Video Stream 2 and VCarns cannot beused simultaneously.
Mctil'h.UlM ]'>\W- LI (
i'lr.
2.1mm PC Irprrtjsck
(>p>M Pho-i:ii-: ioresrtariii I/O
BNG!o; test vioeo output
Network Cable Type CAT5 01 better lot 10OBase-TX CAT5 or bettei for 10OOBase-TX
Power Input 12 VDC, 1.0 A (mrn) LPS or NEC Class 2 power supply or
Power over Ethernet (PoE), IEEE standard 802.3af
Power Consumption (maximum) 4,05 W (PoE 48 VDC) / 3.19 W (DC 12 VDC) 3.4 W (PoE 48 VDC) 17.32 W (DC 12 VDC)
Camera Mount Surface or Pendant mount

Weight Surface 5.68 kg (12.52 lbs) 5.64 kg (12.43 lbs)
Pendant 6.30 kg (13.89 lbs) 6.34 kg (13.97 lbs)
Dimensions Surface 183 x 161 x 122 mm (7.2 x 6.3 x 4.8 in.)
(LxWxH) Pendant 195 x 161 x 146 mm (7.7 x 6.3 x 5.7 in.)
Housing Material Etectropoltshed marine grade 316 stainless steel with polymer bubble
Operating temperature range -40to+55C (-40 to+131 "F)

Ingress Protection 1P69K
Impact Resistant* IK10
IEEE802.3af, CE, AS/NZS CISPR 22:2009+A1:2010, CISPR 24:2010 (Class A),

FCC, ICES-003, KCC, CU, RCM, SASO, UL 60950-1 (ed.2) and
CAN/CSA C22.2 No. 60950-1-07, RoHS, REACH, IP69K, IK10
Spectra Pendant Mount

IDM4012SS
(Not Included)
Surface Mount
2 0 1 6 , 2017 Oncam Global Group AG. All rights reserved.

Oncam Grandeye is the trade name of Oncam Global Group AG. Specifications and configurations subject to change without notice.
Pelco by Schneider Electric | 3500 Pelco Way, Clovis, California 93612-5699 United States | U S A & C a n a d a Tel (800) 2 8 9 - 9 1 0 0 Fax ( 0 0 0 ) 2 8 9 - 9 1 5 0
International T e l + 1 (559) 292-1981 F a x + 1 ( 5 5 9 ) 3 4 8 - 1 1 2 0 | VAW/.pelco.com | www.pelco.com/community
.I'M,-.,,,, | . I I.
1
'^^l M M Iii ':-:.- Wiliiiiiii: h'K'Inii-r"', w h i f i - i-nI--Xî-::i=fi-".I'l
UP TO 3 MPX, H.264, IP CAMERAS WITH WDR AND LOW-LIGHT PERFORMANCE
SureVision" 2.0
SureVision 2.0 Technology, Including:

- True Wide Dynamic Range (WDR)
- Advanced Low-Light Performance
- Anti-Bloom Technology
- 3D Noise Filtering
- Enhanced Tone Mapping
Up to 3 Megapixel (MPx) Resolution
Up to 30 Images per Second (ips) at 3 MPx
Autofocus Varifocal 3 - 9 mm and 9 - 22 mm MPx Lenses
Power over Ethernet (PoE), IEEE 802.3af Compatible willi Pelco and Third-Party Video Systems
Built-in Pelco Analytics Suite - ONVIF Profile S and Profile G Conformant
Local Storage (Micro SD) 3-Year Warranty and Support
S a r i x E n h a n c e d R a n g e w i t h S u r e V i s i o n 2.0 Video
Sarix Enhanced (E) range cameras f e a t u r e SureVision The IME Series supports two independently-configurable video
technology, delivering high definition (HD) resolution, consistent streams in addition to a service video stream. The streams can be
color science, fast processing power, and simultaneous advanced compressed in MJPEG and H.264 formats across several resolution
l o w - l i g h t performance w i t h w i d e dynamic range (WDR) and configurations. The IME Series offers real-time video (30 ips) with
anti-bloom technologies. New advancements include 3D noise full HD resolution (up to 3 MPx) using H.264 compression for
filtering, smooth response to illumination changes, and improved optimized bandwidth and storage efficiency.
tone mapping to retain color accuracy and overall image contrast.
The streams can be configured to a variety of frame rates, bit rates,
Designed to install quickly, the cameras include autofocus, motorized and group of pictures (GOP) structures for additional flexibility in
zoom, built-in analytics, and other advanced features needed for bandwidth administration. In addition, streams can be encoded as
demanding security applications. constrained variable bit rate (CVBR), constrained bit rate (CBR), or
variable bit rate (VBR).
Camera
The IME Series contains an integrated varifocal 3 ~ 9 mm or Open and Integrated
9 - 22 mm MPx autofocus lens. All models include a camera in a Sarix Enhanced range cameras seamlessly connect to Pelco video
compact in-ceiling, surface mount, or pendant enclosure that is ready management systems such as Endura version 2.0 (or later), and
to install. The vandal-resistant and environmental models feature a Digital Sentry version 7.3 (or later). Sarix Enhanced range
sturdy metal design that is both vandal- and tamper-resistant. The cameras integrate w i t h major third-party video management
environmental model features worry-free use in a wide range of systems through the Pelco API, and other third-party software and
environmental operating conditions. All in-ceiling models have a systems through the ONVIF Profile S and Profile G standards.
back box that is plenum rated per 2008 NEC article 300.22(C)(2).
Built-in Analytics
Sarix Enhanced range cameras include four unique, advanced Pelco Analytics enhance the flexibility and performance of Sarix
autofocus options: temperature change (every 10c / 18F|, day/night Enhanced range cameras. Eight Pelco behaviors are preloaded and
transition, a daily autofocus routine, and manual autofocus. These included as standard features. Pelco behaviors can be configured
benefits ensure clear, focused images regardless of the scene or and enabled using a standard Web browser, and they are compatible
environment. All autofocus options are available through the web Ul. w i t h Endura or a third-party system that supports alarms using
Pelco's API.
n v i F Ifsterratkiaal Standard5 I S
Otgafiiiatkn Registered Firm;
ISO9O0I QuaGtySystEra
mm
r. { j r i n r o
CW42/REVISE01-19-1G
by Schneider E l e c t r i c
M.-.ll'liinii I...i I 1 "
Pelco analytics behaviors can be scheduled to work during a certain

Sarix Enhancer] range cameras are designed w i t h Power over time or condition. For example, during the day, a camera can be
Ethernet (PoE) to reduce costs and simplify planning, wiring, and configured with Object Counting to count the number of people that
installation. PoE functionality works w i t h PoE-enabled network enter a lobby door. At night, the operator can change the profile to
switches or power injectors, eliminating the need for separate power Camera Sabotage to trigger an alarm if a camera is moved or
supplies and cabling, and increasing camera fail safety through an obstructed. Available Pelco behaviois include:
uninterruptable power supply (UPS). Abandoned Object: Detects objects placed within a defined zone and
triggers an alarm if the object remains in the zone longer titan tire
PELCO A N A L Y T I C S user-defined time allows. An airport terminal is a typical installation for
this behavior. This behavior can also detect objects left behind at an
Sarix Enhanced range cameras includes eight user-configurable
ATM, signaling possible card skimming.
behaviors. The camera is capable of running up to two behaviors at
Adaptive Motion Detection: Detects and tracks objects that enter a
the same time; although, the number of behaviors is limited to the scene and then triggers an alaim when the objects enter a user-defined
available processing power of the camera and the type of analytic zone. This behavior is primarily used in outdoor environments with light
being used. traffic to leduce the number of false alarms caused by environmental
changes.
Note: Available processing power is determined by the settings for Camera Sabotage: Detects contrast changes in the field of view. An
compression standards, resolution, image rate, bit rate, and analytic alarm is triggered if the lens is obstructed by spray paint, a cloth, or a
configuration. lens cap. Any unauthorized repositioning of the camera also triggers an
alarm.
For each behavior, you can create several custom profiles that Directional Motion: Generates an alarm in a high traffic area when a
contain different camera settings. With these profiles, you can set up person or object moves in a specified direction. Typical Installations for
different scenarios for the behavior, which will automatically detect this behavior include an airport gate or tunnel where cameras can detect
objects moving in the opposite direction of the normal flow of traffic or an
and trigger alarms when specific activity is detected. individual entering through an exit door.
Pelco analytics are configured and enabled using a standard Web Loitering Detection: Identifies when people or vehicles remain in a
browser, and Pelco behavior alarms are compatible with Endura or a defined zone longer than the user-defined time allows. This behavior is
effective in real-time notification of suspicious behavior around ATMs,
third-party system that supports Pelco's API system. stairwells, and school grounds.
Ob|ect Counting: Counts the number of objects that enter a defined
zone. This behavior can be used to count the number of people at a store
entrance/exit or inside a store where the traffic is light. This behavior is
based on tracking and does not count people in a crowded setting.
Object Removal: Triggers an alarm if an object is removed from a
user-defined zone. This behavior is ideal for customers who want to
detect the removal of high value objects, such as a painting from a wall or
a statue from a pedestal.
Stopped Vehicle: Detects vehicles stopped near a sensitive area longer
than the user-defined time allows. This behavior is ideal for airport
curbside drop-offs, parking enforcement, suspicious parking, traffic lane
breakdowns, and vehicles waiting at gates.
VALUES IN PARENTHESES ARE INCHES; ALL OTHERS ARE CENTIMETERS.
(!)
Indoor, In-Ceiling
Single Back Box for Suspended or Hard Ceiling Applications
617 Requires 8.26 cm (3.25 in.) Space Above Ceiling
424 U47)
Minimum Ceiling Thickness 0.64 cm (0.25 in.); Maximum Ceiling Thickness
(1JB7)
4.45 cm (1.75 in.)
11.78
|4.B) 3/4 in. NPT or 25 mm Conduit Attachments on Side and Top of Back Box
Microphone
Plenum Rated Back Box
1650 |S.50|
Alodlne Aluminum Construction
kl.18I3.22H
White Back Box is Standard; Black is Available
Indoor, Surface Mount

Attaches to Single-Gang Electrical Box
Microphone
Polycarbonate/ABS Constitution
J4A0_
(5.67)
Indoor, Pendant
Microphone
11.94
(4.71)
3/4 In. NPT or 25 mm Conduit/Pipe Attachment
Polycatbonate/ABS Construction
. 8.18
(332) "
Environmental/Vandal-Resistant, In-Ceiling
Single Back Box for Suspended or Hard Ceiling Applications
Requires 8.26 cm (3.25 in.) Space Above Ceiling
IM Minimum Celling Thickness 0.97 cm (0.38 in,); Maximum Ceiling Thickness
(253) , 5.B4 3.81 cm |1.50 in.)
J(U2) 3/4 in. NPT or 25 mm Conduit Attachments on Side and Top of Back Box
Microphone on Vandal-Resistant Models
1254
(4.94| Vandal-Resistant Model Meets IP56
Environmental Model Meets IP66 and NEMA Type 4X
-19.18(755)- NEMA TS-2 (Temp.) para 2.2.7.3 - 2.2.7.7
)--9.78(3.85)-H Meets IK10++(50J)
Plenum Rated Back Box
Alodine Aluminum Construction
Light Gray Finish
Environmental/Vandal-Resistant, Surface Mount
-15.80(6.22) - Attaches to Standard 4 in. Square Outlet Box and Standard 2-Gang
u 11.74
(4*2|
Electrical Box
3/4 In. NPT or 25 mm Conduit Attachments on Side and Top of Back Box
Vandal-Resistant Model Meets IP56
o NEMA TS-2 (Temp.) para 2.2.7.3 - 2.2.7.7
<> Meets IK10++(50J)
-9.78(315)- Alodine Aluminum Construction
Light Gray Finish _
Environmental/Vandal-Resistant, Pendant
1-1/2 in. NPT Thread for Use with Pelco Wall Mounts
Vandal-Resistant Model Meets IP56
NEMA TS-2 (Temp.) para 2.2.7.3 - 2.2.7.7
Meets IK10++(50J)
Alodine Aluminum Construction
Light Gray Finish
Mcif'lium lnwj I K 1
'1
Imaging Device 1/3-inch Weight Unit Shipping

Imager Type CMOS Indoor, In-Celling 1.2 kg (2.6 lb) 1.6 kg (3.6 lb]
Imager Readout Progressive scan Indoor, Surface Mount 1.0 kg (2,0 lb) 1.4 kg (3.0 lb!
Indoor, Pendant 1.0 kg (2.1 lb) 1.4 kg (3.1 Ih
Highest Resolution Environmental, In-Celling 1.4 kg (3.1 lb) 1,9 kg (4.1 lb
3 MPx 2048x1536
Environmental, Sudace Mount 1.5 kg (3.3 lb) 2.0 kg (4.3 lb;
2 MPx 1920x1060
Environmental, Pendant 1.3 kg (2.91b) 1.8 kg (3.9 lb;
1 MPx 1280x960
Vandal-Resistant, In-Ceiling 1.4 kg (3.1 lb) 1.9 kg (4.1 lb]
0.5 MPx 800x608
Vandal-Resistant, Surface Mount 1.5 kg (3.3 lb) 2.0 kg (4.3 lb]
Signal-to-Noise Ratio >60dB Vandal-Resistant, Pendant 1.3 kg (2.9 lb) 1.8 kg (3.9 lb]
Electronic Shutter Range 0.5- 1/48,000 sec Product Box Dimensions (approximate) 22.2x32.9x 17.6 cm
True Wide Dynamic Range UptolOOdB* (8.7G" D x 12.94' W x 6.94" H)
White Balance Range 2,000 to 10,000K
Sensitivity 3 ~ 9 mm f/1.2; 2,850K; SNR>20dB NVIROfMMENTAL
Color (33 ms) 0.1 lux Operating Temperature
Color (500 ms) 0.005 lux Indoor/Vandal-Resistant -10 to 50C (14 to 122F)'
Mono (33 ms) 0.05 lux Environmental -40 to 50C (-40 to 122F)'
Mono (500 ms) 0.0013 lux 74C (165.2F) absolute maximum ambient
Sensitivity 9 - 2 2 mm f/1.6;2,850K; SNR>20dB temperature per NEMA TS-2
Color (33 ms) 0.4 lux
0.009 lux 'Thermostatically controlled active heating and cooling elements aie
Color (500 ms) used to achieve operating temperature range. A blower (fan) is used
Mono (33 ms) 0.09 lux
0.002 lux to achieve operating temperatures to 50C (122F). Active heating
Mono (500 ms| elements are used to achieve operating temperatutes below
Yes -10C(14F).
Day/Night Capabilities
Yes, (ON/OFF/AUTO selectable), with
Mechanical IR Cut Filter different set points on lux Cold Start
Indoor/Vandal-Resistant -10C (14F|
"Sensor level is not inclusive of SureVision image processing, -20C H F ]
Environmental o o o
Storage Temperature -10 to60C(14 to140 F)

LENS
Operating Humidity
Lens Type Built-in; varifocal 20 to 80%, RH noncondensing
Indoor/Vandal-Resistant
Focal Length f/1.2,3-9 mm, orf/1.6.9- 22 mm 10 to 95%, RH condensing
Environmental
Focus Autofocus, motorized 20 to 80%, RH noncondensing
Storage Humidity
Zoom Remote IK10++ (50J| per IEC 62262 (environmental/
Impact Resistance vandal-resistant models)
Auto Iris Type DC drive P-iris lens
Field of View in Degrees Shock and Vibration EN50155 Category 1, Class B; IEC 60068:2-6
and 2-27 (environmental/vandal-resistant
Focal models)
Lens Mode Diagonal Horizontal Vertical
Length
Wide 4:3 105 84 63 ELECTRICAL
38 30 23 Network Port RJ-45 connector for 10OBase-TX
Tele 4:3 Auto MDI/MOI-X
3 - 9 mm
Wide 16:9 97 84 47 Accessory Port Micro B USB connector for Pelco accessories
Tele 16:9 35 30 17 Cable Type Cats or better for 100Base-TX
30 23 Input Power PoE (IEEE 802.3af, Class 3)
Wide 4:3 38
Power Consumption' 8.5 W nominal
Tele 4:3 15 12 8.9 350 mA maximum
9 - 2 2 mm Cunent Consumption
Wide 16:9 35 30 17 Local Storage Micro SD, SDHC (see manual for details)
Tele 16:9 14 12 6.6 Alarm
Unsupervised Detects open or closed alarm state
AUDIO Supervised Detects open and short alarm state with
external 1-kohm resistor
Streaming Bidirectional: full or half duplex Input 3.5 VDC maximum, 3,5 mA maximum
Input/Output Line level/external microphone input; Relay Output 32 VDC maximum, 150 mA maximum
600-ohm differential, 1 Vp-p max. signal level;
built-in microphone (indoor and Does not include optional accessories connected to aaessory port.
vandal-resistant models)
Compression G.711 PCM 8 bit, 8 kHz mono at 64 kbit/s NETWORK
Supported Protocols TCP/IP, UDP/IP (Unicast, Multicast IGMPj,
MECHANICAL UPnP, DNS, DHCP, RTP, RTSP, NTP, IPv4, IPv6,
SNMPv2c/v3, QoS, HTTP, HTTPS, LDAP
Dome Attenuation (client), SSH, SSL, SMTP, FTP, ARP, ICMP, and
Clear f/0.0 light loss
802.1x(EAP)
Smoked 171.0 light loss
Users
Pan/Tilt Adjustment Manual Unicast Up to 20 simultaneous users depending on
Pan 355 the resolution settings
Tilt 180 Multicast Unlimited users H.264
Rotation 360
Security Access Password protected
Software Interface Web biowser view and setup
MeiiPli.nni limii L U . |'):')
Video Streams Multiple simultaneous streams with up to Pelco System Integration Endura 2.0 (or later)
2 different configurations plus service Digital Sentry 7.3 (or later)
stream; the secondary stream is variable DX4700/DX480O
based on the setup of the primary stream Open API Pelco API or ONVIF Profile S and Profile G
Available Resolutions Two configurable streams as follows: Mobile Application Integrated with Pelco Mobile Application
Max
Aspect
Camera Model MPx Mbps Width Height Ratio
CVBB Multilingual menus in user interface: English, French, Italian, German,
Spanish, Portuguese, Russian, Chinese, Turkish
3 MPx 3.0 9.2 2048 1536 4:3
16 window blanks, configurable in size
2 MPx 1.9 5.7 1600 1200 4:3 Password protection
3.8 1280 960 4:3 Snapshot with JPEG capture at 2016 x 1523 resolution
1 MPx 1.2
Text overlays for camera name, time, date
0.5 0.5 2 800 608 4:3
MPx CERTIFICATIONS/RATINGS
0.3 1.6 640 480 4:3
0.08 0.5 320 240 4:3 CE, Class A
FCC, Class A
3 MPx and 2 MPx 1080p 6 1920 1080 16:9 ICES-003, Class A
1 MPx 720p 2.9 1280 720 16:9 UL/cUL Listed
KCC
0.5 0.5 1.7 800 448 16:9 C-Tick
MPx 16:9 CB
0.2 1.2 640 352
Meets NEMA Type 4X, IP66 rating (Environmental!,
0.06 0.4 320 176 16:9 and IP56 (Vandal-Resistant)
Note: Default mbps values ate based on High profile (30 ips; default IP GOP NEMA TS-2 (Temp.) para 2.2.7.3 - 2.2.7.7
length). Compliant with applicable immunity sections of EN 50155, EN 50121-3-2,
Frame Rate Up to 30,25,15,12.5,10, 5,1 (depending on and EN 50121-4
the coding, resolution, and stream ONVIF Profile S and Piofile G Conformant
configuration)
Video Encoding H.264 High, Main, or Base profiles; and
MJPEG
Bit Rate Control Constrained variable bit rate (CVBR), WMVE-SR Wall mounL light gray; for use with
constant bit rate (CBR), and variable bit rate environmental and vandal-resistant pendant
(VBR) with target range mount options
Service Stream JPEG stream; the aspect ratio will be WMVE-SW Wall mount, white; for use with indoor
consistent with the independent streams pendant mount options
PA101 Pole adapter for use with WMVE-SR wall
M I N I M U M SYSTEM REQUIREMENTS mount
IMEP-VCM Indoor comer mount
Processor Intel Core" i3 processor, 2.4 GHz
Operating System Microsoft Windows 7 (32- and 64-bit), or O P T I O N A L ACCESSORIES
Window Vista; or Mac OS X 10.4 (or later)
Memory 4 GB RAM IPCT01 Pelco IP camera tester"
Network Interface 100 megabits (or greater) ALM-1 External alarm accessory
Monitor Minimum of 1024 x 768 resolution, POE20U560G Single port PoE injector
16- or 32-bit pixel color resolution IMELLD1-0I Lower dome assembly, smoked, in-ceiling,
Web Browser* Internet Explorer 7.0 (or later) or Mozilla white
Firefox 3.5 (or later); Internet Explorer 8.0 (or IMELLD1-0BI Lower dome assembly, smoked, in-ceiling,
later) is recommended for configuring black
analytics IMELD1-0S Lower dome assembly, smoked, surface
Media Player' Pelco Media Player or QuickTime 7.6.5 for mount/pendant, white
Windows 7, XP, or Vista; or QuickTime 7.6.4 IMELD1-0BS Lower dome assembly, smoked, surface
for Mac OS X 10.4 (or later) mount/pendant, black
* Internet Explorer is not supported by Mac OS X10.4. IMELD1-0V Lower dome (bubble only), smoked,
'This product is not compatible with QuickTime version 7.6.4 for environmental/vandal-resistant
Windows XP or Windows Vista. If you have this version installed on your IMELD1-1V Lower dome (bubble only), clear,
PC, you will need to upgrade to QuickTime version 7.6.5. environmental/vandal-resistant
' Contact Pelco Product Support for more information about the use of
ANALYTICS the Pelco IP camera tester with cameras.
Required Systems for Pelco Analytics
Pelco Interface WS5200 Advanced System Management
Software on an Endura 2.0 (or later) system
Open API The Pelco API can transmit behavior alarm
data to third-party applications, available at
pdn.peko.com
4
Mfil*li.in 11 ( *fi
Type Lens Mount Color Resolution Model

0.5 MPx IMES19-1I
\Alhitn 1 MPx(720p) IME119-II
In-Ceiling wnue 2MPx(1080p) IME219-1I
3MPx(1080p) IME319-1I
Black 3MPx(1080p) IME319-B1I
0.5 MPx IMES19-1S
1 MPx(720p) IME119-1S
White
Indoor 3 - 9 mm Focal Range Suiface Mount 2MPx(1080p) IME219-1S
3MPx(1080p) IME319-1S
Black 3MPx(1080p) IME319-B1S
0.5 MPx IMES19-1P
1 MPx(720p) IME119-1P
White
Pendant 2MPx(1080p) IME219-1P
3MPx(1080p) IME319-1P
Black 3MPx(1080p) IME319-B1P
0.5 MPx IMES19-1EI
1 MPx(720p) IME119-1EI
In-Ceiling IME219-1EI
2MPx(1080p)
3MPx(1080p) IME319-1EI
0.5 MPx IMES19-1ES
1 MPx(720p) IME119-1ES
Environmental 3 - 9 mm Focal Range Surface Mount Light Gray
2MPx(1080p) IME219-1ES
3MPx(1080p) IME319-1ES
0.5 MPx IMES19-1EP
1 MPx(720p) IME119-1EP
Pendant IME219-1EP
2MPx(1080p)
3MPx(1080p| IME319-1EP
0.5 MPx IMES19-1VI'
1MPx(720p) IME119-1VI'
In-Ceiling
2MPx(1080p) IME219-1VI'
3MPx(1080p) IME319-1VP
0.5 MPx IMES19-1VS'
1MPx(720p) IME119-1VS'
Vandal-Resistant 3 - 9 mm Focal Range Surface Mount Light Gray
2 MPx(IOBOp) IME219-1VS'
3MPx(1080p) IME319-1VS'
0.5 MPx IMES19-1VP'
1
1 MPx(720p) IME119-1VP
Pendant
2MPx(1080p) IME219-1VP'
3MPx(1080p) IME319-1VP'
White IME3122-1I
In-Ceiling IME3122-B1I
Black
White IME3122-1S
Indoor 9 ~ 22 mm Focal Range Surface Mount
Black IME3122-BIS
White IME3122-1P
Pendant
Black IME3122-B1P
3MPxl10R0nl
In-Ceiling IME3122-1EI
Environmental 9 - 2 2 mm Focal Range Suiface Mount IME3122-1ES
Pendant IME3122-1EP
t inht firav
In-Ceiling Liyi ii uiay IME3122-1VP
Vandal-Resistant 9 ~ 22 mm Focal Range Surface Mount IME3122-1VS'
Pendant IME3122-1VP'
*AII environmental models are vandal resistant.
'This vandal-resistant model Is for indoor use only.
Pelco, lire Pelco logo, and other trademarks associated with Pelco products referred
Pelco by Schneider Electric to In this publication ae tiademarte ol Pelco, Inc. or Its affiliates. ONVIF and the
3600 Pelco Way, Clovis, California 93612-5699 Onited States ONVIF logo are tiademarte of ONVIF Inc. Another product names and
USA & Canada Tel (800)289-9100 Fax (800) 289-9150 services are the property ol their respective companies.
International Tel+1 (559)292-1981 Fax+1 (559)348-1120 Product speclllcallons and avallablllly are subject to change without notice,
Copyright 2015, Pelco, Inc. All lights reserved.
www.pelco.com www.pelco.com/community
{
,\U-:vU'i;;.iili JuvVH. 5 J A j >1
Sarix IMP Indoor and Environmental Mini Domes

UP TO 5 MEGAPIXEL, H.264, IR, DAY/NIGHT IP DOMES
* Up to 5 megapixel (MPx) resolution

Up to 30 images per second (ips) at 3 MPx
Autofocus motorized remote zoom lens
< Integrated adaptive IR illumination (environmental IR models)
* Operating temperature upto55C(13rF)
* Up to 64 GB edge stotage with Micro SD card
* Motion detection and camera sabotage detection
* Power over Ethernet (PoE+) Class 4, 24 VAC (environmental models),
PoE, Class 3,24 VAC, 12 VDC (indoor models)
" Pelco Smart Compression Technology
* All models vandal resistant to IK10
* Compatible with Pelco and third-party video systems
ONVIF Profile S, Profile G, and Profile Q conformant
* Full 3-year warranty and support
Sarix Professional Range Edge Storage

Sarix Professional range cameras feature onboard edge storage
Powerful, versatile, and affordable, the Sarix Professional (P)
range cameras pack the most popular features and functionality of with a micro SD card. Video clips of varying lengths can be stored to
Sarix technology into a wide range of indoor and outdoor options, the card upon alarm, or video can be written continuously to the
including bullet cameras and mini domes. There are also indoor-only SD card in the case of network outage. Video can be retrieved from
options such as a vandal resistant wedge and micro dome. Mix and the card through the FTP protocol or by using an ONVIF Profile G
match the perfonnance options and form factor you need for almost enabled client.
any lighting condition, environment, and application.
Sarix Professional range cameras feature a simple motion
Ca sner a detection algorithm that allows the camera to record or send an
Within the Sarix Professional range, the Sarix IMP Series mini alarm when there is motion detected in a selected zone or within the
dome cameras feature a remote zoom lens for wide angle or long entire scene. A camera sabotage alarm is triggered if the lens is
range surveillance needs. Autofocus capability ensures the camera obstructed or when the camera is repositioned.
can be automatically refocused when needed. Additionally, the
Sarix IMP Series features advanced color science and a Open and Integrated
mechanical IR cut filter for increased sensitivity in low-light Sarix Professional range cameras seamlessly connect to Pelco
installations. video management systems such as VideoXpert"", Endura version
2.0 (or later), and Digital Sentry version 7.3 (or later). Sarix
Video Professional range cameras integrate w i t h major third-party
Sarix Professional range cameras support up to two simultaneous systems through the open Pelco API or the ONVIF Profile S, Profile G,
video streams and a third service stream. The two streams can be and Profile Q standards.
compressed with efficient H.264 High or Main profiles or MJPEG
formats. The streams can be configured to a variety of frame rates Standard W e b interface
and variable bit rates to optimize image quality with bandwidth and Pelco cameras use a standard Web browser interface for easy
storage efficiency. remote setup and administration. Controls are optimized for
convenient one-step camera configuration for features including
color, exposure, flicker control, and streaming.
)r | \ / | P I toratoul Swhtk 5P<

1
ISO SOOI QuaEty System I.CLkXII'"
, . . , . G402I/REVISED8-31-17
by Schneider Electric
l
Mo.H'1,'Jin II t s
bubble
bubble
IMPICM-11 AND IMPICM-1ER IN-CEIUNG MOUNT IMPPM-11 AND IMPPM-1ER PENDANT ADAPTER
I LBS I I
tLA
IMPPMB-ll WALL MOUNT BRACKET

Mi'dPhiiiiii iov Li t ! 9')
Imaging Device MPx Sensor Maximum Resolution

5 MPx 1/1.8-inch 2592x1944 (5.0 MPx)
3 MPx 1/2.8-inch 2048x1536(3.1 MPx)
2 MPx 1/2.8-inch 1920x1080(2.1 MPx)
1 MPx 1/3-inch 1280x960 (1.3 MPx)
Imager Type CMOS

Imager Readout Progressive scan
Electtonic Shutter Range 1/5-1/30,000 sec (1 and 5 MPx),
1/6-1/25,000 sec (2 MPx),
1/5-1/45,000 sec (3 MPx)
Wide Dynamic Range 75 dB, 90 dB (Backlight Compensation On)
White Balance Range 2,000 to 10,000K
3D Noise Reduction Yes (ON/OFF selectable)
Minimum Illumination Color Mono

MPx Sensitivity Mono(IRon)
33 ms 200 ms 33 ms 2O0ms
5 MPx f/1.2 0.30 lux 0.03 lux 0.01 lux 0.002 lux 0.00 lux
Mechanical IR Cut Filter Yes (AUTO/MANUAt selectable), with different set points on lux
IR Illumination Adaptive IR up to 25 m; auto ON in night mode, or off
Signal to Noise Ratio >50dB
LENS
Lens Type Built-in; varifocal
Focal Length f/1.4,3-10.5 mm
Focus Autofocus, motorized
Zoom Remote
DC drive lens
Auto Iris Type
Angle of IMPx 2 MPx 3 MPx 5 MPx
Lens
View
Field of View*
Diagonal 110- 33 116-35 115-34 110-46
3 to 10.5 mm Horizontal 85~27 100- 31 88~30 88- 37
Vertical 62- 19 54- 17 52-16 64~ 27
"Field of view may vary with changes in resolution settings.
U ^ P V i i " ! rmv. T I C ion
Video Streams Up to 2 simultaneous streams, plus service stream; the secondaiy stream is variable based on the setup of tire pi iraaiy stream
Video Overlay Camera name, time, date, and customizable text with multiple supported languages
Available Resolutions MPx Width Height Aspect Ratio

5.0 2592 1944 4:3
3.1 2048 1536 4:3
2.1 1920 1080 16:9
1.2 1280 960 4:3
0.9 1280 720 16:9
0.5 800 600 4:3
0.3 640 480 4:3
0.1 320 240 4:3
0.1 320 180 16:9
Frame Rates MPx Images per Second (ips)

5 MPx 15,12.5,10,7.5,5,3,2,1
3 MPx 30,25,20,16.67,15,12.5,10,7.5,5,3,2,1
2 MPx 30,25,20,16.67,15,12.5,10,7.5,5,3,2,1
1 MPx 30,25,20,16.67,15,12,5,10,7.5,5,3,2,1
Note: Available frame rates are selectable for each independent stream depending on the coding, resolution, and stream
configuration.
Video Encoding H.264 High or Main profiles; and MJPEG
Bit Rate Control Constant bit tate (CBR), constrained variable bit tate (CVBR) with configuiable maximum value
Corridor Mode Electronic image flip and mirror: 180, 90 and 270 (H.264 only)
Service Stream 640x480 or 640 x 352; 2 ips, JPEG
Window Blanking 8 configurable windows
PELCO'S S M A R T C O M P R E S S I O N T E C H N O L O G Y
Pelco's Smart Compression Technology lowers bandwidth and storage
requirements by up to 70%. Our technology allows the user to make
Intelligent decisions regarding storage savings and Image quality.
Pelco's Smart Compression Technology dynamically analyzes motion

occurring within live video in real-time, to Intelligently compress the
information you don't need, while retaining details with clear quality in tlie
areas that are important in the scene. By enabling Dynamic GOP, an added
feature of Smart Compression, the number of l-fiames are automatically
reduced in scenes with low motion. Based on the complexity of scenes and
motion occurring, such as a store room that has limited entry and exit, up to
70% bandwidth savings can be achieved.
AUDIO
Streaming Bi-directional
Input Line in and out
Encoding G.711 A-law/G.711 U-law
\ie.1Ph.-n-n) low;' I ).f | UK
RJ-45 connector for 100Base-TX Supported Protocols TCP/IP, UDP/IP (unicast, multicast IGMP),
Network Port ICMP, IPv4, IPv6, SNMPv2c/v3, HTTP, HHPS,
Power Input PoEr Class 4 or 24 VAC (Environmental),
SSL, SSH, SMTP, FTP, RTSP, UPnP, DNS, NTP,
PoE Class 3,24 VAC nominal, 18 to 32 VAC RTP, RTCP, LDAP (client), QoS, GB28181
range, 12 VDC (Indoor)
Users
Power Consumption Unicast 1 administrator, up to 4 viewers
Indoor <6W
Multicast Unlimited usets H.264
Outdoot <16W(with heater ring) Multiple user access levels with password
Security Access
Local Storage Up to 64 GB on Micro SDHC or SOXC card protection
Alarm
Input
Output 1; PhotoMOS relay (30 V, 1 A)
Triggers Unsupervised mode that detects switch Video Management VideoXpert;
closures (N.O, and N.C.) Endura 2.0 (or later);
Digital Sentry 7.3 (or later);
Third-party VMS through Pelco API, ONVIF
Profile S, Profile G, and Profile Q
Operating Temperature
Outdoor 0 0
- 4 0 to55C(-40 to131F)" Mobile Application Pelco Mobile
Indoor o o
-10to55 C(14 to131F) Analytics Simple motion detection and camera
74C (165.2F) absolute maximum ambient sabotage detection
temperature per NEMA TS-2 (Environmental Local Storage Capture 1-,5-or 10-second video clips on
models only). camera sabotage, motion detection, or alarm
Stotage Temperature -40 to 60C (-40 to 140F) input; record video continuously in the case of
network outage with option to ovetwrite;
Operating Humidity 5% to 90%, RH noncondensing access video through FTP protocol and ONVIF
Thermostatically controlled heating provides ramped heating control Profile G
between the initial heatet on at 15 C|59F)and full heating mode at
Camera Discovery
-40C |-40F], Discover cameras upgrade firmware upgrade
and Firmware
using the Pelco Device Utility 2 version 2.2 or
GENERAL later; or Pelco Utilities
Construction Aluminum body and trim ring (environmental); Web Browser Support Microsoft Internet Explorer 9.0, Apple
plastic body and trim ring (indoor); Safari 7.0.6, Mozilla* Firefox 31.0,
8
polycarbonate bubble (indoor and Google Chrome" 37.0.2062.124 m and later
environmental) Multilingual Uset Interface English, French, German, Italian, Portuguese,
Finish Arabic, Russian, Spanish, Turkish, Korean,
Indoor White, RAL 9003 Simplified Chinese
Outdoor RAL 7047
Pan/Tilt Adjustment Manual
Pan 370
Tilt 90
Rotate 355
IndootOutdoor
Unit Weight.80 kg (1.76 lb)1.40 kg (3.09 lb)
Shipping Weight 1.20 kg (2.66 lb) 1.80 kg (3.97 lb)
Exhibit B
^ ' t f r V 7' Sf"'"- -

I i l l i f I N I
1 I -1E:Ê P R E W ^
A R! IE U N D F ^
CONSTANT VIDEO
SURVEILLANCE
Part C , Subpart 3c.
Exhibit A
MedPhann Iowa, L L C J104
I ' I 1
www.bosclisecuiity.com
I n v e n t e d f o r life
Fully integrated intrusion, fire, and access control

allows users to interface with one system instead of
three
Provides up to 599 points using a combination of

hardwired or wireless devices for installation
flexibility, and up to 32 areas and 32 doors for up to
2,000 users
On-board Ethernet port f o r Conettix IP alarm

communication and remote programming,
compatible with modern IP networks including IPv6/
IPv4, Auto-IP, and Universal Plug and Play
Installer-friendly features for simple installation and

communications, including on-board USB for easy
on-site RPS programming, plus support f o r Remote
Connect Service (not available in Europe, the Middle
East, or Africa), and plug-in PSTN and cellular
communication modules f o r simple installation and
communications
Remote Security Control (RSC) app which allows

users to control their security systems - and view
system cameras - remotely f r o m mobile devices
such as phones and tablets
The B9512G Control Panel and the B8512Q Control For users, programmable keypad shortcuts, situation
Panel are the new premier commercial control panels sensitive on screen help, and a bilingual user interface
f r o m Bosch. B9512G control panels integrate make system operation simple and easy.
intrusion, fire, and access control providing one simple With the B9512Q Control Panel, you can:
user interface for all systems. Monitor alarm points for intruder, gas, or fire alarms.
Program all system functions local or remote using
With the ability to adapt to large and small
Remote Programming Software (RPS) or by using
applications, the B9512G provides up to 599
basic programming through the keypad.
individually identified points that can be split into 32
Add up to 32 doors of access control using the
areas. optional B901 Access Control Module. Optionally use
The control panel can communicate through its built-in the D9210C Access Control Interface Module for up
Ethernet port (not applicable to "E" control panels), or to eight of the 32 doors.
through compatible plug-in modules that can send The B9512G is a direct replacement for previous
events over the public switched telephone network control panel models D9412GV4, D9412GV3,
(PSTN) or over cellular network communications.
D9412GV2, and D9412G.
opening doors. A standard system user must have a

passcode, a credential (token or card), and
Programmable o u t p u t s appropriate command authority permissions.
Four alarm-output patterns
Door c o n t r o l
Programmable bell test
Using the B901 Access Control Module or D9210C
Point response Access Control Interface Module, the control panel
Selectable point response time provides a fully supervised access control solution.
Selectable EOL values and configuration The solution offers 14 programmable levels of access
Cross point capability authority. Authority for door access is controlled by
Fire alarm verification the user level, the group of the user, the t i m e of day,
Dangerous gas indicator includes carbon monoxide the door state, and the area armed (On/Off) state.
(NFPA720)
Watch mode Easy exit control
63 point indexes The control panel changes f r o m one On (armed) state
to another w i t h o u t turning o f f (disarming) the system.
User interface
For example, if you change the state f r o m Part On
Supervision of up to 32 keypads
(Perimeter Arm) to All On (Master Arm), the control
Custom keypad text is fully programmable through
panel complies and reports the change. Easy Exit
RPS
Control reduces the number of keystrokes, simplifying
Full function menu including customizable shortcuts
system operation.
Authority by area and 32 character name for each
user Programmable passcode-controlled menu list
14 custom authority levels to restrict system features Passcode-controlled shortcuts provide users only w i t h
that each user can access the options and information pertinent to t h e m ,
Programmable primary and secondary language by simplifying system operation.
user and keypad; select from English, Spanish,
French, and Portuguese Flexible control
The system provides the flexibility to choose added
Area configurations
convenience or high security. For example, you can
Link multiple areas to a shared area such as a lobby or
restrict to a keypad's immediate local area turning on
common entryway. The shared area then automatically
(arming) and turning o f f (disarming) the system w i t h a
turns On (arms) when all associate areas are armed
passcode, even if the user has access to other areas.
and turns Off (disarms) when any one associate area
This is particularly useful for high security areas,
is disarmed. For higher security applications, the Area
where a user may have access to the area, but would
Re-Arm feature guarantees that areas are always
prefer to only turn off (disarm) the area individually
rearmed, and are disarmed f o r no longer than a
rather than with the rest of the system.
specific, configurable, amount of time (for example,
service time). Monitor Delay/Delayed Response
Create a special point index that delays the reaction of
Custom functions
a point f o r a specified time (up t o 1 hour in minutes
For added convenience, the installer can program
and seconds). This delay provides time f o r the
custom functions that allow customers to complete
specified condition to reset before activating any
complex tasks w i t h one simple action. For example, a
annunciation. The system can annunciate locally and
custom function can bypass a group of points and arm
send a report, if desired. When the system is armed,
the system, allowing the user to perform these
the point can respond like a normal point - providing
functions with one easy command. Users can activate
dual functionality. Use this feature to ensure that
custom functions w i t h a keypad, keyfob, token, or
perimeter doors have not been propped open, or to
card, or the control panel can activate a f u n c t i o n in
monitor critical areas such as computer rooms and
reaction to a faulted point, or automatically through a
safes, f o r example.
scheduled event (SKED).
System users
Passcode security
The system supports up to 2,000 users. Each user can
Two-man rule. Requires two people with two unique
passcodes to be present at the time of opening. have a personalized passcode, a wireless keyfob, and a
Early ambush. Allows users to verify that the facility is credential to control the system. You can assign
safe by requiring two passcodes. The control panel passcodes to one of 14 customized authority levels in
sends a duress event if the user does not enter the each area that can be restricted to operate only during
passcode a second time after inspecting the certain times. You can program a primary and
premises. secondary language for each user and by keypad
Dual authentication. Requires two forms of (select f r o m English, Spanish, French, and
identification before processing certain system Portuguese). The keypad changes to the user's
commands, including turning off the system and programmed language when the user enters his
passcode or holds the Help key.
Communication formats Bosch Remote Connect (Cloud)

The control panel prioritizes and sends reports to four Remote Connect simplifies connections f r o m RPS, and
the Remote Security Control app, using Bosch Cloud
route groups. Network and phone communications can
services. This service creates a secure connection to
use one of t w o communication formats: Modem4,
the control panel w i t h o u t specific router settings or
Contact ID. Each group has a programmable primary
the need for a static IP address or DNS.
and backup destination.
The control panel provides flexible communications f o r
most central stations w i t h reporting capabilities such | Notice
as: The Bosch Remote Connect service is not
Individual point numbers available In Europe, the Middle East, or Africa.
Opening or closing reports by user and area number
Remote programming attempts Firmware updates
Diagnostic reports The system allows remote firmware updates:
Control panel updates. Remotely update the control
| Notice panel firmware for easy feature enhancements
For premises equipment used in the without replacing ROM chips.
communication path, such as routers, use only UL Module update support. Remotely update the
listed equipment. firmware on connected SDI2 modules for easy feature
enhancements without visiting each individual
IP communication module.
The control panel can use IP to communicate w i t h a Firmware updates occur through Remote Programming
Conettix D6600 or a Conettix D6100IPv6 Software (RPS) and the RPS Firmware Update Wizard.
Communications Receiver/Gateway. Use one of the The Firmware Update Wizard uses the on-board USB
following f o r IP: connection or the on board Ethernet (IP) connection
The on board Ethernet connection (the on board (the on board Ethernet port is excluded on "E"
Ethernet port is excluded on "E" versions). versions) to transfer firmware updates.
AB426. The control panel can optionally receive f i r m w a r e
A plug-in cellular communicator (B440/B440-C/B441/ updates f r o m RPS. Use one of the following
B441-C/B442/B443/B444). communication methods:
Conettix IP communication provides a secure path that B426
includes anti-replay/anti-substitution features, and Plug-in cellular communicator: B440/B440-C/B441/
enhanced security w i t h up to AES 256-bit encryption B441-C/B442/B443/B444
(using Cipher Block Chaining (CBC)).
The control panel supports Domain Name System ~-~ Notice
(DNS) f o r both remote programming and central Data rate apply
station communication. DNS provides ease of use, Cellular firmware updates require more time than
eliminating the need to use static IP addresses as your Ethernet updates and carrier data rates apply.
reporting destination, and accommodates a simple
solution f o r central station disaster recovery. The A wide variety of input options
control panel supports both IPv6 and IPv4 networks. Each point:
Single 1 kO, single 2 k n , dual 1 kO (1 kO + 1 kO), and
Communication paths No EOL (end-of-line) (EOL) resistor options (for on-
The control panel accommodates up to four separate board and B208 Inputs)
phone and four separate network paths to the central Programmable for Fire, Intrusion, Access, Gas, and
station receiver. When resetting alarms or turning a Supervisory devices
system on and o f f , the user is identified by name and Supports hardwired and wireless devices
number. Supports IP cameras by Bosch as point and output
Personal notification devices
The control panel can send text messages and emails IP camera support
for personal notification over Ethernet or using a The control panel can integrate directly w i t h Bosch IP
cellular communicator. You can configure up to 32 cameras, using them as fully supervised points and
destinations using a combination of cellular phone outputs.
numbers and email addresses. The control panel sends Integration of cameras allows the camera's video
notifications in the user's programmed primary motion detection to activate points on the control
language. panel. The control panel's virtual outputs can be
configured to trigger camera actions, including
sending video snapshots via email.
Security and fire detection Remote Security Control app

The control panel provides eight on board points, and The Remote Security Control (RSC) app allows users
up to 591 additional off-board points (depending on to control their security systems remotely f r o m their
model and expansion interfaces). You can program devices. Users can:
individual points to monitor some types of burglar Turn their security system On or Off
Turn specific areas On or Off
alarms, fire alarms, and supervision devices.
Control outputs for applications such as lighting
Event log control
The event log stores up to 10192 local and reported View live video from Bosch IP cameras
events. The event log includes time, date, event, area, Grant access remotely by unlocking and locking doors
point, and user. View the event log f r o m a keypad or The app requires the installing dealer to create a
use RPS to remotely retrieve event information. When Remote Access Profile for users, and to install the
the event log reaches a programmed threshold of profile on their devices.
stored events, it can send an optional report to a Bosch Video Management System integration
receiver. With Bosch Video Management System (Bosch VMS)
Scheduled events (SKEDs) and an intrusion system, the VMS operator has a single
The internal clock and calendar start individually user interface to monitor and control the intrusion
scheduled events (SKEDs). SKEDs perform several system combined w i t h video surveillance. With Bosch
functions such as turn on or off, relay control, or point VMS and a control panel, the operator can, f o r
bypassing. example:
The control panel offers: View videos triggered by intrusion events, including
80 scheduled events with up to 31 different functions all relevant information such as areas, point, and user
32 opening windows and 32 closing windows show in the display with the event.
32 user group windows View areas, points, outputs, and doors - with their
Day-of-week, date-of-month, or holiday only schedules statuses - on the Bosch VMS map, providing the
8 holiday schedules of 366 days (leap year) exact location in the system.
Turn on (arm) and turn off (disarm) areas.
Dual bus and SDI keypad r e t r o f i t s
Bypass and unbypass points.
The dual SDI2 device bus design provides greater
Lock and unlock doors (Bosch VMS 6.0 and higher).
installation flexibility, such as bus isolation f o r
Requirements to integrate Bosch VMS with a control
Intrusion and Fire. To use popular SDI keypads (for
panel:
example D1255 and D1260), program one of the t w o
A licensed Bosch VMS system using Professional
SDI2 buses for SDI operation.
Editions v5.5 or higher or Bosch VMS Enterprise
ZONEX and POPEX retrofits Edition v5.5 or higher.
To retrofit legacy Bosch control panels that use ZONEX Expansion license to integrate the intrusion control
and POPEX devices, the control panel is compatible panel. One license needed per control panel. Order
w i t h the B600 Retrofit (ZONEX) Module. The B600 number MBX-XINT-xx for the expansion license added
adds t w o ZONEX buses to the control panel which can to a Bosch VMS base license. Refer to the Bosch
connect to existing legacy point bus (POPEX) devices Video Management Software product page on the
(for example, the D8125). Bosch website, www.boschsecurity.com.
Access to Remote Programming Software (RPS).
Programming
Installers can perform limited programming on-site
w i t h a keypad (critical parameters; such as account
Region Regulatory compliance/quality marks
IDs, central station and RPS IP addresses and phone
numbers, reporting formats, and more). They can also USA ANSI- CP-01-2010-Control Panel Standard -
do full programming on-site or remotely (attended or SIA Features for False Alarm Reduction
unattended) w i t h RPS. A programmable system [B9512G]
Australia RCM
passcode prevents unauthorized remote programming.
RCM [B8512G]
Diagnostics
Keypads and RPS o f f e r diagnostic help f o r monitoring RCM ACMA
and troubleshooting. The diagnostics features allow Europe CE EMC, LVD, RoHS [B9512G. B9512G-E,
you to view the status of the wired and wireless BB512G, B8512G-E]
devices. The features provide the status of the control
USA UL [B9512G, B9512G-E, B8512G,
panel and its connected devices, such as firmware B8512G-E, B299, B600, B901. B925F,
version, power, and missing conditions. View the B926F]
status of each area. UL UL 294 - Standard for Access Control
Units and Systems
Region BegulMtory compliipee/nyality. marks

UL UL 365 - Police Station Connected Bui
glai Alarm Units n n Notice
Not all products and features are available in all
UL UL 609 - Standard for Local Burglar regions. Consult your local Bosch representative
Alarm Units and Systems
for availability details.
UL UL 636 - Holdup Alarm Units and Sys-
tems
Compatible products
UL UL 864 - Standard for Control Units and
Accessories for Fire Alarm Systems Keypads
UL UL 985 - Household Fire Warning Sys- B942/B942W Touch Screen Keypad (SDI2)
tem Units
B930 ATM Style Alphanumeric Keypad (SDI2)
UL UL 1023 - Household Burglar Alarm Sys-
tem Units B926F Fire Keypad (SDI2)
UL UL 1076 - Proprietary Burglar Alarm B925F Fire Keypad (SDI2)
Units and Systems
UL UL 1610 - Central Station Burglar Alarm B921C Two-line Capacltive Keypad (SDI2)
Units
B920 Two-line Alphanumeric Keypad (SDI2)
UL UL 1635 - Standard for Digital Alarm
Communicator System Units B915/B915I Basic Keypad (SDI2)
FM Central Station D1255 Series Keypads
FM Local Protective Signaling D1260 Series Keypads
FM Remote Station D1256RB Fire Keypad

CSFM California State Fire Marshal (see our D1257RB Remote Fire Alarm Annunciator
website)
FCC Part 15 Class B Power

FDNY- Fire Department of New York City D164016.5 VAC 40 VA Transformer
CoA [B9512G.B9512G-E.B8512G,
B8512G-E] DE-45-18Transformer
Canada ULC [B9512G,B9512G-E,B8512G, D126 Standby Battery (12 V, 7 Ah)

B8512G-E, B299, B600, B901, B925F,
B926F] D1218 Battery (12 V, 18 Ah)
ULC CAN/ULC S303 - Local Burglar Alar m D122Dual Battery Harness
Units and Systems
ULC CAN/ULC S304 - Standard for Signal Re- D122L Dual Battery Harness with Long Leads
ceiving Center and Premise Burglar
Alarm Enclosures
ULC CAN/ULC S545 - Residential Fire Warn- B8103 Universal Enclosure (White)
ing System Control Units
ULC CAN/ULC S559 - Fire Signal Receiving D8103 Universal Enclosure (Gray)
Centres and Systems
D8108A Attack Resistant Enclosure
ULC ULC-ORD C1023 - Household Burglar
Alarm System Units D8108A-CE Attack Resistant Enclosure with Built-in Transformer
ULC ULC-ORD C1076-Proprietary Burglar D8109 Fire Enclosure

Alarm Units and Systems
IC ICES-003-Information Technology Accessories
Equipment (ITE)
B56 Keypad Surface Mount Box
Brazil ANATEL 04450-16-01855 [B9512G, B8512G
when used with B430 or B442] B96 Keypad Trim Bezel
B99 USB Direct Connect Cable
B501-10 Interconnect wiring cables (pack of 10)
D161 Dual Modular Telephone Cord (7 f)

B442 Conettix Plug-in Cellular Communicator (using GPRS)

D162 Modular Telephone Cord (2 ft)
D166 Telephone Jack (RJ31X) B443 Conettix Plug-in Cellular Communicator (using HSPA+)
B450 Conettix Plug-in Communicator Interface

Detectors
B520 Auxiliary Power Supply Module
D705O Series Addressable Photoelectric Smoke and Smoke Heat
Detector Heads B600 Retrofit (ZONEX) Module
F220-B6PM/S 12/24 VDC Addressable Detector Bases with POPITs B810 wireless receiver (RADION)
F2 20-B6 12/24 VDC Two-wire Base B820 SDI2 Inovonics Interface Module
F220-B6R Standard 12/24 VDC Four-wire Base) B901 Access Control Module
F2 20-P Photoelectric Smoke Detector D113 Battery Lead Supervision Module
F220-PTH Photoelectric Smoke Detector with +135F (+57C) Heat D125B Dual Class B Initiating Module
Sensor D126 Standby Battery (12 V, 7 Ah)
F220-PTH Photoelectric Smoke Detector with + 1 3 5 T (+57C) Heat
D129 Class A Initiating Module
Sensor and Carbon Monoxide Sensors
D130 Auxiliary Relay Module
F220-B6C 12/24 VDC Four-wire Base with Auxiliary Form C Relay
D132A Smoke Detector Reversing Relay Module
FCC-380 Carbon Monoxide Detector
D133 Single Relay Module
FCH-T320 Heat Detector
D134 Dual Relay Module
FCP-OT320 Multisensor Detector Optical/Thermal
D185 Reverse Polarity Signaling Module
FCP-0320 Optical Smoke Detector
D192G Class "B", Style Y Bell Circuit Supervision
MX775i Addressable PIR Detector
D1218 Battery (12 V, 18 Ah)
MX794i Long Range Multiplex PIR Detector
D8125 Addressable Expansion Module
D8125MUX Multiplex Bus Interface
D8128D OctoPOPIT Eight-point Expander
ZX776Z PIR Detector
D8129 Octo-relay Module
ZX794Z Long Range PIR Detector
D8130 Door Release Module
ZX835 TriTech Microwave/PIR Detector
D9127U/TPOPIT Module
ZX935Z PIR Detector
DS7461i Single-zone Input Module
ZX938Z PIR Detector
DS7465i Input-output Module
ZX970 PIR/Microwave Detector
D9210C Access Control Interface Module
Bosch conventional detectors, including Professional Series, Blue Line
Gen2, Blue Line, Classic Line, Commercial Line, and Ceiling Mount ICP-EZTS Cover and Wall Tamper Switch
motion detectors, as well as glass break, seismic, request-to-exit,
photoelectric, heat, and smoke detectors. ICP-SDI-9114 SDI Splitter
Modules Applications
Remote Programming Software (RPS or RPS-LITE) v6.03 and higher
B208 Octo-input Module
B299 POPEX Module Bosch Video Management System v5.5 and higher
B308 Octo-output Module Remote Security Control (RSC)
B426 Conettix Ethernet Communication Module Conettix receivers

B430 Plug-in Telephone Communicator (Managed and configured with Conettix D6200 Programming/
Administration Software v2.10)
B440 Conettix Plug-in Cellular Communicator (using 3G)
Conettix D6600 Communications Receiver/Gateway (with only D6641
B441 Conettix Plug-in Cellular Communicator (using CDMA) line cards installed) with CPU version 01.10.00
Conettix D6100IPv6 Communications Receiver/Gateway with CPU EN1247 Glass-break Detector Transmitter
version 61.10.00
EN1249 Bill Trap Transmitter
Conettix D6100i Communications Receiver/Gateway with CPU version
EN1242 Smoke Detector Transmitter
61.10.00
EN1260 Wall Mount Motion Detector
RADION wireless from Bosch
EN1261HT High Traffic Motion Detector
B810 wireless receiver (RADION)
EN1262 Motion Detector with Pet Immunity
RFBT-A/RFBT bill trap
EN1265 360 Ceiling Mount Motion Detector
RFDL-ll-A/RFDL-11 TriTech motion detector
EN4200 Serial Receiver
RFDW-RM-A/RFDW-RM recessed mount door/window contact
EN5040-T High Power Repeater with Transformer
RFDW-SM-A/RFDW-SM surface mount door/window contact
RFGB-A/RFGB glass break detector

Properties
RFKF-A/RFKF two-button keyfob
Dimensions 10.625 in x 7.75in x 1.875 in (26.99 x
RFKF-FBS-A/RFKF-FBS four-button keyfob
1 9 . 6 9 x 4 . 7 6 cm)
RFKF-TBS-A/RFKF-TBS two-button keyfob
Weight 1.95 lbs (0.88 kg)
RFPB-SB-A/ RFPB-SB single-button panic
Communications
RFPB-TB-A/RFPB-TB two-button panic
Ethernet 10/100 full duplex (N/A for "E" control
RFRP-A/RFRP repeater panels)
RFSM-A/RFSM smoke detector
Environmental considerations
RFPR-12-A/RFPR-12 PIR motion detector
Relative humidity 5% to 93% at +32C (+90F)
RFPR-C12-A/RFPR-C12 PIR curtain motion detector
0 0
Temperature (operating) 0 C t o + 4 9 C ( + 3 2 F t o + 120F)

RFUN-A/RFUN universal transmitter
Power requirements
Inovonics Wireless
Current (maximum) Standby: 180 mA
B820 SDI2 Inovonics Interface Module Alarm: 260 mA
ENKIT-SDI2 SDI2 Inovonics Interface and Receiver Kit. Includes B820 2 A at 12 VDC
Output (alarm)
and EN4200
Output (auxiliary, 1.4 A at 12 VDC nominal
EN1210UniversalTransmitter (Single-input)
continuous power, and
EN1210EOL Universal Transmitter with EOL Resistor switched auxiliary
combined)
EN1210W Door-Window Transmitter with Reed Switch
Voltage (operating) 12 VDC nominal
EN1215EOL Universal Transmitter with Wall Tamper, Reed Switch, and
EOL Resistor Voltage (AC) 16.5 VAC 40 VA plug-in transformer
(D1640/D1640-CA)
EN1223D Water-resistant Pendant Transmitter (Double-button)
EN1223S Water-resistant Pendant Transmitter (Single-button) Wiring
EN1224-ON Multiple-Condition Pendant Transmitter Terminal wire size 12 AWG to 22 AWG (2.0 mm to 0.65
mm)
EN1233D Necklace Pendant Transmitter (Double-button)
SDI2 wiring Maximum distance - Wire size
EN1233S Necklace Pendant Transmitter (Single-button) (unshielded wire only): 7,500 f t
(2,286 m ) - 22 AWG (0.65 mm)
EN1235D Beltclip Pendant Transmitter (Double-button)
EN1235DF Fixed-location Transmitter (Double-button) Number of...
EN1235S Beltclip Pendant Transmitter (Single-button) Areas 32
EN1235SF Fixed-location Transmitter (Single-button) Custom functions 32

Keypads 32 keypads, including 16 SDI keypads D12.2L Dual battery harness, 35", 12V
Harness with circuit breaker and leads measuring
Events Up to 10,192 35 in. (89 cm). Connects t w o batteries (in parallel) to
a compatible control panel in a separate enclosure.
Passcode users 2000, plus 1 Installer passcode
Order number D 1 2 2 L
Points 599 (8 on board, up to 591 off-board
and virtual) D126 Battery, 12V 7Ah
A rechargeable sealed lead-acid power supply used as
Programmable outputs 599 (3 on board, up to 596 off-board a secondary power supply or in auxiliary or ancillary
and virtual) functions.
Order number D 1 2 6
RF points 504
D1218 Battery, 12V 18Ah
IP cameras 16
The D1218 is a 12 V 18 Ah sealed lead-acid battery
SKEDs 80 w i t h t w o bolt-fastened terminals. It is used f o r standby
and auxiliary power. It connects to a compatible
control panel using a D122 or D122L Dual battery
harness.
B9512G IP control panel, 32 areas, 599 points Order number D 1 2 1 8
Supports up to 599 points, 3 on-board outputs, and 32
areas f o r intrusion, commercial fire. On-board D1238 BATTERY, 12V 38 AH
A 12 V sealed lead-acid battery for standby and
Ethernet.
auxiliary power with two bolt-fastened terminals.
Order number B 9 5 1 2 G
Includes hardware for attaching battery leads or spade
B9512G-E Control panel 32 areas 599 points, no IP connectors.
The B9512G-E is available only in kits. Order number D 1 2 3 8
Order number B 9 5 1 2 G - E
D137 Accessory mounting bracket for enclosure
B901 Door Controller Used to mount accessory modules in B8103, D8103,
Fully supervised, addressable SDI2/SDI bus device D8108A, and D8109 enclosures.
that allows access control integration f o r Bosch G and Order number D 1 3 7
B Series Control Panels.
Order number B 9 0 1 D1640 Transformer plug-in, 16V 40VA
System transformer rated at 16.5 VAC, 40 VA.
D1640-CA 16VAC 40VA xfmr Canada Order number D 1 6 4 0
For use in Canada. System transformer rated at
D9002-5 Mounting plate, 6 location 3-hole, 5 pes
16.5 VAC, 40 VA.
5 pack of mounting skirts f o r B8103, D8103, D8108A,
Order number D 1 6 4 0 - C A
and D8109 enclosures. Each skirt can hold up to six
Accessories standard 3-hole mounting modules.
B520 Auxiliary power supply module, 2A 12V Order number D 9 0 0 2 - 5
Provides auxiliary power to 12 VDC devices or to SDI2
modules. D101 Enclosure lock and key set
Order number B 5 2 0 Short-body lock set with one key supplied. Uses the
D102 (#1358) replacement key.
B208 SDI2 8-lnput Expansion Module Order number D 1 0 1
Provides 8 programmable inputs.
Order number B 2 0 8 DUO TAMPER SWITCH 2/PKG
Screw-on tamper switch that fits all enclosures.
B308 SDI2 8-Output Expansion Module Shipped in packages of t w o .
Provides 8 programmable relays. Order number D U O
Order number B 3 0 8
ICP-EZTS TAMPER SWITCH-DUAL
B810 RECEIVER-SDI2 Combination tamper switch w i t h a wire loop f o r
Receives RF signals f r o m RADION transmitters, additional tamper outputs.
repeaters, and glassbreaks. Operates at 433.42 MHz. Order number I C P - E Z T S
For use w i t h compatible SDI2 bus control panels.
Order number B 8 1 0 B8103 Universal enclosure, white
White steel enclosure measuring 4 1 cm x 4 1 cm x 9 cm
D122 Dual battery harness, 17" 18AWG (16 in. x 16 in. x 3.5 in.).
Harness w i t h circuit breaker. Connects t w o batteries Order number B 8 1 0 3
(in parallel) to a compatible control panel.
Order number D 1 2 2
D8103 Steel enclosure, large, grey B930 ATM Style-Alpha Numeric Keypad (SD12)
Grey steel enclosure measuring 4 1 cm x 4 1 cm x 9 cm Five-line ATM style alphanumeric keypad
(16 in. x 16 in. x 3.5 in.). Order number B 9 3 0
Order number D 8 1 0 3 B942 Touch Screen KP Prox/lnput/Output, black
D8108A Attack resistant enclosure, large, grey Black SDI2 touch screen keypad w i t h inputs and one
Grey steel enclosure measuring 4 1 cm x 4 1 cm x 9 cm output.
(16 in. x 16 in. x 3.5 in.). UL Listed. Includes a lock and Order number B 9 4 2
key set. B942W Touch screen KP, prox/input/output,white
Order number D 8 1 0 8 A
White SDI2 touch screen keypad with inputs and one
D8109 Fire enclosure, 16x16x3.5", red output.
Red enclosure measuring 16 in. x 16 in. x 3.5 in. Order number B 9 4 2 W
(41 cm x 4 1 cm x 9 cm). Made f r o m 16 gauge (1.5 mm)
B925F Fire and intrusion keypad, SDI2
cold-rolled steel with a full-length hinge. Includes a
Two-line alphanumeric fire and intrusion keypad.
lock and key set. UL Listed f o r commercial fire/
Order number B 9 2 5 F
burglary alarm applications.
Order number D 8 1 0 9 B926F Fire keypad, SDI2
Two-line alphanumeric fire keypad
D8004 Transformer enclosure kit, grey
Order number B 9 2 6 F
For applications that might require a remote
transformer in an enclosure. Can be used with B Software Options
Series control panels and D9412GV4/D7412GV4 D5500C-USB Kit with DVD and USB security dongle
control panels. Account management and control panel programming
Order number D 8 0 0 4 software with USB security key (dongle).
Order number D 5 5 0 0 C - U S B
BATB-40 Battery box/enclosure, 22x20.75x7.25"
Holds t w o dry or wet cell batteries. Optional BATB-
SHELF battery shelf increases number of batteries.
Suitable f o r residential/commercial fire or burglary
applications.
Order number B A T B - 4 0
BATB-80 Battery box/enclosure, 14x20.75x7.25"

Battery box/enclosure w i t h shelf holds up to four dry
or w e t cell batteries. Suitable f o r residential/
commercial fire or burglary applications.
Order number B A T B - 8 0
B99 USB direct connect cable

Male A to Male A USB cable f o r local programming of
control panels w i t h on-board USB ports.
Order number B 9 9
B915 Basic Keypad

Two-line alphanumeric basic keypad with English
f u n c t i o n keys.
B915I LCD keypad, icon keys, SDI2

Two-line alphanumeric basic keypad w i t h icon function
keys.
Order number B 9 1 5 I
B920 2 Line Alpha Numeric Keypad (SDI2)

Two-line alphanumeric keypad
B921C Two-line Keypad w/Touch keys, Inputs

Two-line alphanumeric keypad with inputs and
capacitive touch keys in black.
Order number B 9 2 1 C
Represented by:
North America: Asia-Pacific:

Europe, Middle East, Africa: Germany:
Bosch Security Systems, Inc. Robert Bosch (SEA) Pte Ltd, Securily Syste
Bosch Security Systems B.V. Bosch Sicherheitssysteme GmbH
130 Perinton Parkway 11 Bishan Street 21
P.O. Box 80002 Robert-Bosch-Ring 5
Fairport, New York, 14450, USA Singapore 573943
5600 JB Eindhoven, The Netherlands 85630 Grasbrunn
Phone: +1 800 289 0096 Phone: +65 G571 2808
Phone:+ 31 40 2577 284 Germany
Fax: +1 585 223 9180 Fax: +65 65712699
emea.securitysystems@bosch.com VAVw.boschsecurity.com
onlinehelp@us.bosch.com apr.securitysy5tems@b0sch.com
efnea.bo5chsecurity.com vwAV.boschsecurity.asia
VA'Av.bosch security, us
Bosch Security Systems 2017 | Data subject to change without notice

13825787531|en,V23, 22. Aug 2017
www.boschsecui ily.com
ii)
Enhanced signal processing
3 6 0 x 7.5 m (24 f t . ) pattern
Surface/semi-flush mountable
Internal pointability, sealed detector chamber
The ceiling mount, low profile panoramic DS936 PIR Region Certification
Detector uses alternate polarity pulse count. It also
UL UL 639 - Standard for Intrusion Detec-
uses a pointable Fresnel lens t o provide up to 7.5 m tion Units
(24 f t ) of coverage and can be mounted on the
surface, or semi-flush directly to a ceiling or a China CCC 2009031901000548
standard octagonal electrical box.
Enhanced Signal Processing

Field-selectable for standard, intermediate or high.
Test Features
External visible alarm LED. Internal noise voltage test
pins provide precise pattern location and background
disturbance evaluation using a standard analog meter.
Europe DS936 compiles with EN50131-1, Grade 2
Region Certification
Europe CE EMC, LVD, RoHS [DS936]
Russia GOST EAC

Top View
USA UL [DS936]
Broad Coverage: Up to 7.5 m x 3 6 0 (24 f t x 3 6 0 ) .

Provides 3 6 0 coverage pattern. Coverage diameter is
DS936 Low Profile Panoramic PIR Detector
approximately two times the mounting height.
Provides enhanced signal processing, 3 6 0 x 7.5 m (24
4m 0m 4 m f t ) pattern, mounts to surfaces, or mounts semi-flush
Oft" 0 m into a ceiling.
Order number D S 9 3 6
DS936B Low Profile Panoramic PIR Detector

Provides enhanced signal processing, 360 x 7.5 m (24
f t ) pattern, mounts to surfaces, or mounts semi-flush
into a ceiling. Black housing and w h i t e lens.
11 ft 3m
Order number D S 9 3 6 B
13 fl Oft 13ft
DS936-FRA Low Profile Panoramic PIR Detector
Side View For use in France. Provides enhanced signal
Broad Coverage: Up to 7.5 m x 3 6 0 (24 f t x 3 6 0 ) . processing, 3 6 0 x 7.5 m (24 f t ) pattern, mounts to
Provides 3 6 0 coverage pattern. Coverage diameter is surfaces, or mounts semi-flush into a ceiling.
approximately two times the mounting height. Order number D S 9 3 6 - F R A
DS936-CHI Low Profile Panoramic PIR Detector

For use in China. Provides enhanced signal processing,
3 6 0 x 7.5 m (24 f t ) pattern, mounts to surfaces, or
Enclosure design mounts semi-flush into a ceiling.
Order number DS936-CHI
Mater ial High impact ABS plastic enclosure
Accessories
Dimensions 3.05 cm x 11.7 cm (1.2 in. x 4.6 in.) TC600O Test Cord
Test cord f o r connecting a compatible detector's test
Environmental considerations pins to a voltmeter. It is 4.6 m (15 f t . ) long.
Order number T C 6 0 0 0
Temperature (operating) -29C to +49C (-20T to+120F)
For UL Certificated installations, 0C to
+49C(*32rto+120F)
Radio Frequency No alarm or setup on critical frequencies

Interference (RFI) in the range from 26 MHz to 950 MHz at
Immunity 50V/m.
Mounting
Height range 2 m to 3.6 m (7 ft to 12 ft)
Location Surface or semi-flush on ceiling or on standard

10 cm (4 in.) octagonal electrical box
Pattern 15 rotational
portability
Outputs
Alarm Normally-closed reed relay rated at 3.0 W, 125 mA at

28 VDC for resistive loads and protected by a 4.7 0
resistor in the common C leg.
Tamper Normally-closed cover activated tamper switch with

separate terminals. Tamper contacts rated 125 mA at
28 VDC maximum.
Power requirements
Current 20 mA at 12 VDC
Voltage 10 VDC to 15 VDC

Represented by:
Germany: North America: Asia-Pacific:

Europe, Middle East, Africa:
Bosch Sicherheitssysteme GmbH Bosch Security Systems, Inc. Robert Bosch (SEA) Pte Ltd, Security Systems
Bosch Security Systems B.V.
Robert-Bosch-Ring 5 130 Perinton Parkway 11 Bishan Street 21
P.O. Box 80002
85630 Grasbrunn Fairport, New York, 14450, USA Singapore 573943
5600 JB Eindhoven, The Netherlands
Germany Phone: +1 800 289 0096 Phone: +65 6571 2808
Phone:+ 31 40 2577 284
www.boschsecurity.com Fax:+i 585 223 9180 Fax: +65 6571 2699
emea.securitysystems@bosch.com
onltnehelp@us.bosch.com apr.securitysystems@bosch.com
emea.boschsecurity.com
www.boschsecurity.us www.boschsecurity.asia
Bosch Security Systems 2017 | Data subject to change without notice

2628145931 | en, V10, 28. Mar 2017
w w w . boschsecurity.com
Fully adjustable optics for coverage integrity and

customization
Hinged chassis and base plate for easy installation
High efficiency LED and light pipe system for easy

walk testing
First Step processing, or FSP
Each DS9370 Series TriTech PIR/Microwave Motion for the application. Each sensor is processed
Detector model is panoramic and uses several individually and both must agree there is an alarm
patented processing techniques to provide excellent before the alarm relay is activated.
catch performance w i t h f r e e d o m f r o m false alarms. Microwave Signal Processing
Each model can be mounted on ceilings as high as Adaptive processing adjusts to background
7.6 m (25 f t ) . With three separate PIR sections that disturbances. This helps to reduce false alarms while
are fully adjustable, the DS9370 Series provides maintaining catch performance.
coverage integrity at all mounting heights, plus the
ability to customize the coverage for specific areas. Microwave Supervision
Patented fully supervised microwave provides single
technology coverage in the event the microwave
subsystem fails.
Signal Processing
Uses passive infrared and microwave technologies to Test Features
provide an alarm condition when both fields of High efficiency LED and light-pipe system provide
protection are simultaneously activated. Alarm signals walk test indication that is easily viewable from any
angle and at any mounting height.
must meet the signaling requirements of both
Alarm memory feature allows detector to latch the
technologies to activate an alarm.
alarm LED to aid in response.
First Step Processing Remote LED walk-test control allows the LED to be
FSP allows virtually instant response to human targets enabled or disabled using a switched input without
without sacrificing false alarm immunity to other accessing the detector.
sources. By adjusting its sensitivity based upon signal
amplitude, polarity, slope and timing, FSP eliminates
the need f o r the installer to select the sensitivity level
33ft 20ft 7ft 7ft 20ft 33ft

39ft 26ft , 13ft Oft 13ft 26ft 39ft
4m 13ft
Australia DS9370:AUSC-tick
7ft
i I
CCC 2004031901000038 i
China I- -1 I
- i - I-I- -I Oft
12m 8m 4m Om 4m 8m 12m
Europe Complies with EN50131-1, Grade 2 10m 6m 2m 2m 6m 10m
Side View
Region Certification
Mounting Considerations
Australia RCM DS9370 The mounting height range is f r o m 2.4 m to 7.6 m (8 f t
CE EMC, LVD. R&TTE, RoHS [DS9370, to 25 f t ) . The recommended mounting height range is
Europe
DS9371.DS9370-C] f r o m 3.7 m to 7.6 m (12 f t to 25 f t ) . The coverage area
can be set between 9.1 m and 21.3 m (30 f t and 70 f t ) .
EN5013
1 If mounted at 2.4 m (8 f t ) high, the coverage area can
be set between 6.1 m and 12.2 m (20 f t and 40 f t ) . If
Belgium INCERT B-509-0013(DS9370only) mounted at 3 m (10 f t ) high, the coverage area can be
INCERT B-509-0013/b (DS9370 BEL only) set between 6.1 m and 15.2 m (20 f t and 50 f t ) .
These detectors can be mounted directly on the
USA UL DS9370: ANSR: Intrusion Detection ceiling or on a standard 9 cm (3.5 in.) rectangular
Units (UL639), ANSR7: Intrusion Detec-
tion Units Certified for Canada (cULus) electrical box.
DS9370 The maximum range of the detector depends on the
ESV9370 mounting height and the vertical adjustment of the PIR
FCC
coverage pattern. In areas where part of the area
Canada IC 1249A-12073 needs a targeted coverage, the optical modules can be
AFNOR 28002000101A0 adjusted f o r the correct coverage.
France
A masking kit containing t w o 1 2 0 and t w o 9 0 masks
China CCC 2015031901000325 is included to allow masking unwanted areas. Apply
Sweden INTYG 15-473 Alarm Class 1/2, Environmental the masks to the outside of the detector. With the
Class II (Larmklass 1/2 miljoklass II) supplied masks, you can mask 9 0 , 1 2 0 , 1 8 0 , 2 1 0 ,
ANATEL Certificado Anatel 0871-03-1855 2 4 0 , or 3 3 0 .
Brazil
[DS9370&DS9371]
Coverage Information
Singapore IDA LPREQ-S0154-2004 Provides 3 6 0 x 2 1 m (70 f t ) diameter coverage when
the detector is mounted at 3.7 m to 7.6 m (12 f t to
25 f t ) .
Provides 3 6 0 x 15 m (50 f t ) diameter coverage when
33ft 20ft 7ft 7ft 20ft 33ft
39ft 26ft 13ft Oft 13ft 26ft 39ft the detector is mounted at 3 m (10 f t ) . 12 m (40 f t )
12m 39ft when mounted at 2.4 m (8 f t ) .
33ft Pattern consists of 69 zones in 2 1 barriers. Each
10m
barrier is 11 m (35 f t ) long and 1.5 m (5 f t ) wide at
8m 26ft 11 m (35 f t ) . The barriers are grouped into three
l f #
20ft groups of seven barriers each. Each group has vertical
6m
adjustment for customized coverage.
4m 13ft
Copyright
2m 7ft This document is the intellectual property of Bosch
W4- Security Systems, Inc. and is protected by copyright.
Om Oft
All rights reserved.
2m
4m
II 7ft
13ft
Enclosure Design
6m 20ft
Design Modular chassis and hinged mounting
8m 26ft
base design provide easy access to field
10m 33ft setup switches and wiring.
12m 3 9 , 1
Dimensions 8.9 cm x 17.8 cm
12m 8m Am Om ., 4m 8m 12m
(3.5 in. X 7 in.)
10m 6m 2m 2m 6m 10m
Top View Material High impact ABS plastic enclosure

Environmental Considerations
Operating Temperature -40Cto +49C (-40Flo +120T)

For UL Certificated installations, 0C to
+49C(+32Fto +120T)
Radio Frequency No alarm or setup on critical frequencies

Interference (RFI) in the range from 26 MHz to 950 MHz at
Immunity 50V/m.
Mounting
Height Range 3 m to 7.6 m (8 ft to 25 ft) recommended
Location Mounts directly to ceiling or to standard 10.2 cm

{3.5 in.) octagonal electrical box.
Outputs
Alarm Form C reed relay rated at 3.0 W, 125 mA at28 VDC for
resistive loads.
Tamper Cover and ceiling tamper. Normally Closed (with cover in

place) tamper switch. Contacts rated at 28 VDC, 125 mA
maximum.
Power Requirements
Current 19 mA standby, 39 mA in alarm.
Voltage 9 VDC to 15 VDC
DS9370 Panoramic TriTech Ceiling Mount Detector

Provides PIR and microwave, 3 6 0 x 2 1 m (70 f t )
diameter coverage and 2.4 m to 7.6 m (8 f t to 25 f t )
mounting height. 10.525 GHz. White.
Order number D S 9 3 7 0
DS9370-C Panoramic TriTech Ceiling Mount Detector

mounting height. 10.588 GHz. White.
Order number D S 9 3 7 0 - C
DS9370-BEL Panoramic TriTech Ceiling Mount Detector

mounting height. For use in Belgium. 10.525 GHz.
White.
Order number D S 9 3 7 0 - B E L
DS9370-CHI Panoramic TriTech Ceiling Mount Detector

For use in China. Provides first step processing, 3 6 0 x
21 m (70 f t ) diameter coverage, and up to 7.6 m (25
f t ) mounting height. 10.525 GHz. White.
Order number D S 9 3 7 0 - C H I
DS9371 Panoramic TriTech Ceiling Mount Detector

mounting height. 10.525 GHz. Black enclosure and
lenses.
Order number D S 9 3 7 1
S E C T I O N 3 . 0 2 . P A R T C . S U B P A R T 4: A D V E R T I S I N G AND MARKETING
a. Describe planned marketing and advertising activities consistent with proposed
administrative subrale 154.20(1), including templates for manufacturer displays, signs,
website pages, and educational materials.
MedPharm Iowa has designed and planned a number of marketing and advertising
activities consistent with proposed administrative subrale 154.20(1). Although MedPharm Iowa
acknowledges that certain aspects of these activities may be subject to review and approval by the
Department, this section highlights the key points of MedPharm Iowa's planned marketing and
advertising activities.
MedPhann Iowa's finished products w i l l be produced under the brand name " M X " . In
addition, MedPhami Iowa has developed the following specific content:
Manufacturer Displays - MedPharm Iowa has developed a point of sale product
display and a product brochure holder. Examples of these displays are attached
hereto and incoiporated herein as Part C , Subpart 4a, Exhibit A and Part C ,
Subpart 4a, Exhibit B. These items w i l l be provided to each dispensary licensed
by the Department. Please see the "Educational Materials" bullet point below
for more information regarding the proposed content of the product brochures.
Signage - MedPhann Iowa's logo w i l l be displayed in the interior reception

area of the Proposed Facility. A copy of this logo is attached hereto and
incorporated herein as Part C , Subpart 4a, Exhibit C. A l l restricted access areas

w i l l be marked with a sign that states "Do Not Enter - Restricted Access Area
- Access Limited to Authorized Personnel Only", pursuant to proposed
administrative subrule 154.18(2)cY. Signage w i l l be installed at every entrance
to the Proposed Facility that reads in capital letters "THESE PREMISES ARE
UNDER CONSTANT VIDEO SURVEILLANCE", pursuant to administrative
subrule 154.18(3)/:
Website Pages - MedPharm Iowa's website w i l l contain only the information
permitted by proposed administrative subrule 154.20(l)c. A n example of a
screenshot from the website is attached hereto and incorporated herein as Part
C , Subpart 4a, Exhibit D.

Educational Materials - MedPharm Iowa w i l l include product brochures with
its products. These brochures w i l l contain contact information for MedPharm

Iowa and the forms available, as approved by the Department, as well as
information about MedPhami Iowa's manufacturing, formulation, and quality
assurance processes. These brochures w i l l also contain guidance on use of the
specific products, within the guidelines of the proposed administrative subrales.

A n example of certain educational materials is attached hereto and incorporated
herein as Part C , Subpart 4a., Exhibit E.

b. Describe other marketing and advertising activities consistent with proposed
administrative subrule 154.20(2) intended to be conducted in the first year.

In addition to planned marketing and advertising activities consistent with proposed
administrative subrule 154.20(1), MedPharm Iowa has developed a robust plan for other marketing
and advertising activities, subject to approval by the Department consistent with proposed
administrative subrule 154.20(2). Although MedPharm Iowa acknowledges that this plan is subject
to written approval by the Department, this section highlights the key points of MedPhann Iowa's
proposed other marketing and advertising activities.

MedPharm Iowa's other marketing and advertising activities focus on community relations
initiatives and educational opportunities regarding both medical cannabidiol and medical
Cannabis generally, including educational outreach with respect to health issues. These activities
seek to promote the importance of improving the quality of life for those dealing with chronic pain,
cancer, and other debilitating medical conditions, as described in Applicable Law. These efforts
1
also seek to possibly help alleviate the opioid epidemic i n Iowa.
During the first year of operation, MedPharm Iowa intends to engage and educate
community stakeholders, business leaders, and public officials on the components and health
benefits of medical cannabidiol and medical Cannabis, how to effectively manage the use of
medical cannabidiol pursuant to Iowa law, and the economic impact of the medical cannabidiol
program i n Iowa and medical Cannabis generally. To achieve these goals, MedPharm Iowa has
identified two primary groups for educational partnerships and shared learning opportunities:
healthcare group, such as hospitals, clinics, individual medical professionals, and other health
1
David Powell, Rosalie Pacula and Mireille Jacobson. "Do Medical Marijuana Laws Reduce Addictions and Deaths
Related to Pain'Killers?" Rand Corporation (2017) Available at: http://works.bepress.com/david_powell/17/
networks; and public safety officials, such as police departments, firefighters, paramedics, and
other emergency medical personnel.

MedPhann Iowa would engage the above-referenced groups to participate in the following
types of opportunities:
Partnerships with the Iowa Department o f Health and other government
agencies to offer continuing medical education classes and other educational
opportunities for healthcare professionals on the topic of medical cannabidiol,
medical Cannabis, and health;
Partnerships with public safety officials, law enforcement officials and
prosecutors to offer framings on how to increase the expertise and knowledge
regarding the legal and regulatory issues sunounding medical cannabidiol and
medical Cannabis generally.
Participation in events with local law enforcement in communities to raise
awareness for the safe use of medical camiabidiol and medical Cannabis;
Hosting of town hall meetings and events with health care providers, law
enforcement officials, advocacy groups, scientists, experts and cunent and past
patients as panelists to discuss medical cannabidiol and medical Cannabis in
Iowa; and
A community and/or neighborhood campaign that may include adopting a city
park or community garden or conducting donation drives, among other
activities.
Through these types of partnerships and opportunities, MedPharm Iowa w i l l act as a
community partner and supporter in conjunction with the State of Iowa and other relevant industry
players to improve the quality of life for lowans with debilitating medical conditions.
c. Describe how interior displays of medical cannabidiol, signs and other exhibits will be
arranged to prevent viewing from outside the manufacturing facility consistent with
proposed administrative subrule 154.20(3).
MedPharm Iowa's Proposed Facility w i l l have limited exterior windows from which the
public could view the interior of the facility. MedPharm Iowa standard operating procedures also
prohibit interior displays of medical cannabidiol, signs and other exhibits at or near any o f the
entrances or exits from the Proposed Facility.

Exterior windows w i l l exist around the single entrance for both employees and visitors, but
these windows w i l l open only to the interior reception area. The interior reception area w i l l not
contain displays of medical camiabidiol or any other exhibits; signage w i l l be limited to MedPharm
Iowa's logo and applicable security signage, including signage alerting visitors that an escort w i l l
be required at all times.
The meeting/conference room has also been designed with exterior windows, but
MedPhann Iowa's standard operating procedures prohibit any interior displays of medical
cannabidiol, signs and other exhibits from placement in the conference room, subject to certain
exceptions described here. The conference room w i l l be equipped with blackout shades; in the
event interior displays of medical cannabidiol, signs and other exhibits need to be displayed i n this
room temporarily for legitimate business reasons, MedPharm Iowa staff w i l l ensure that the shades
are drawn before any displays are arranged and are only raised after all such displays have been
removed.
The only other exterior windows in the Proposed Facility are the exterior windows on the
north side of the building that open to the grow area. These windows, however, are approximately
eight (8) feet above the exterior grade, and thus they will not permit the public to see into the grow
area.
Part C . Subpart 4a.

Exhibit A
Grown by
MED PHAfiM
Product Display Example

Part C. Subpart 4a.

Exhibit B
Product Brochure Holder Example

Part C. Subpart 4a.

Exhibit C
i H A k M
. O R M U L A T ,NO THE FUTURE OF CANNABjS
U
MISSION
O MedPharm Iowa will lead the industry in developing medicinal cannabis products to improve the human condition and better the
lives of those who suffer from disease.
TO
-S3 Available MX Branded Products
T3
lotion / Cream
-
OS
SoftmtXaosules
Elevated THC THC lOmg / CBD lmg Balanced - THC lOmg / CBD lOmg
Suppositories
&
Elevated T H C - THC lOmg / C B D lmg Elevated CBD THC l m g / CBD lOOmg
-Q Balanced - T H C lOmg / CBD lOmg Balanced - THC lOmg / CBD lOmg
Low T H C - T H C lmg / C B D lOmg Lour THC -THC lmg / CBD lOmg
Elevated C B D T H C l m g / C B D l O O m g B e r a t e d C B D - T H C lmg / CBD lOOmg
U
cc Good Manufacturing Practices

Ph To provide medicinal cannabis type products using current Good Manufacturing Practices (cGMP) that would include pre-
formulation, formulation development, small scale commercial manufacturing, analytical method development and validation,
routine quality control analysis, and stability studies.
Contact us: MedPharm Iowa LLC 1953 East Market Street Des Moines, 1A50317, 515-707-8092, MedPharmlA.gmail.com
N O T I C E : P r o d u c t s h a v e n o t b e e n a n a l y z e d o r a p p r o v e d b y t h e U n i t e d S t a t e s F o o d a n d D r u g A d m i n l s t r a t i o n . T h e r e i s l i m i t e d i n f o r m a t i o n o n t h e s i d e e f f e c t s of
u s i n g t h i s p r o d u c t , a n d t h e r e m a y b e a s s o c i a t e d h e 3 l t h r i s k s a n d m e d i c a t i o n i n t e r a c t i o n s . T h i s p r o d u c t is n o t r e c o m m e n d e d for u s e by p r e g n a n t o r
b r e a s t f e e d i n g w o m e n . K E E P T H I S P R O D U C T O U T O F R E A C H O F C H I L D R E N . T h e m e d i c a l c a n n a b i d i o l is for t h e r a p e u t i c u s e o n l y . U s e o f t h i s p r o d u c t by a p e r s on
other than the patient listed on the label is unlawful a n d may result in the c a n c e l l a t i o n of the patient's medical c a n n a b i d i o l registration c a r d . Return u n u s e d
Part C. Subpart 4a.

Exhibit E
3/;,
'''-''.(I
"'Is,..
Start with One Dose

Start with a low-dose or single serving
product until you know how It will effect
you.
Walt. Go Slow
Everyone's metabolism Is different effects
can take up to 2 hours or longer to take
effect.
Don't Mix
THC should not be mixed with alcohol or
controlled substances
Out of Reach
Keep away from children, pets, or ANYONE
under 21, and store In original packaging.

a>
o
o
a Zl
I I O
(
5'
m
I n I ,;
ft) rt>
{ I
J p
5'
n
o <1> 3
T3
O '-< 3
"C O*
CL
W "
3
,T, X
ui "
73 </> o
c w
CL *
O
o (D * ft)
XJ "1
O 3 fl>
o 51 , -fl
n Ln O
CTj
p c
O
S E C T I O N 3.02, P A R T C , S U B P A R T 5: P A C K A G I N G AND L A B E L I N G
a. Describe planned medical cannabidiol packaging consistent with proposed

MedPhami Iowa's packaging has been designed to comply with proposed administrative
submle 154.21(1). Each container has child-resistant lids and tamper evident seals. None of
MedPhann Iowa's packaging bears a reasonable resemblance to commonly available non-medical
commercial products. Final products w i l l be transported to dispensaries in plain cardboard boxes
that w i l l not depict any logos or other identifying marks. Tamper-evident tape w i l l seal each box,
and a scannable label w i l l be affixed to trace each package. Please see Part C , Subpart 5a., Exhibit
A, attached hereto and incorporated herein, for an example the tamper-evident bulk container.
Each container is dark in color and plain, free of fanciful designs or marketing verbiage,
which should minimize its appeal to children. In addition, the dark coloring helps maximize the
shelf life of each medical cannabidiol product MedPharm Iowa produces. Each packaged medical
cannabidiol product w i l l be labeled in accordance with proposed administrative subrule 154.21(3),
as described below in Section 3.02, Part C , Subpart 5c.
b. Describe the intended medical cannabidiol trade names consistent with proposed

MedPharm Iowa has selected the trade name " M X " for its products, is consistent with
proposed administrative submle 154.21(2). A n example of the stylized trade name is attached
hereto and incorporated herein as Part C , Subpart 5b., Exhibit A. This trade name is not identical
or similar to the name of an existing non-medical cannabidiol product or any unlawful product or
substance, and it does not contain language that suggests using medical cannabidiol for
recreational purposes or for a condition other than a qualifying debilitating medical condition.
The " M " in " M X " stands for "medicinal" and the " X " stands for dose (i.e., "take X dose").
With respect to the logo, the " M " is blue because this color is often associated with depth and
stability, and it symbolizes trust, loyalty, wisdom, confidence, intelligence, faith and truth. Blue is
often considered beneficial to the mind and body. The " X " is green in color; green often is refened
to as the color of life, renewal, nature, and energy, and it is often associated with growth, harmony,
freshness, safety, fertility, and the environment.
c. Describe medical cannabidiol package labeling consistent with proposed administrative
subrule 154.21(3), including a sample label template for each type of product proposed.
MedPhami Iowa has created sample label templates for each type of product that it
proposes to manufacture, which are attached hereto and incorporated herein as Part C , Subpart
5c, Exhibit A. The format described below w i l l be consistent across all of MedPharm Iowa's
products. No label text w i l l be smaller than six (6) point font, and all labels have been designed to
prevent the inclusion of any false or misleading statements regarding health or physical benefits
to the customer.
The front label w i l l contain MedPharm Iowa's logo, identifying it as manufacturer, and the
logo for its trade name, " M X " . The front label w i l l also contain colored bars that describe the form
type (e.g., soft gel, tincture, suppository, or lotion) and the product's chemical composition,
including the THC and cannabidiol milligrams per dose. With respect to soft gels, an image o f the
soft gel is included to depict its size, and with respect to the suppositories, an image o f the
suppository is included to depict its size. The universal warning symbol that w i l l be provided by
the Department pursuant to proposed administrative submle 154.21(3)c/.(9) is also included on the
front of the label.
The back label w i l l contain a manufacturer's statement identifying MedPharm Iowa as
manufacturer and providing its address, along with the date of manufacture, expiration date, and
the lot and product number. It w i l l also include directions for use, including the recommended
dosing (if applicable), and instructions for storage. The back label includes the product fact panel,
an ingredient list in the form prescribed by proposed administrative submle 154.21(3)a.(4), and an
allergen statement. The product fact panel includes levels of THC and cannabidiol, reflected in
milligrams and percentage per does; the serving size and servings per container; and the percentage
of daily nutritional value, i f applicable. Space has also been allotted to accommodate a dispensary
label containing the information described in proposed administrative submle 154.46. Finally, the
notices required by proposed administrative submle 154.21(3)a.(8) and 154.21(3)<7.(10) w i l l be
included on the back label. To the extent more information needs to be included on MedPhann
Iowa's back label, or MedPharm Iowa requires more space on the back label, the label w i l l be
designed as a multi-panel, foldout label to accommodate all necessary information.
The bottom of each label w i l l also include a barcode to allow MedPhami Iowa to trace each
final product.
Bulk Container for Transport to Dispensaries.
NO LOGOS, or I dentifying Marks will be used
IF S E A t
. - * =
Tamper-evident Tape to seal box
Manifest #
RFP Coded label f o r traceability t o
specific ma n ifest #
ebb
Part C , Subpart 5c.

Exhibit A
P R O D U C T : M X - Softgel, 1 0 / 1
SAFETY/ BACK LABEL
COMPONENTS Store in a cool,dry pi ace, away from sunlight
Directions f o r u s a : Take 1 softgel as needed with a meal
Supplement Facts
Servng Size 1 Softgei (333mg)
Serungs Pee Container 30
A m o u n t Per Serving 1 % Daily V a l u e *
Cannabis Oil Blend 333 mg '

10 mg - THC (3% tetrahydrocannabinol)
Reversible Cap
1 mg - C B D (.3% cannabicfio!)
Rule 1 5 4 . 2 1 ( 1 ) a.
"Daily Value rot established
C h i l d - r e s i s t a n t & Elderly
Othor Ingredients: Phosphatidylcholine, Coconut Oil, Caprylic/Capric Trigycerides
Patients - E a s y O p e n
No: Milk, Egg, Fish, Crustacean Shelllish, Tree Nuts, Peanuts, Wheal, Soybeans,
Yeast, Artificial Colors or Flavors
STATE WARNING: This medicalcannabldiol Is D I S P E N S A R Y PATIENT L A B E L

(or therapeutic use only, Use olthls product by
Tracking H
a personotiier than the patient listed on tlie
label Is unlawful and may result in the Date & Time
cancellation of the patient's medial Dispensary Name
Tamper-evident seal can nabldol registration card.Return unused
Address
medical cannabidiol to a dlspensaiyf or
located under the c a p City, I A , Zip
disposal.
This producthasnotbeen analyiedor Patient IDH
approved bytheUnitedStatesl-ood and Drug
Patient N a m e
Adminlstration.Thereis limited informatlonon
the side effects of using this product, and there Patient D O B
may be assodated health risks and medication Patient A d d r e s s
Interactions.] his product Is not recommended
Barcode fortraceability, City, IA, Zip
for use by pregnant or breastfeeding women.
l o c a t e d on bottom of KEEPTHIS PRODUCT OUT OF REACH OF Instructions: See product label
bottle. CHILDREN.
M a n u f a c t u r e d by: Manufacture Date:xx/xx/xxxx

M e d P h a r m Iowa L L C Expiration D a t e : xx/xx/xxxx
1 9 5 3 E. Market St Lot Number. XXXXX
mm D e s Moines IA 5 0 3 1 7 Product H M X S 1 0 1
P R O D U C T : M X - Softgel, 1 0 / 1 0
CONTAINER/ SAFETY/ BACK LABEL
FRONT LABEL COMPONENTS Store Ina cool, dry place, away f r o m sunlight.
Supplement F a c t s
Serving Size 1 S o gel (333mg)
Servnqs Per Container 30
Amount P e r Serving 1 % Dally V a l u e *

Reversible C a p 10 mg C B O (3% cannabidiol) _ . - , .
Rule 1 5 4 . 2 1 ( 1 ) a . 'Daily Value not established
Child-resistant & Elderly Other Ingredients: Phosphatidylcholine, Coconut Oil, Caprylic/capric Trigycerides
Patients-EasyOpen Ho: Milk, Egg, Fish, Crustacean ShellSsh, Tree Nuts, Peanuts, Wheat. Soybeans,
Yeast, Artificial Cdors or Flavors
STATE WARNING: This medicalcannabldiol Is DISPENSARY PATIENT LABEL

for therapeutic us eonly. Use of this product by
Tracking #
a personothfir than the patient listed on the
label Isunlawfuland mayresultlnthe Date & Time
ca nee llatlon of the patient's medical Dispensary Name
Tamper-evident seal cannabidiol registration card.Return unused
Address
medicalcannabldiol to a dispensary for
located under the cap disposal. City, IA, Zip
This product hasnotbeenanalyzedor P a t i e n t IDS
approved bythe United StatesFood and Drug
Patient Name
Ad ml nlslratlon-Therels limltedlnformab'onon
the side effects of using this product,andthere Patient D O B
maybe associated health risks and medication Patient Address
I nte Tactions. This p roduct Is not recommended
B a r c o d e for t r a c e a b l l i t y , City, LA, Z i p
l o c a t e d on b o t t o m of KEEP THIS PRODUCT OUT OF REACH OF I n s t r u c t i o n s : S e e product l a b e l
bottle. ruunRFN
M a n u f a c t u r e d by: Manufacture Date: xx/xx/xxxx
M e d P h a r m I o w a LLC Expiration Date: xx/xx/xxxx
1 9 5 3 E . M a r k e t St Lot N u m b e r : XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product tt M X S 1 0 1 0
/
P R O D U C T : M X - Softgel, 1/10
FRONT LABEL COMPONENTS Store in a cool,dry place, away from sunlight-

Direcliont for una: lake 1 softgel as needed with a meal
Supplement Facts
Serving Size 1 Softgel (333mg)
Sendnqs Per Container 30 "
Amount Per Serving % Dally V a l u e *

1 mo - THC (.3% tetrahydrocannabinol)
Reversible Cap 10 mg CBD (3% cannabidol)
Rule 1 5 4 . 2 1 ( 1 ) a . Daly Value not established
C h i l d - r e s i s t a n t & Elderly Other Ingredients: Phosphatidylcholine. Coconut Oil. Caprylic/CapricTrigycerides
Patients - E a s y O p e n No: Milk, Egg, Fish, Crustacean Shellfish, Tree Nuts, Peanuts, Wheat, Soybeans,
Yeast, Artificial Colors or Flavors
STATE WARNING: This medicalcannabldiol Is D I S P E N S A R Y PATIENT LABEL

for thera peutic use only. Use of this product by
Tracking #
a personother than the patient listed onthe
label Is unlawful and may result In the Date & Time
cancellationof the patient's medical DispensaryName
cannabidiol registration card. Return unused
Tamper-evident seal Address
medical cannabidiol to a dlspensaryfor
l o c a t e d under the c a p disposal. City, IA, Z i p
This producthas not been analyzed or P a t i e n t IDW
approved bythe UnitedStatesFood and Drug
Patient N a m e
Administration. There Is limited Information on
the side effects of using this product,and there Patient D O B
may be associated health risks and medication Patient A d d r e s s
I nte ractlons. Thisproduct Is not recommended
Barcode fortraceability, City, IA, Zip
l o c a t e d on b o t t o m of KEEP THIS PRODUCT OUT OF REACH OF I n s t r u c t i o n s : S e e product l a b e l
bottle. CHILDREN.

M e d P h a m i Iowa L L C Expiration D a t e : xx/xx/xxxx
1 9 5 3 E. Market St Lot Number: XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product M X S 1 1 0
PRODUCT: MX - Tincture, 10/1

BACK LABEL
SAFETY/
Directions for use: 1 dropper, besl lo take the drops directly under the tongue. If
COMPONENTS necessary, dilute the tincture in a small amount of water or juice. - Store in a cool,
dry place, away from sunlight.
Serving Si2e ,34 ml (1 dropper)
Servings Per Contairer 90
Amount P e r Serving % Dally V a l u e '

Tamper-evident seal
Camabis Oil Blend
wrapped around the 10 mg - THC (3% telrahydrocannafainoO
closure
1 ^-'ÎJ^^^'^t.
'Daily Value not established
Other Ingredients Ethanol, MCT Oil, CarxyliciCapric Triglycerides
No: Milk, Egg, Fish. Crustacean Shellfish. Tree Nuts, Peanuts, Wheal. Soybeans,
Child Safety - Push D o w n Yeast, Artificial Colors or Flavors
& T u m closure STATE WARNING: This medlcalca nnabldiol Is D I S P E N S A R Y PATIENT L A B E L
for thera peutic use only. Use of this p roduct by
T r a c k i n g fl
a personotherthan the patient listed onthe
label Is unlawful and may result In the Date & Time
cancellalionofthe patient's medical Dispensary Name
Address
disposal. City, IA, Zip
Dropper - .34 m l for This product has not been analyzed or Patient IDA
approved by the UnltedStatesFood and Drug
accurate dose delivery Patient N a m e
Adminlstration.Thereis limited! nformationon
the sldeeffectsof using this product, and there Patient D O B
may be a ssoclated health ris ks and medication Patient Address
Interactlons.Thlsp roduct Is not recommended
City, IA, Z i p
Barcode fortraceability, I n s t r u c t i o n s : S e e product l a b e l
KEEPTH1S PRODUCT OUT OF REACH OF
located o n bottom of CHILDREN.
bottle. Manufacture Date:xx/xx/xxxx
M a n u f a c t u r e d by:
M e d P h a r m I o w a LLC Expiration Date: xx/xx/xxxx
1 9 5 3 E . M a r k e t St Lot N u m b e r : XXXXX
Des M o i n e s IA 5 0 3 1 7 Product M X T 1 0 1
PRODUCT: M X - T i n c t u r e , 10/10

Directions for use: 1 dropper, bast to take the drops directly under the tongue. K
F R O N T LABEL COMPONENTS nacessary, dilute the tincture in a small amount ol water or juice. - Store in a cool.
dry place, away from sunlight,
Supplement Facts
Serwng Size .34 ml (1 dropper)
Servings Per Container go
Amount Per Serving V, Dally Value
Tamper-evident seal
Cannabis Oil Blend
w r a p p e d around the
closure
10 mg C B D (3% cannabidiol)
Daily Value not established

Other Ingredients: Ethanol, MCT Oil, Caprylic/Capric Triglycerides
Mo: Milk, Egg, Fish. Crustacean Shellfish, Tree Nuts, Peanuts, Wheat, Soybeans,
Child Safety - Push D o w n
Yeast. Artificial Colors or Flavors
& T u m closure ST ATE WARNING: This me dcaicannabldiol Is DISPENSARY PATIENT LABEL
fo rlhe rapeutic use only. Use oflhls product by
Tracking 8
a personotherthan the patient listed on the
label is u nlawful and may resuli In the Date & Time
m cancellation of the patient's medical
cannabldot registration card. Return unused
Dispensary Name
Address
medlcalca nnabldiolto a dispensary for
Dropper - .34 ml for This producthas not been analyzedor Patient IDA
approved by the United StatesFood and Drug
a c c u r a t e d o s e deliverv Patient Name
Administration.There Is llmitedlnlormalionon
90s livings Patient DOB
the sloe effects of uslngthlsproduct,andthere
900 mg
active THC may be associated health rlsksand medication Patient Address
Intera(lions.Thlsproductts not recommended
City, IA, Zip
tor use by pregnant orb reastfee ding worn en.
Barcode fortraceability, I n s t r u c t i o n s : S e e product l a b e l
KEEP THIS PRODUCT OUTOF REACH OF
l o c a t e d o n bottom of CHILDREN.
M e d P h a r m Iowa L L C Expiration D a t e : x x / x x / x x x x
1 9 5 3 E. M a r k e t St l o t Number: XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product # M X T 1 0 1 0

Directions for usa: 1 dropper, best to take the drops directly under the tongue If
F R O N T LABEL COMPONENTS rBcessary, dilute the tincture in a small amount ol water or juice - Store in a cool,
dry place, away from sunlight. ^
Supplement Facts
Serving Size .34 ml (1 dropper)
Servings Per Contarer 90
Amount Per Serving % Daily Value'

Tamper-evident seal
w r a p p e d around the Cannabis Oil Blend
closure
10 n'O - CjLSJj^JLî^H^'l^tL-
Other Ingredients: Ethanol, MCT Oil, Caprylic/Capric Triglycerides
No: Milk, Egg, Fish, Quslacean Shellfish, Tree Nuls, Peanuts, Wheat, Soybeans,
Child Safety - P u s h D o w n Yeast, Artificial Colors or Flavors
& Turn c l o s u r e STATE WARMING: 1 his medical ca nnabldiol is D I S P E N S A R Y PATIENT LABEL

fortherapeuticuseonly. Use of this produetby
Tracking
V / a pe rsonotherthan the patient listed on the
D a t e & Time
label Is unlawful and may re suit in the
ca ncellatlon of the patient's medical Dispensary Name
Address
medlralcannabldloltoa dlspensacyfor
Dropper - .34 ml for This producthasnotbeen analyzedor Patient IDB
approved by the United States Food and Drug
a c c u r a t e d o s e deliverv Patient N a m e
Administration. The re Is limited I nformab'on on
maybe associated health rlsksand medication Patient A d d r e s s
Interactions.Thlsproductls not recommended
City, IA, Zip
foruse bypregnant or breastfeeding women.
B a r c o d e for traceability, I n s t r u c t i o n s : S e e product label
KEEPTHtS PROOUCT OUTOF REAOf OF
l o c a t e d on b o t t o m of CHILDREN.
bottle. M a n u f a c t u r e d by: Manufacture Date:xx/xx/xxxx
M e d P h a r m Iowa L L C Expiration Date: xx/xx/xxxx

1 9 5 3 E. Market St Lot N u m b e r : XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product K M X T 1 1 0
!:.,.. ,!, ' . i l l '-S:

SAFETY/ BACK LABEL
COMPONENTS Directions for use: 1 dropper, best lo lake Ids drops direclly under (he tongue. If
necessary, dilute the tincture In a small amount of water or |uice - Store In a cool,
StCWftStAi
Serving Size 1 ml (1 dropper)
Servings Per Container 30
Tamper-evident seal Amount Per S i rvina .. 1 % Daily V a l u e *

w r a p p e d around the 1 ml '
Cannabis Oil Blend
closure 100 mo CBD (10% cannabidiol)
1 mg - THC (.1% cannabidiol)
Daily Value not established

Othor Ingredients: Ethanol, MCT Oil, Caprylic/Capnc Triglycerides
No: Mils, Egg, Fish, Crustacean Shellfish, Tree Nuts. Peanuts, Wheat, Soybeans,
Child Safety - P u s h D o w n Yeast, Artificial Colors or Flavors
S T u r n closure STATE WARNING: This medical ca nnabldiol Is D I S P E N S A R Y PATIENT L A B E L
fortherapeuticuseonly. Use ofthls product by
Tracking H
a pe rsonotherth3n the patient listed on the
label IsuNawfulandmayresultinthe Date & Time
cancellation ofthepatlent'smedical Dispensary Name
Address
Dropper - .34 ml for This producthasnot been analyzed or Patient IDH
a c c u r a t e d o s e dellverv Patient N a m e
Administration. There Is limited information on
may be assodated health risks and medication Patient Address
Interactions. This product Is not recommended
City, IA, Zip
B a r c o d e for traceability, I n s t r u c t i o n s : See product l a b e l
KEEP THIS PRODUCT OUT OF REACH OF
l o c a t e d on b o t t o m of CHIIOREN.
MedPharm Iowa LLC Expiration Date: xx/xx/xxxx
1 9 5 3 E. M a r k e t St Lot N u m b e r : XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product It M X T 0 1 0 0
PRODUCT: M X - N A N O T i n c t u r e , 10/1
BACK LABEL
SAFETY/
CONTAINER/ Directions for use: 1 dropper, best to take the drops directly under the tongue. If
COMPONENTS necessary, dlule tire tincture in a small amount ol water or juice. - Store in a cool,
FRONT LABEL dry place, away from sunlight.
Supplement Facts
J. iiillfPllpiifll^>i@s
Tamper-evident seal
closure
|Serving Size
Servings Per Container
Amount Pe r Serving
Cannabis Oil Blend

1 mg - CBD (.3% cannabidiol)

.34 ml (1 dropper)
BO
Other Ingredients: Caprylic /Capric Triglycerides. Veegum, Acacia

% Dally Value'
No: Milk, Egg, Fish, Crustacean Shellfish, Tree Nuts, Peanuts, Wheat, Soybeans,
Child S a f e t y - P u s h D o w n Yeast, Artificial Colors or Flavors
& Turn c l o s u r e STATE WARNING: This medicalcannabldiol Is DISPENSARY PATIENT LABEL
fortherapeuticuseonly. Use of this product by
Tracking (t
a pe rsonother than the patienttisted on the
label Isunlawfulandrmyresultinthe Date & T i m e
Enhanced Absorptton cancellation of the patient's medical Dispensary Name
Address
medical ca nnabldiol to a dispensary for
Dropper - .34 ml for This product has not been analyzed or Patient IDS
a pproved bythe United States Food and Drug
a c c u r a t e d o s e delivery Patient N a m e
Administration.There Is limited Information on
90 servings the side effectsof using this product and there Patient D O B
900 mg
maybe assodated health rlste and medication Patient A d d r e s s
Interacttons.Thlsproductis not recommended
City, IA, Zip
B a r c o d e for traceability, Instructions: S e e product l a b e l
KEEP THIS PRODUCT OUT OF REACH OF
l o c a t e d o n bottom of CHILDREN.
bottle. M a n u f a c t u r e d by: M a n u f a c t u r e D a t e : xx/xx/xxxx
M e d P h a r m Iowa LLC Expiration D a t e : xx/xx/xxxx
I...-I I
1: 1953 E . Market St Lot Number: XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product S M X N 1 0 1
tllKMlitit'l
MedPharm Iowa, LLC I 143
PRODUCT: MX NANO Tincture, 1 0 / 1 0

BACK LABEL
SAFETY/
CONTAINER/ Directions for use: 1 dropper, best to lake the drops directly under the tongue K
COMPONENTS necessary, iftule the tincture in a smalt amount d water or juice. - Store In a coot,
FRONT LABEL riry place, away from surtrght. _____
Supplement Facts
J.
Serwng Size ,34 ml (1 dropper)
Amount Per Serving 1 % Dally Value*
Tamper-evident seal Cannabis Oil Blend 0.34 ml *

wrapped around the 10 mg - THC (3% tetrahydrocannabinol)
closure lOmq-J^
'Daily Valus not established
Other Ingredients: Capiylic /Capric Triglycerides, Veegum, Acacia
No: Milk. Egg, Fish, Crustacean SheMsh, Tree Nuts, Peanuls, Wheal, Soybeans,
Child S a f e t y - P u s h Down Yeast, Artificial Colors or Flavors
S T u r n closure STATE WARNING: This medicalcannabldiol Is D I S P E N S A R Y PATIENT LABEL
for therapeutic use only. Use of tills product bf
Tracking K
a pe rsonotherlhan the patient listed ontlte
label Is unlawful and may result In the D a t e & Time
cancellation of the patient's medical Dispensary Name
Address
medlcalcannabldiottoa dlspensaryfor
Dropper - .34 ml for This product has not been analyzedor P a t i e n t IDS
accurate dose delivery Patient N a m e
Ad ml nlstralion. There Is limited 1 nformarjonon
the side effects of uslngthls pro duct, and these Patient D O B
Interactions.Tti is productls notrecommended
City, IA, Zip
foruse bypregnantorbreastfeeding women.
B a r c o d e for traceability, Instructions: S e e product l a b e l
KEEPTHIS PRODUCT OUT OF REACH OF
l o c a t e d on bottom of rmincru
bottle. M a n u f a c t u r e d by: Manufacture Date:xx/xx/xxxx
M e d P h a r m Iowa L L C Expiration Date: xx/xx/xxxx
1953 E. Market St Lot Number: XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product M X N 1 0 1 0
P R O D U C T : M X - N A N O Tincture, 1 / 1 0
SAFETY/ BACK LABEL
CONTAINER/
COMPONENTS Directions for use: 1 dropper, best to lake the drops directly under the tongue. II
F R O N T LABEL necessary, dilute the tincture In a small amount of wafer or juice. - Store in a cool,
dry place, away from sunlight. _____
J.
Supplement Facts
Serving Size .34 ml (I dropper)
Amount Per Serving %Daily Vlu'

Tamper-evident seal
w r a p p e d around the Cannabis Oil Blend
closure 1 nig THC [1V, leliahydrocanmbnd)
10 mg - CBD (3% cmrBtjotol)
'Daily Value nol established

Other Ingredients: Caprylic /Capric Triglycerides, Veegum, Acacia
No: Milk, Egg, Fish, Crustacean Shellfish, Tree Nuls, Peanuls, Wheat, Soybeans,
Child Safety - Push D o w n Yeast, Artificial Colors or Flavors
& Turn c l o s u r e STATE WARNING: This medcalcannabldiol is D I S P E N S A R Y PATIENT LABEL

for therapeutic use only. Use of this product by
Tracking fl
a personotherthan tlie patient I Isted on the
label Is unlawful andmayresult In the D a t e & Time
cancellationofttiepatient's medical DIspensaryName
ca nnabidlol registration card. Return unused
Address
Dropper - .34 ml for This product has not been analyzedor Patient IDA
approved by the UnltedStates Food and Drug
accurate d o s e deliverv Patient N a m e
Admlnlsbatlon.Therelsllmltedlnfomiatlonon
the side effectsofuslngthls product, and there Patient D O B
interact!ons.Thisproductfs not recommended
City, IA, Zip
foruse bypmgnantorbreastfeeding women.
Barcode for traceability, Instructions: S e e product label
KEEPTHIS PRODUCT OUT Or REACH OF
located on bottom of CHItOREN.
bottle. Manufacture D a t e : x x / x x / x x x x
M e d P h a r m Iowa L L C Expiration b a t e : xx/xx/xxxx
;-i-, .1 | | 1953 E . Market St Lot Number: XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product M X N 1 1 0
PRODUCT: M X - NANO Tincture, 1/100

SAFETY/ BACK LABEL
CONTAINER/
COMPONENTS
F R O N T LABEL Directions for use: 1 dropper, bast to take tie drops directly uncfer the tongue H
necessary, dilute tl>3 tincture In a smali amount of water or juice. - Store in a cool,
J. Tamper-evident seal
closure
Supplement Facts
Serving Size
Amount Per Serving
Cannabis Oil Blend

100 mg - CBD (10% cannabidiol)
1 m o - T H C (.1% cannabidiol)
"Daily Value not established
t ml (1 dropper)
30
1
1 ml
.
%Dally Value*
Other Ingredients; Caprylic /Capric Triglycerides, Veegum, Acacia

No: Milk, Egg, Fish, Crustacean Shellfish, Tree Nuts, Peanuts, Wrest, Soybeans,
Child S a f e t y - P u s h D o w n Yeast, Artificial Colors of Flavors
&Turn closure STATE WARNING:fhIs medicalcannabldiol Is DISPENSARY PATIENT LABEL
fortherapeuticuseonly. Use ofth is product by
Tracking ft
a personotherthan die patient listed on the
label is unlawful and mayresultinthe Date & Time
cance llatlon of the p atient's medical Dispensary Name
cannabidiol registration card.Return unused
Address
medlcalcann3bid!Ottoa dIscensaryfor
Dropper - 1 ml for This product has not beenanalyiedor Patient IDA
accurate dose deliver/ approved bythe UnltedStates Food and Drug Patient N a m e
Adminlstration.Thereis limited Information on
Patient D O B
die side effects of uslngth Is product, and there
maybe associated healthrisksandmedicatlon Patient A d d r e s s
Interactlons.Thlsproductts not recommended City, IA, Zip
B a r c o d e for traceability, for use by pregnant or breastfeeding women. Instructions: See product l a b e l
KEEPTHIS PRODUCT OUT OF REACH OF
located on b o t t o m of
CHILDREN
bottle. Manufacture Date: xx/xx/xxxx
M e d P h a r m Iowa L L C Expiration D a t e : x x / x x / x x x x
1 9 5 3 E . Market St Lot N u m b e r XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product M X N 0 1 0 0
P R O D U C T : M X - T r a n s d e r m a l Cream, 1 0 / 1 0 0
SAFETY/ BACK LABEL
CONTAINER/ Directions for usa: Turn dial on bollom of container, each "click" dispenses 1 g Apply
COMPONENTS
cream drecUy to specific area. - Store In a cool, dry place, away from sunlight.
F R O N T LABEL
Supplement Facts
Serving Size 1 g mete red -dosing applicator
Sewings Pec Container 30
Amount Per Serving %Dally Value'
Tamper-evident seal Cannabis Oil Blend 1 gm

w r a p p e d around the 10 mg - THC (1% telrahydiocanfabirK)!)
closure 100 mg - CBD (10% careiabidiot)
['Pasty Value not established
1 Other Ingredients: Aoylates Copolymer, B Lit yros perm urn Parkii (Shsa Butter),
Caprylic/Capric Triglycerides, Carthamus Tinctorius
No: Milk, Egg, Fish, Crustacean Shells!., Tree Nuls, Peanuts, Wheat, Soybeans,
Yeasl, Artificial Colors or Flavors
Child S a f e t y - P i n c h &
Turn c l o s u r e STATE WARNING: This medicalcannabldiol is DISPENSARY PATIENT LABEL
(ortherapeutic use only. Use of this product by
Tracking ff
a parson other than the patient listed on the
label is unlawful and may re suit in the D a t e & Time
cancellation of the patient's medical Dispensary Name
cannabidiol registration card,Return unused
Address
medical camabidiolto a dlspensaryfor
This product has not been analyzed or Patient IDtf
Turn a n d click for
approved by the United States Food andDiug
a c c u r a t e dose delivery Patient N a m e
Administration. There Islimf ted informationon
the side effectsof using this product, and there Patient D O B
maybe assodated health risks and medication Patient A d d r e s s
Inte ractions. Thisproduct is not recommeraJed
City,IA, Zip
for use by pregnant or breastfeeding wome a
KEEP TUB PRODUCT OUT Of REACH OF Instructions: S e e product label
l o c a t e d o n bottom of
M e d P h a r m Iowa L L C Expiration D a t e : xx/xx/xxxx
D e s M o i n e s IA 5 0 3 1 7 Product fl M X C 1 0 1 0 0 _ 3 0
PRODUCT: MX-Transdermal Cream, 10/100
SAFETY/ BACK LABEL

CONTAINER/
COMPONENTS
FRONT LABEL Direclions lor use: Turn 6>ai on bottom of container, each "click" dispenses 1 g Apply
cream directly to specifc area. - Store in a cool, dry place, away from sunlight.
Supplement Facts
Serving S e e 1 g ma tared-dosing appticator
'ISijiiiiii" Tamper-evident seal

Settings Per Container
Amount Per Serving
6 0 ^ ^ ^ ^ ^ ^ ^ ^ ^
% Daily Value*
w r a p p e d around the Cannabis Oil Blend Torn

closure 10mg- THC (1% tetrahydrocannabinol)
Daily Vafua not established

Other Ingredients: Acrylates Copdymer, Butyrospermum Partdi (Shea Butter),
Caprylic/Capric Triglycerides, Carihamus Tinctorius
No: Milk, Egg, Fish, Crustacean ShePfish, Tree Nuts, Peamrts, Wheat, Soybeans,
Child S a f e t y - P i n c h & Yeast, Artificial Colors or Flavors
Turn c l o s u r e STATE WARNING: This medical cannabidiol is D I S P E N S A R Y PATIENT LABEL
for therapeutic u se only. Use of this product by
Tracking II
a personotherthan the patient listed on the
I a bells unlawful and may result in the Date & T i m e
cancellation ofthe patlent/smedical Dispensary Name
Address
medlcalcanrebidiolto a dlspensa/yfor
disposal City, IA, Zip
Turn and click for This product has not been analyzed or Patient IDA
approved bythe UnitedStatesFood and Drug Patient N a m e
a c c u r a t e d o s e delivery
Adminlstration.Thereis limited! nformationon
the side effectsof using this product, and there Patient D O B
maybe associated health risks and medication Patient Address
Interactions.Thlsproductis not recommended
City, IA, Zip
B a r c o d e for traceability, Instructions: See product label
KEEPTMIS PRODUCT OUT OF REACH OF
located on bottom of CHILDREN.
M e d P h a r m Iowa LLC Expiration D a t e : xx/xx/xxxx
Product H M X C 1 0 1 0 0 _ 6 0
1 . ,||- : ! ' i l l ! D e s M o i n e s IA 5 0 3 1 7
P R O D U C T : MX - Suppository - Rectal, 1 0 / 1 0
BACK LABEL
SAFETY/ Directions for use: Insert the suppository Into the rectum, narrow end first. Gently but
CONTAINER/ firmly, push the suppository past the sphincter. The sphincter is ttra muscular opening of
COMPONENTS the rectum. For adults, push It in one Inch. For children, depending on their size, push it
FRONT LABEL in ahalfinchtooneinch Keep In refrigerator or freezer
Supplement Facts
Seruing Size 1 Suppository (1g)
Servings Pet Container 10
Child S a f e t y - S e a l e d
Amount Per Scrying % Daily Value'
Blister P a c k s
Cannabis Oil Blend 1 g
10 mg - THC (1%
10 mg - CBD (1% canrebjdjd)
'Patty Value not established

Otlier Ingredients: Phosphatidyl Choline, Coconut Oil, Cetea/yl Alcohol
Tamper-evident s e a l Mo: Milk, Egg, Rsh, Crustacean Shellfish, Tree Nuts, Peanuts. Wheat, Soybeans,
w r a p p e d around the Yeast, Arthicial Colors Of Flavors
closure
STATE WARNING: This medicalcannabldiol is DISPENSARY PATIENT LABEL
for therapeutic useonly.Use of this product by
a personotherthan the patient listed on tlie Tracking ii
label is unlawful and mayresuttlnthe Date & Time
ca nee Nation of the patient's medkal Dispensary Name
cannatid'ol registration card. Return unused
Address
medical cannabidiol toa dispensaryfor
disposal. City,IA, Zip
B a r c o d e for traceability,
This product has not been analy/edor Patient I DM
located on bottom of approved by the United States Food and Drug
Admi nlstratlon,There is limitedlnformationon Patient N a m e
box.
may be associated health risks and medication Patient Address
T interactions. This product is not recommended
City, IA, Zip
, THC j for use by pregnant or breastfeeding women,
KEEPTHtS PRODUCT OUT OF REACH OF Instructions: S e e product label
I
10 Rectal
Suppositories
100 mg Grown by
adlveTHC ^PD"PrtiH Manufactured by: M a n u f a c t u r e D a t e : xx/xx/xxxx
MedPharm. Iowa L L C Expiration D a t e : xx/xx/xxxx
-1 r1; JI" - 1 9 5 3 E. Market St Lot Number: XXXXX
D e s Moines IA S0317 Product IIMXSR1010
.MM-!., i|.|ir .Ii- I.1
P R O D U C T : MX - Suppository, Vaginal, 1 0 / 1 0
BACK LABEL
CONTAINER/ SAFETY/ Dlrectionsforuse: Genlly insert Ihe applicator into the vagina as for as It will
comfortably go. Press the applicator's plunger as (ar as il goes. This will push the
FRONT LABEL COMPONENTS suppository far back Into your vagina. Remove the applicator from your vagina.
Keep In refrigerator or freezer _____
Supplement Facts
Servng Size 1 Suppository <1g)
Servings Per Container 10
Child S a f e t y - S e a l e d
Blister Packs Amount Per Serving % Dally Value'
Cannabis Oil Blend

10 nig - THC (1% tetrahydrocannabinol)
10 mg - CBD (1% cannabidiol)

Other Ingredients: Phosphatidyl Choline, Coconut Oil, Cetearyl Alcohol
Tamper-evident seal
No: Milk, Egg, Fish, Quslacean Shellfish, Tree Nuts, Peanuls, Wheat, Soybeans,
closure
Yeast, Artificial Colors a Flavors
STATE WARNING: Tills medical ca mabidlol is DISPENSARY PATIENT LABEL
for therapeutic use only. Use of this product by
Tracking tl
a personolher than the patient listed on the
la bells unlawful and may result In the Date & T i m e
ca nee llatlon of the patient's medical Dispensary Name
Suppository B a r c o d e for traceability, ca nnabldiot registration card. Return unused
Address
located on bottom ol medical cannabidiol to a dispensaryfor
THC 10 mg per pill disposal. City, IA, Z i p
box.
CUD 10 niR per pill This product has not been analyzed or P a t i e n t ID/1
Patient N a m e
Administration. There Is limited Informabonon
Ihe side effeefcof usingthlsprodoct,and the;? Patient D O B
maybe associated health risks andrnedicalion Patient A d d r e s s
10VgrrI Disposable interactions.This product Is not recommended
City, IA, Zip
Supposltorier for use by pregnant or breastfeeding women.
Applicator
II lODispasatfe / KEEPTHISPRODUCT OUTOF REACH OF Instructions: S e e product label

Applicalos \ / CH11DREN.

M e d P h a n n Iowa LLC Expiration D a t e : xx/xx/xxxx
1 9 5 3 E. Market St Lot N u m b e r : XXXXX
D e s M o i n e s IA 5 0 3 1 7 Product If M X S V 1 0 1 0
S E C T I O N 3.02. P A R T C , S U B P A R T 6: T R A N S P O R T A T I O N O F M E D I C A L C A N N A B I D I O L AND
PLANT MATERIAL
a. Describe experience in transporting product of high value with potential risk for
diversion.
Although MedPharm Iowa is a relatively new company, it has garnered an immense
amount of information from Kemin with respect to transporting product of high value with
potential risk for diversion. Kemin ships high-dollar value products around the world on a daily
basis, and it has shared this knowledge and experience with MedPharm Iowa as MedPhami Iowa
developed its transportation standard operating procedures. That knowledge and experience is
evident throughout this Section 3.02, Part C , Subpart 6.

b. Describe how medical cannabidiol will be transported to and from dispensaries, the
laboratory, and a waste facility consistent with proposed administrative rule 154.22.
Include the following in the narrative:

MedPharm Iowa recognizes the many important regulations regarding transportation o f
medical cannabidiol contained in the Applicable Law, and it has developed a plan to ensure
adherence to these regulations. MedPharm Iowa intends to transport medical cannabidiol pursuant
to the protocols described below. I n addition, please also find below a response to each specific
question posed by the Department in the RFP.

MedPharm Iowa's Tracking System (as defined in Section 3.02, Part C , Subpart 8b.) w i l l
allow it to maintain a chain of custody that complies with proposed administrative subrule
154.22(3). The Tracking System records each of the requirements described in proposed
administrative subrule 154.22(3)a. through barcoding or through manual entry. Standard operating
procedures for MedPharm Iowa's transportation personnel w i l l require that this information is
recorded and that a notification is provided to the dispensary or laboratory of the expected arrival
time. A copy of the transportation manifest w i l l be made available to the dispensary or laboratory
as well. Standard operating procedures also provide for the manner in which each transport w i l l
be approved by an authorized employee when departing the Proposed Facility. A l l transportation
manifests w i l l be maintained for at least five (5) years and w i l l be made available to the Department
upon request.
As noted below, MedPhann Iowa does not intend to transport waste medical cannabidiol
or waste Cannabis plant material to any waste facility without first rendering the waste inactive.
Willi respect to vehicle requirements, MedPharm Iowa's standard operating procedures
require that all transported medical cannabidiol is at all times packaged in tamper-evident, bulk
containers; is not visible or recognizable from outside the vehicle; and is transported in a vehicle
that does not bear markings indicating the vehicle contains medical cannabidiol or MedPharm
Iowa's name or logo. More information with respect to packaged medical cannabidiol for
transportation is described in Section 3.02, Part C , Subpart 5a.

In addition, the employees w i l l be required to travel directly to the approved location to
which the medical camiabidiol is to be delivered. Employees w i l l be required to document all stops
in transit, in accordance with proposed administrative submle 154.22(4)6. MedPhami Iowa's
standard operating procedures for transportation also require employees to notify 911 in the event
of an emergency and to f i l l out an incident report. No employee or other person, other than the
designated and authorized transportation employees, will at any time have actual physical control
of any motor vehicle transporting medical cannabidiol. No vehicles transporting medical
cannabidiol w i l l be left unattended overnight.

A l l shipments to a dispensary w i l l require a minimum of two (2) employees per vehicle,
and at least one employee w i l l remain with the vehicle at all times that the vehicle contains medical
cannabidiol. MedPhann Iowa w i l l ensure that each employee in a transport vehicle has
communication access to MedPharm Iowa personnel and the ability to contact law enforcement at
all times. A l l employees must cany their identification cards at all times.
(1) The frequency of medical cannabidiol transport to each location.
With respect to frequencies of transport, MedPharm Iowa projects biweekly deliveries o f
medical cannabidiol to each dispensary. As MedPharm Iowa gathers more information about the
demand for its products, however, these delivery schedules may be revised to better serve each
dispensary and its customers.

MedPharm Iowa anticipates weekly deliveries of medical cannabidiol to the laboratory for
testing, although this schedule must remain subject to change based on the laboratory's testing
protocol and turnaround times. More infonnation regarding MedPharm Iowa's planned
relationship with a laboratory may be found i n Section 3.02, Part C , Subpart 10c.
Medical cannabidiol w i l l not be directly transported to any waste facility for disposal;
instead, waste medical cannabidiol w i l l be added to the compost pile to be rendered inactive, as
described below in Section 3.02, Part C , Subpart 7. Once inactive, Waste Management w i l l
transport the entire compost pile to a waste facility every ten (10) weeks.
(2) The frequency of collection of waste medical cannabidiol from dispensaries and the
laboratory consistent with proposed administrative subrule 154.23(1).
MedPharm Iowa acknowledges that proposed administrative subrule 154.23(1) requires it
to collect at no charge, unused, excess, or expired medical camiabidiol from dispensaries, including
medical camiabidiol returned to a dispensary, and from the laboratory that has tested samples.
Initially, MedPharm Iowa anticipates collecting waste medical cannabidiol from
dispensaries biweekly. If, however, the dispensaries reasonably require more or less frequent
collections, whether on a routine or as-needed basis, MedPharm Iowa intends to work closely with
each to establish collection protocols and frequencies mutually satisfactory to the dispensary and
MedPharm Iowa. Regardless of the specific schedule established with a particular dispensary,
however, MedPhami Iowa w i l l collect waste medical cannabidiol at least once a month from each
dispensary.
Similarly, MedPharm Iowa anticipates collecting waste medical cannabidiol from the
laboratory weekly. MedPhaim Iowa intends to establish a mutually agreeable schedule with the
laboratory as well, although it recognizes that as with each dispensary, the laboratory may require
more or less frequent collections at certain times. I f the laboratory reasonably requires collections
in addition to the regularly scheduled collections, MedPharm Iowa intends to meet these requests.
(3) The location of the waste facility.
MedPharm Iowa intends to render inactive all waste medical cannabidiol and all waste 5?
plant material before it leaves MedPhann Iowa's Proposed Facility. This process is described
below in Section 3.02, Part C , Subpart 7. MedPhami Iowa intends to contract with Waste
Management for removal of the inactive compost pile, and it expects that Waste Management w i l l
transport this composted material to the Metro Park East Landfill (12181 N E University Avenue,
Mitchellville, Iowa 50169) or a similar compost or landfill facility.
(4) Proposed methods for minimizing the risk of diversion or theft of medical
cannabidiol during transport.

() The manifest or tracking system to be used in the event that the secure sales and
inventory system is not operational.

Regardless of whether the Department's secure sales and inventory system is operational,
MedPharm Iowa w i l l utilize its Tracking System (as defined in Section 3.02, Part C , Subpart 8Z>.)
to comply with proposed administrative submle 154.22(3). The functions of the Tracking System
with respect to transportation of medical cannabidiol are explained above. The Tracking System
w i l l either provide a report that MedPhann Iowa w i l l then provide to the Department, i f the
Department's system is not operational, or it w i l l integrate with the Department's secure sales and
inventory system to provide the same information, in the event the Department's system is
operational. Please see Part C , Subpart 6b.(5), Exhibit A for an example of MedPhann Iowa's
transport manifest.
c. Describe how Cannabis plant material will be transported to a waste disposal site
consistent with proposed administrative rule 154.22. Include the following in the
narrative:
MedPhami Iowa has designed its manufacturing process and its disposal process in such a
way that it does not intend to transport any Cannabis plant material unless and until such material
has been composted and rendered unusable and unrecognizable, pursuant to proposed ^
administrative subrule 154.23(2). This means that no Cannabis plant material should ever be j
transported from the Proposed Facility; instead, all plant material that w i l l leave the Proposed U
Facility should be categorized simply as compost or waste. More information regarding MedPharm >|
Iowa's process for disposing of Cannabis plant material waste can be found in Section 3.02, Part
C , Subpart 7.
(1) The frequency of transport to the waste facility.
MedPhann Iowa anticipates that Waste Management w i l l transport the entire compost pile
to a waste facility every ten (10) weeks.

(2) The location of the waste facility.
( MedPhami Iowa intends to contract with Waste Management for removal of the inactive
compost pile, and it expects that Waste Management w i l l transport this composted material to the
Metro Park East Landfill (12181 N E University Avenue, Mitchellville, Iowa 50169) or a similar
compost or landfill facility.
(3) Proposed methods for minimizing the risk of diversion or theft of Cannabis plant
material during transport.
In no circumstances w i l l MedPhami Iowa permit its employees to transport Cannabis plant
material, and thus there should be no risk of diversion or theft. A l l Cannabis plant material w i l l be
rendered unusable and recognizable by composting before it is ttansported from the Proposed
Facility to a waste facility. Please see Section 3.02, Part C , Subpart 7 below for more information
regarding MedPharm Iowa's processes for disposing of Cannabis plant material. Additionally,
because of the Tracking System, it w i l l be obvious i f a plant or material in process is missing at
the end of each business day.
(4) The manifest or tracking system to be used in the event that the secure sales and
inventory system is not operational.
I Regardless of whether the Department's secure sales and inventory system is operational,
MedPharm Iowa w i l l utilize its Tracking System (as defined in Section 3.02, Part C , Subpart Sb.)
to track all Cannabis plant material waste as it is produced and disposed of in the compost pile. In
addition, the Tracking System w i l l record all transportation activities with respect to composted
waste that is transported from the Proposed Facility by Waste Management. The Tracking System
w i l l either provide a report that MedPhann Iowa w i l l then provide to the Department, i f the
Department's system is not operational, or it w i l l integrate with the Department's secure sales and
inventory system to provide the same information, in the event the Department's system is
operational.
Exhibit A
CARGO MANIFEST PAGE OF.
NAME OF DRIVER DESTINATION(S)
NAME OF DRIVER VEHICLE ID
REPORT TO: IF DELAYED CONTACT
DEPARTURE INTERMEDIATE STOPS DESTINATION__

PLACE TnT ETA PLACE ' ETD TfA~
1
' CARGO CARGO RETURN ITEMS c f\RGO CARGO
CARGO NAME WEIGHT IN WEIGHT OUT WEIGHT IN WEIGHT OUT
1.
2.
3.
4.
5.
6.
7.
8.
9.
SIG NATURE OF AUTHORIZED REPRESENTATIVE DATE

S E C T I O N 3 . 0 2 . P A R T C , S U B P A R T 7: D I S P O S A L O F M E D I C A L C A N N A B I D I O L AND P L A N T
MATERIAL
a. Describe the process for collecting and documenting medical cannabidiol that has been
returned from patients and dispensaries as detailed in proposed administrative subrule
154.23(1).
MedPhann Iowa recognizes its responsibility for collecting from dispensaries at no charge,
unused, excess, or expired medical cannabidiol, including medical cannabidiol that was returned
to a dispensary from a customer. MedPhaim Iowa's proposed collections are more fully explained
above in Section 3.02, Part C , Subpart 6; as described there, MedPharm Iowa anticipates
collecting waste medical cannabidiol from dispensaries biweekly, although it also recognizes that
more or less frequent collections may be necessaiy. Regardless of the specific schedule established
with a particular dispensary, however, MedPharm Iowa w i l l collect waste medical cannabidiol at
least once a month from each dispensaiy.

Once collected, the medical cannabidiol from each dispensaiy w i l l be transported to
Proposed Facility for disposal in accordance with proposed administrative subrule 154.23(2). This
process is explained in more detail below in Section 3.02, Part C , Subpart 7, b. MedPharm Iowa's
Tracking System (as defined in Section 3.02, Part C , Subpart 86.) w i l l maintain a record of
disposal that includes each of the requirements in proposed administrative submle 154.23(l)c/. As
previously noted and as described below, waste medical cannabidiol w i l l be marked for disposal
and added to the compost pile at the proper time.

b. Describe how medical cannabidiol and plant material waste will be stored and disposed
of consistent with proposed administrative subrule 154.23(2). Include estimates of the j
amount of waste products that will need to be stored and disposed of. M
c. Describe the process for disposal o f liquid and chemical waste consistent with proposed
administrative subrule 154.23(3). Include estimates of the amount of liquid and chemical
waste that will need to be disposed of and the location of the waste facility.
MedPhann Iowa anticipates very little liquid or chemical waste w i l l be generated from its
manufacturing process. It does, however, expect that the winterization process (described below
in Section 3.02, Part C , Subpart 9m. w i l l result in leftover ethanol, provided that ethanol is
approved by the Department for use in MedPharm Iowa's operations. Based on current estimates,
which are subject to change as MedPhann Iowa runs its manufacturing process, MedPharm Iowa
believes it may have up to 1,200 liters of ethanol waste annually.

Ethanol used in the winterization process may be recycled several times, but eventually it
w i l l need to be disposed. MedPharm Iowa anticipates that this ethanol w i l l contain nondetectable
residue level of THC and CBD and that it w i l l be disposed of by a certified hazardous waste
removal company, which w i l l dispose of it in a proper waste facility.

Part C , Subpart lb
Exhibit A
35
a
S E C T I O N 3.02. P A R T C . S U B P A R T 8: R E C O R D - K E E P I N G REQUIREMENTS
a. Describe how the record-keeping requirements in proposed administrative rule 154.24
will be met, including how and where each type of record will be stored.
MedPhann Iowa's Tracking System (as defined in Section 3.02, Part C , Subpart 8b.)
serves as the backbone of its structure for meeting the record-keeping requirements of proposed
administrative rule 154.24. For other records that must be kept pursuant to Applicable Law,
MedPhann Iowa has procured services from the vendors described below.
With respect to sales and distribution, the Tracking System w i l l maintain all of MedPhaim
Iowa's sales transactions records, including the date of sale; the unique identifying number, the
name o f the product and its description, and the quantity sold; and the sale price. The Tracking
System w i l l collect this information through barcode scans or manual entry, depending on the
particular record.
The Tracking System w i l l also be used to help maintain records of financial transactions,
and MedPhaim Iowa w i l l utilize QuickBooks for recording its transactions. The sales records can
be easily translated into a fonn that accounting personnel w i l l enter into the QuickBooks systems.
A l l invoices, sales records, and other supporting documents for goods or services purchased w i l l
be maintained in QuickBooks, as w i l l all accounting, tax, and bank records. Any other financial
transactions w i l l be catalogued in this system. MedPharm Iowa has established a records mention
policy that, among other things, requires copies of all financial documents, including contracts and
agreements, which w i l l be kept for a minimum of five (5) years.
MedPhann Iowa w i l l also utilize a variety of other systems to maintain other records. A l l
personnel records w i l l be maintained in MedPhaim Iowa's ADP system. Controlled access system
data and visitor manifests w i l l be maintained through the S2 system and EasyLobby, respectively.
Data w i l l be collected from the Tracking System and QuickBooks to create and maintain records
of theft, loss, or unaccountability of any medical cannabidiol or plant material. The Tracking
System w i l l also contribute data into the transportation manifests and incident reports, which w i l l
be stored in MedPharm Iowa's Microsoft Office 365 cloud system. Finally, the Tracking System
w i l l be responsible for tracking and maintaining records with respect all items described i n
proposed administrative subrule 154.24(3)6.

MedPhaim Iowa has established a retention policy for records not otherwise described that
requires records to be maintained in physical or electronic form for a minimum of five (5) years.
Electronic data w i l l be stored in secure and redundant cloud service platforms or on MedPhann
Iowa's secure on-premises servers, which are located in secured rooms with limited access and
under constant surveillance via the Surveillance System.

b. Describe contingency plans in the event that the Department's secure sales and inventory
tracking system is not available in the first year of operation.

MedPhann Iowa continues to review several seed to sale tracking systems and plans to
select a solution based on careful consideration of the features of each system and on Applicable
Law. Because of the importance of this tracking system to MedPhami Iowa's operation, it intends
to secure a tracking system regardless of whether the Department's secure sales and inventoiy
tracking system is available during the first year of operation.

Although a final decision on MedPhami Iowa's tracking system has not been made, it has
confirmed with each potential vendor that the potential vendor's system can integrate with any of
the available secure sales and inventoiy systems available to government agencies. Additionally,
each potential system can be customized to integrate with a new system should the Department
choose to build its own secure sales and inventoiy tracking system.
For puiposes of this RFP, MedPhami Iowa's seed to sale tracking system that is to be
secured is referred to as the "Tracking System ".

( S E C T I O N 3.02. P A R T C , S U B P A R T 9: P R O D U C T I O N R E Q U I R E M E N T S
a. Describe the process for hiring of, qualifications of and training for employees involved
in the cultivation of Cannabis.
MedPhaim Iowa w i l l recruit employees through numerous channels, with the goal of
attracting the most qualified talent. MedPhaim Iowa w i l l consider both prior education and
previous growing experience in a horticultural or agricultural based field in evaluating the
qualifications of potential employees. Potential employees w i l l be expected to possess, at a
minimum, an associate's degree from an accredited college or university in horticulture, biology,
agronomy, or a similar field. These potential hires must understand the general process for growing
plants in controlled environments. Preferred experience and knowledge may include, without
limitation, general watering practices; fertilization schedules and mixing of fertilizers; general
horticultural practices such as propagation, transplanting, and pruning; understanding o f light,
temperature, and humidity in the growing environment; and a general understanding of

entomology and pathology and the associated pests which could pose a problem in the growing
environment. Potential employees must possess or be able to obtain a commercial pesticide
/ applicator's license issued by the Iowa Department of Agriculture and Land Stewardship (the
"Department of Agriculture").
MedPharm Iowa w i l l also require potential employees to be able to lift up to fifty (50)
pounds daily. A l l applicants w i l l be subject to a physical conducted by an accredited physician's
clinic, and all applicants must undergo a drug screening prior to employment, in addition to the
background investigations performed by or on behalf of the Department. Applicants should have
knowledge of computer programs and ideally w i l l have previous experience with inventoiy
management. Once hired, employees w i l l be expected to participate in a rotational "on-call"
schedule that w i l l require availability twenty-four (24) hours a day during the "on-call" period. I n
addition, employees w i l l be expected to work alternating weekends and holidays to provide care
for the Cannabis plants.

Employees hired by MedPhann Iowa w i l l be provided training through many avenues,
including through review of standard operating procedures and hands-on training from qualified
MedPharm Iowa staff or expert consultants hired by MedPharm Iowa for this purpose. Initially,
MedPharm Iowa anticipates that its growing consultants w i l l assist employees through the growing
(
MedPhann Iowa, L L C . 163
and cultivation process um

process alone. s o p M P W a 0 0 1 Employee training methods
, addition, MedPharm Iowa 1 - d vel ed ^ ^ ^ t f f l m m g
the specific phases o ^ f " ^ ^ ^ ~ ^

(in cluded in Section 3.02, Part D.. O p e ( s ) respon sibie for
b Describe the procession""""
cîde,, of a m * * * * f " f " ; a s s u K , u e m p l o y e e s and consultants are
a g . 1 8 oio,deiandhaveno beencov,^ t
esub.ec, to mandatory
a third-party vendor, - * - ^ ^ ^ ^ ^ t t e production by an apphcant of

Common crosscheck methods used by Me PharmI ^ . ^ .. c e n s e
w o forms of federaUy accepted i d e n t i f y ^ ^

Socia, Security card, or a passport, as we!, as co P ^ ^ m t l K
F o r m as issued by die United Slates < an b V ^

l^sed a d m e snbr.es _ rf o n l y co ns,der for h ,
d bv the Department of PuDiic j
c .,
s g M rire with Kemin to provide expert
Iowa w-U enter into a ^ ^ U - ^ . ^ ^ ^
e x p e r i e n c e and hi .rowing potato, and ^
cowing f a ^ s include .eeubo.se sp ** ^ w , s
chambers and other controiied t 0 out s , d e processes and conbo.s.
v e r t l c a ) l y integrated r o w m P ^ a m s
g g ^ p l a n t b r e e di g and are then
A U crops in these programs - , K e n . MedPharm lowa -
pcopagated, grown, managed, harveste ,

1 have identified two Kemin employees who have experience with these Kemin programs and w i l l
assist MedPhann Iowa with its growing operation.

Dr. John A. Greaves, Vice President of Specialty Crops, and Nick TeBockhorst, Plant
Production Associate, w i l l serve as MedPharm Iowa's lead consultants. Dr. Greaves obtained his
PhD in plant physiology from the University of Wales in the United Kingdom. He has 35 years of
experience in plant breeding and agronomic production across a wide range of crops, and he was
instrumental in trait development in com at ICI Seeds. Dr. Greaves currently leads Kemin's
Specialty Crops program. Nick TeBockhorst obtained his Bachelor of Science degree from the
University of Northern Iowa in biology with an emphasis in plant science. Mr. TeBockhorst has
eight years of professional horticulture growing experience, including experience in multiple
greenhouse facilities. Both Dr. Greaves and Mr. TeBockhorst have extensive growing experience
in greenhouse spaces, outdoor nurseries, fanns, and indoor, controlled environments.
d. Describe the number, experience, and training of staff who will be producing medical
cannabidiol, including the extraction, refinement, and production of medical
cannabidiol. Describe the qualifications of and the number of employees to be involved
s in extraction, refinement, and production of medical cannabidiol. Describe the
experience of any person employed by the applicant who has expertise in these areas,
including the person's name and position. Cite any experience the applicant may have
in turning Cannabis into medical cannabidiol.
MedPharm Iowa has divided its manufacturing process into the growing and cultivation
phase and the extraction, refinement, and production. The growing and cultivation operation w i l l
employ a Grow Supervisor and a Grow Assistant.

The Grow Supervisor plays a pivotal role in developing and executing breeding, selection,
and optimization strategies to increase the production of specific phytochemical molecules in
specialty crop plants. Minimum background requirements are a PhD or Masters in plant genetics,
plant breeding, botany or horticulture and practical experience i n creating genetic variation via
crossing and/or mutagenesis in conventional or alternative crop species. The essential functions to
be perfomied by the Grow Supervisor include developing breeding, selection and optimization
strategies to increase the production of target phytochemical molecules in alternative crop species
of interest; executing the breeding program for target crops; generating test hybrids or advanced
clonal lines, evaluate and collect phenotype data; analyzing data and perfonning statistical
analyses; conducting initial field testing of selected lines and hybrids; providing input on field
scale-up o f selected lines; setting up and executing an in-house marker-assisted breeding program
for rapid development of improved breeding lines; taking a lead role in writing internal white paper
and peer reviewed publications and patent applications; and conducting literature searches on
relevant topics.
The Grow Assistant plays a pivotal role in assisting with day-to-day greenhouse
environmental control, plant well-being and health, rapid scale up of select plant lines, as well as
furthering the breeding program using conventional lab breeding techniques. In addition, the Grow
Assistant w i l l oversee the day-to-day laboratory functions, including micro-propagation and tissue
culture. The Grow Assistant w i l l report to the Grow Supervisor. Minimum background
requirements are a B.S. or M.S. degree in plant science or a related field, with a general knowledge
in chemistry, horticulture and biology and a minimum of three (3) years of practical experience in
a plant biology laboratory or research greenhouse. The essential functions to be performed by the
Grow Assistant include rapidly multiplying select lines of plant species of interest in the lab via i n
vitro propagation in micropropagation lab and in the growth chambers; developing micro-
propagation protocols to ensure adequate numbers of plants are generated each year; developing
standard operating procedures for new or improved micro-propagation protocols; understanding

the basic chemistry and laboratory skills to make plant growth media effectively and efficiently;
developing the necessary skills to operate the plant growth chamber to control environmental
conditions for growing i n vitro plants; executing in vitro mutagenesis program for target plant
species; managing and operating facilities, including the growth chambers; overseeing daily
growth chambers maintenance, including watering, fertilizing, and general plant health; adopting
safe working standards, including safe disposal of hazardous waste; purchasing and maintaining
an inventory of supplies for the growth chambers; trouble-shooting and operating essential
machinery in the growth chambers; and being on-call to monitor growth chamber alann systems.
The Extraction/Formulation position produces the full line of MedPhaim Iowa products,
while maintaining all manufacturing performance and quality standards. The minimum education
requirements are a bachelor's degree with zero to three years of applicable experience. The
essential functions to be performed by this employee include assembling and preparing raw
materials and correct ingredients, including measuring and blending, for manufacturing of product
line(s); operating and monitoring all equipment by reading and following equipment monitoring
systems, standard operating , instructions, specific procedures and protocols, process flow charts,
and adhering to the required measures, including safety procedures and protocols; utilizing
computer system for creating manufacturing orders and inventory control; perfonning initial
quality control/analysis on both raw materials and finished product, (i.e. detennine product
consistency and ensure quality in finished product through variety of assessments such as, moisture
content, consistency & appearance, texture, pigment strength, etc.); and ensuring that the final
product meets all required production standards.

Descriptions for other relevant positions, including packaging/delivery, customer service,
quality assurance manager, and quality control manager can be found in Section 3.02, Part C ,
Subpart 126.
e. Describe the controlled growth environment, systems, and automation that will be used
to cultivate Cannabis from seed or cutting to harvest.
/.' Describe the expected hours of operation of the cultivation operations, the number of
staff expected to be working in the cultivation operations at any one time, and the total
number offull-time and part-time employees or contractors.

MedPhann Iowa anticipates that its cultivation hours will be &oiT^^m^m^^^^|.
daily; employees will also be assigned "on-call" shifts during nonworking hours in the event of a
malfunction or other serious error i n the cultivation process. In addition, cultivation staff w i l l
alternate weekends (Saturday and Sunday) and subsequently w i l l be granted two weekdays o f f
following any weekend work. MedPharm Iowa expects that it w i l l utilize two full-time employees
in its cultivation operations, and up to two cultivation consultants as needed. Because all stock
plants, propagules, vegetative plants, and flowering plants need daily inspection and maintenance
to ensure optimum growth and development, cultivation operations w i l l be staffed 365 days a year,
including all holidays.

g. Describe the proposed propagation, cultivation, and harvesting procedures, including
biosecurity measures to minimize contamination consistent with proposed administrative
subrule 154.25(1).
CONFIDENTIAL pursuant to Iowa Code Sec. 22.7(3) & (6)
so
Describe what crop inputs, including growing media, will likely be used from
propagation to harvest, and how these will be applied and recorded, consistent with
proposed administrative subrule 154.25(2). If the applicant manufacturer proposes to
grow organically, specify the standards with which it intends to comply.
8
Describe the processes and computer systems that will be used to manage crop inputs.
Describe the protocol to be used if a fungal or pest outbreak were to occur to both address
the issue and resume/restart cultivation.

k. Describe who will be certified to apply pesticides at the manufacturing facility and how
they will be reviewed to ensure that all licenses and recertification requirements are met
according to Iowa pesticide laws and regulations (Iowa Code chapter 206, and 21 Iowa
Administrative Code chapters 44 and 45) as well as FDA and EPA regulations.
MedPharm Iowa intends to apply for a commercial pesticide license as issued by the
Department of Agriculture. It w i l l also require its employees involved in the growing and
cultivation of Cannabis plants to obtain a commercial pesticide applicator's license from the
Department o f Agriculture before working in the grow operation, and only these certified
employees w i l l be pemiitted to apply pesticides at any point in the grow operations. MedPhami
Iowa w i l l maintain a list of certified employees, and it w i l l notify the Department of Agriculture
i f there is change in employment status for any of these employees. Employees w i l l be required to
recertify their license by undergoing an annual two (2) hour instruction course or by completing
the required written examination every three (3) years.

In addition, all MedPharm Iowa employees with access to the grow and cultivation areas,
or who w i l l be handling plant material, w i l l receive Worker Protection Standard ("WPS") training,
as required by the Environmental Protection Agency. WPS training will include, but is not limited
to, pesticide exposure, proper restricted entry signage, and proper personal hygiene to avoid
pesticide poisoning.
/. Describe the process for propagating and tracking individual plants and assigning them
to batches consistent with proposed subrule 154.25(2).
HI. Describe the method that will be employed to extract the active ingredients from the
Cannabis plant to produce the medical cannabidiol and where the extractions will occur.
Explain how the process ensures that no residual solvents, if any solvents are used, will
remain in the finished product, and how the work environment will be made safe for
employees. Include a description of the protocols and equipment that will be used in
extraction, refinement, and production of medical cannabidiol products. Describe the

method of ensuring product traceability from plant and batch to medical cannabidiol
product through the extraction and refinement process to the final product.
MedPhann Iowa has created Figure 9/w.(l), which depicts each stage of the medical
cannabidiol production process. Please refer to this Figure 9?.(1) throughout this section. A
description of each stage of production is provided below.
MedPharm Iowa, LLC I 175
Figure 9//i.(3) - Apeks scCCh extraction system overview.

Ethanol is considered a class 3 solvent per the FDA, which means it has low toxic potential.
FDA Q3C - Tables and List Guidance for Industry (2017) states that Class 3 residual solvents i n
amounts equal to or less than f i f t y (50) milligrams per day (which is equal to 5,000 ppm or 0.5%)
are acceptable without justification. This guidance is the companion document for the International
Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use
guidance for industry Q3C Impurities: Residual Solvents, which makes recommendations as to
4
what amounts of residual solvents are considered safe in pharmaceuticals.
4
hfips://www.fda.gov/downlo^
5
( (ht1p://www.lieidolplmaxoiii/products/rotaiy-evaporators/hei-vap-value/hei-vap-^
Figure 9/.(5) short-path distillation unit.
n. Describe the hours of operation for extraction, refinement, and production of medical
cannabidiol.
MedPharm Iowa has established hours of operation for extraction, refinement, and
production of medical cannabidiol froni^^m^^m^J Monday through Friday. MedPharm
Iowa w i l l also observe the 2018 holiday calendar described i n Figure 977.(1) below.
6
(http://www.asahiglassplant.coin/products/short-path-evaporator-3/).
Figure 9.(1) - Holiday Calendar.
'1)1. l u l l I 1/ ll II I I I
Holiday D a t e D a y
N e w Year's D a y Jdiiuaiyl M o n d n y
Mcnniii.il D . i y M,jy ?R M o n d a y
InnVpondonco Day Inly 4 Wrdnocdriy
I aboi D a y September 3 Monday
Tb;iiiks(jiviii(j D.iy NnwnitiPi ?? Thuivl.iy
F r i d a y iiftet Thanksgiving N o v e m b e r 23 Friday
Chi istrnas D a y Decembei lb luesday
o. Describe how all production requirements ofproposed subrule 154.25(3) will be met.
MedPharm Iowa has designed both its Proposed Facility and its production process to
comply with proposed administrative submle 154.25(3). The design and construction o f
MedPhann Iowa's Proposed Facility w i l l be reviewed, approved, and inspected by local authorities
having jurisdiction to ensure that all state and local building, fire, and zoning requirements and all
applicable local ordinances w i l l be met. Upon completion of its construction renovations,
MedPhann Iowa w i l l obtain a certificate of occupancy that evidences the satisfaction of each o f
these requirements. Any flammable solvent-based extractions w i l l take place in Class 1/Division
1 rated rooms with Class 1/Division 1 rated equipment, and MedPharm w i l l develop all related
operational, safety, and sanitation standard operating procedures. Safety signage w i l l also be
installed as required by Applicable Law. ^

MedPharm Iowa proposes to use ethanol in the winterization stage of its production
process. As required by proposed administrative subrule 154.25(3)/3., MedPharm Iowa w i l l seek
approval from the Department for this particular process, in the form and method prescribed by ^
o
the Department. Under no circumstances w i l l MedPharm Iowa perform this winterization step 3
without prior approval. <a

c
q. Describe all additives, excipients, flavorings, or other products that will be used in
producing medical cannabidiol.

A l l excipients and other ingredients used in producing medical cannabidiol are listed above
in Section 3.02, Part C , Subpart 1/3.(4). Other than the materials described in that Section,
MedPhann Iowa does not currently anticipate utilizing any other additives, flavorings, or other
products to produce medical cannabidiol.

r. Describe how medical cannabidiol and Cannabis plant material will be stored, consistent
with proposed subrule 154.25(5).
Transportation of medical cannabidiol is discussed in detail in Section 3.02, Part C ,
Subpart 6. Until departure, medical cannabidiol marked for transportation to a dispensary or the
With respect to the prevention of degradation, MedPharm Iowa has designed both its
manufacturing process and its packaging to protect plant material and medical cannabidiol against
physical, chemical, and microbial contamination and deterioration of the product and its container.
Please refer to Section 3.02, Part C , Subpart 5 for more information on packaging of medical
cannabidiol and Section 3.02, Part C , Subpart 9 for more information on the design o f its
manufacturing process, including without limitation the separate grow chambers.

Part C , Subpart 9<?.,

Exhibit A

c
*3I
WALI -IN
he B D W L fj r J r f:> t User p r o g r e m m e b l e ' \ e t e n d forget" EWFTIS tm-<:i: t h e

r b - crirribe~r'c cpe-rcfticm. ven-J'j u h j ^ t n * d p o i n t s This elio-ws
hambe-r t ur t fW e prcc for ^xt^pdo nelly Gzcutate monitoring wrthcu? th? w t d for
I r e-djustmfrnt every time the set point h redefined. Baclaip ' high ' 1
p t vpe
ughout Sow a WHYS p r o v i d s & furthef level o f p r o t e c t i o n v.'hile visual
nten DOUCM end audible notHi cation; is provided vvhert eny etWm &:liv'sted.
-i Contacts for corinertkyn to a building mtnegerrient system are
i e I - t e k o indu-ded.
B
High hoht e v & i k b m t y with u n p e r a i l e l e d ligh: u n i f o r m i t y
lirtmgpi <- C > i " t ^ k n p I~ft rr ngt&^ best trenivfer t o charnb-er eres
I I r I1 - ijr Tr 0
B
T o p dov/n aiHIc-Vi' for 'j-riiform pfsrvt c a n o p y terrvperetures
t r t h ^ I t f- tp- t \.k E
Extended h e i g h t f o r g r o w t h o f [&rge- pie-nts t o m a t u r i t y
IF I \ r IUJ h a
M o d j i e r d e s i g n t o er-co'irimodaiei terger sires
I l J
e
Product c e r L i f ^ & t k u W m e r W r i g s ; ,CGA ... [NRTL), CE
U i 1 r T ii J f
:T e
Lrn -j- p K a. ct ^ r ~i tn
c t,
t , r
c reujr- tr e J n ' I * Li
B
fcltc-i^^r e. e r e *nl > ' r
f
*-n c if 1 "Tp I r*'f t f
1 E
tr r ie- 1 * -i - e. p- F l f p w ju xt_ T n
r r r E
f er e ^ T p i ' - g T n" t ~ ^' -
e:>.ch&nqe air TD t n * chsmfc-ef.
* in f rf
EC e 1 pr~ iHedbj * 1 rte r e d
et^-r d n i n - ur t li n t r c t_,pe f*_
c H I c r^f
- L r p e t T i - J - el^ t~r rr d q
e e p r 1 e t i t p n j : ^rctLr^ w
n i t . L *- i- er ur r r <-t
c r
i_p- a r - ure r r c c * e e> r I J ft- i c r
l
tr e cle ci J f re r c - s r ^ t e n ^ f - m p " refr -p^ret cn
4
r-ft j - ^ .
Q etl^ D * p t r f ^ r
rE e e t* - p-c f e r a u r-
r
Q*t r C-J f r^r~e-nt c L t ^h^ t rcr ej^tcn
x
intormiS'ion end otner rerrigratjGre optsons.
T*mpritur Growth Weight

R i n g * {'C| Cipttcir/ Area {WxDxH) (6m. frwTf limp)
10-40 Sghb on 316 ft 3

40 ft 3
95" 120"x70"x H 4 i 5 " 1000 jjmofe'W/c 12O''205-3J2^CIHZ 24851b.
4 - 4 0 tghte off (8920 L) (3.7 m'") (24 i 5 mm) SOSOx 17Bx2?CC'(mrnS S2S'C 2WJQO-30-SOHI (f 127fcgS
BDW90 10 - 4 0 tghb on 640 ft 1
EO.^ft ' 1
95" 133" x 133,26" x 11456" 1100|amo^''rn"7[. [3:i.''206-Se>-6CHi 38601b.
4 - 4 0 Sghts off (1BI20 L) (7.6 m') (24 "i 5 mm) SOS0 X 8385 >:290iD(mm) 23a'4O0-5<d-KiKx (t 761 kg)
1040 t . j h t on 964 *>. 121.7 fr- S'S" 120" x 196.5" >;!! 45S" 1 iODfjn-.ofa/m-Vs 120;2^S'2>-60Ki 52401b.
4 - 4 0 tiît; off [27 i&OL) ( l U m f ) (24 IS mm) 8050x4Wi x29CO(mmJ #25" 29a'40O-34?>-SOHi (2377kg)
BOV/160 W-40!i|jTfc on t2SSft> 162.2 ft 3
95' T
133" x 259.76" x 1)4.25" liCOjjmoWi-nVs 12Q/20S-3'2HS0HI 52401b.
4 - 4 0 i<ghfc off (36385 0 (15.1 m ! (24 IS mm) 3050 x 65K x 2W0 (mm) ;
i32S" 2 / 4 0 0 - 3 i d H i (2377fcg)
MedPhami Iowa, L L C
E ' D W 'SERIES
1. STANDARD RBFRBtfiATIGN S Y S T E M IS WATERCOOUEO (3WW(l9mm<5) CONNECTION).

2. DEPTH OMENSWfl IS CHAMBER S I M ONLY. DIMENSION D O E S NOT INCLUDE OOOfi LATCH.
3. LENGTH AND WIDTH DMENSiONS i1M{Srcrn). HEIGHT u MENS ION i r ( 2 S m m ) .
- COWOENSWQ UNIT
BARRIERED LAMP LOFT
LAMP LOFT C O O U N G 00*. -
NTROL PANEL
SECTfGMM- LAMP BARRIER
(HUGHS DOVW K3R LAMP
AND BALLAST SERVICING)
- CfiSRVATtQWiHDOWC
1 LIGHT TIGHT COVER
DUAL SIDEWALL MOUNTED
o - AIR HANDLEWHEAT
EXCHANGER PLENUMS
IP -FRESH AK (2)
[ -
1
-
m MAWC0CLWGC0C(2)
- INSTRUMENT PORTS (2)
FRONT VIEW SECTION A-A
FLOOR DRAW OTHERS)
EXHAUSTCOLLAR 40 ( 1 Q 2 n i m 0 )
CLECTRICAL CONNECTION PQMT
PLAN VIEW
BDW40 PLANT GROWTH CHAMBER

D A T E ISSUED: 06/(9/09
DRAWING NO. 231 172
1. STANDARD R E f R l G G R t f ION SYSTEM B WATER COOLED (3M*0 (IftnmB) CONNECTION).

2. GONDENSMQ UNff MS0URE6 SfcPERATE ELECT'tSCAL SERVICE (6CAPPUCATK3N ONLY).
3. BEPTH DIMENSION SS CHAMKH SlfflE ONLY. DtMENStONDOES NOT INO.UDE DtKWLATCH-
4. LENSTH AND Wt)TH EsWWSClNS i l / 4 (6nro). HEffiHTD!MENSiONir(M5rmi).
-CONDENSING UNIT
BAftftiEftD LA**" LOFT
LAW* LWT COOUNGCOC
- CONTROL. BAN EL
SECTIONAL L A I * BARRIER
(HlNGEDDOWNPOKLAMP
AND BALLAST SERVf GNG)
- OBSERVATION WifJDOW QW
UC-MTTBMT COVES
DUAL SJBEWALL MOtNTEC
AJR HANDLEWHEAT
EXCHANGER PLENUMS
-SHA(2)
MAIN COOLING O0i_(4)
- MS'TRUM6NT PORTS (i)
FRONT VIEW SECTION A-A
8DW80 PLANT GROWTH CHAMBER

DATE ISSUED; 06'19/09
1
DRAWING NO. 23i 173 '' ' li ' I ' ' 11 I l " i ''II ,
MedPharm Iowa, LLC 190
BDW5ERE
1.OTMJARDRHW3ERATK>NaYSTEMIS WATER COOLED tHIB (fftwtB) COhKECTICK)

2-CQMDEM8W3 UHT R E C f J S SEPERATE ElECTRJCAL SERViCE (6GHZAFPUCATMK (KLY).
S.DEFTHKME^SC&J 63 Q f i M S E R SIZE CMY. D ^ N 3 D N D C SfcKJTWCLUOSOQOR LATCH.
4.LENGTH A \ 0 WOTKD MevS'O^.S 1/4 :\ j H^'CKT D M ^ . a i O ' . tl" <"S",V- )
-CGNOENSNQUOT
BARRIERED LAMP LCFT
U W P L D F T C C O . ','3 C O L
-CONTROL R W E L
aBCVOWL LAMPB/fiRMR
S
(MHO ED DOWN F O R LAMP
A M ) BALLAST S E R i / K K f i )
-CBSERVATKM w w o c w a n
U G K T T K H T COVHi
S3* (2MOmtTii)
DUAL SDEWA1L M O U M T E D
AR KAHKERiHEAT
EXCHANGER PLEWIM3 -
-FRESKAIRP)
UAM COO.WO C O L (6) -
=STRUMEKT PORTS p)
FRONT ELEVATION SECTION A-A
1ff-ff (5Q5)mm)
-FLOORDRA1N pif OTHERS)
- E X t a U S T C O U A R 6T0 ( m t u t O )
-
-,FtrijrrTna---
ELECTRtCAL COMNECTSOU POUT
PLAN VIEW
B D W K 20 PLANT GROWTI
DATE ISSUED: CS/'iWW I'M
DRAWING N 0 2 S I 1 7 4
MedPhann Iowa, L L C
/ 7
^milium i *
A1000
RLACH-IN
MedPharm Iowa, LLC
RE A C I {-IN
j n rn I I ^ I n 11/ n >li J n ndl'L*

LI ill v I
I i i f 111 i L I i nil uai'di
Hi It il II, t d r L 1 m n
I h I i ul i L -i q i i r In 'purr'-'
, !l I II h f U h n n I I
I ir in ilr h i h r l r h ~] i ri r r Iv In n - n
4 i[ i | ( 11 It L i i L i L L iL ill I I
i II Ir r I i i l r I il h
n f I, il llil
P 6 Kit hemqsidbon
1 r II I J I J n r 1 r I ar ) r i ri 1 Ft.r n r 11 \ t I rf II I
II I I c 1 III 11 r III r J anopy 1 r i I p lly d I LTV I i
I 11 I I p f i u It t u it 1 11 Jl rf t i r i I I il II j i l l
II Ir I hi il I rl t r I rn I r II rn r i r r tnt I r fit r f a, r 11 1
i T i Ir If p 1 Id I rl I r lltlons. j I I i i t r r r i l LI rr
A R Krt : : i-r.- > - - J ! LI L.I . i'n'i|i'-i.il:/ll
f I 1 k r m II i i r ,uch as A / a b l d o p s l s , t h e A R Kit l i e f t l i t i r M r
,l?es efficiency b y p i d l n g live, ( a l l y - u s a b l e g r o w t h t f IN r l lircnt Hi rl il I
H i p
r L
r [ icipte;. A n d with horizontal
d t o capacity without
hi ll r t r rJr ,
II 11 r 1 h h I
I i J jl I rr / " III al f r > p irr
r I i jlr I rll i t i II i II nr t h i
t ul I I T f r i l l 1 IL I L
For Tissue C u l t u r e a p p l i c a t i o n s . To h e l p r e d u c e
c o n d e n s a t i o n o n research s p e c i m e n s , this c o n f i g u r a t i o n
I a; Lh I H riu= y d tl tr fc uI t
delivers p r e c i s e l y c o n t r o l fed vertical a i r f l o w l o e a c h
di ii if f.1 ion
I n d e p e n d e n t l y 111 a n d t h e r m a l l y broken Her.
IN K i t Precisely d e s i g n e d a i r f l o w a n d l i g h t i n g c o n f i g u r a t i o n s
for e a c h a p p l i c a t i o n
C r e a t e d for t h e I n c u b a t i o n of p l a n t l e t s a n d Inserts, t h e
I N Kit p r o v i d e s m a x i m u m f l e x i b i l i t y w i t h r e m o v a b l e a n d Observation w i n d o w
a d j u s t a b l e l a m p M u r e s a n d shelves. A d d l t l o r i a l shelves Casters for ease of m o b i l i t y
a n d l i g h t i n g are a v a i l a b l e t o m a x i m i s e u t i l i s a t i o n of t h e
Product c e r t t o B c f i s t o a r B n g s ; ,-CSA^ SNRTL), CE
c a b i n e t ' s 1000 litre capacity.
By v a r y i n g t h e c o n f i g u r a t i o n o f t h e airflow, l i g h t , a n d
s h e l v i n g , e a c h k.11. d e f i n e s o n e of t h e f o u r a p p l i c a t i o n s .
T h e A 1 0 0 D Is also a v a i l a b l e w i t h several o p t i o n s such as
p h e n o l i c c o a t e d colls a n d n e t w o r k c o m m u n i c a t i o n . T h e
p h e n o l i c c o a l e d colls e n a b l e i h e A10D0 t o b e u s e d for
e n t o m o l o g y research while the c o m m u n i c a t i o n s o p t i o n
f a c i l i t a t e s c o n n e c t i o n t o a facility's l o c a l a r e a n e t w o r k .
Lighting
T h e l i g h t i n g systems for t h e A 1 0 0 0 I n c o r p o r a t e h i g h efficiency

T5 fluorescent l a m p s . L i g h t i n g s y s t e m c o n f i g u r a t i o n is
d e t e r m i n e d b y t h e a p p l i c a t i o n kit w h e r e each M l stipulates
a particular light Intensity a n d l a m p c a n o p y c o n f i g u r a t i o n .
L a m p a n d ballast c o m b i n a t i o n s have b e e n d e s i g n e d t o
ensure a b a l a n c e d light s p e c t r u m while l i g h t Intensity levels
are a d j u s t e d CAR & PG Kits only) t h r o u g h a s t e p p e d s e l e c t i o n
process. O t h e r l i g h t i n g solutions are available I n c l u d i n g h i g h -
light 'light i n l e f f i l t y umoF) a n d e n a g y - s a v i n g t E D s .
Airflow
Precisely d e s i g n e d a n d m a n u f a c t u r e d air p l e n u m s are u s e d

for each' o f t h e four a p p l i c a t i o n kits. T h e Plant G r o w t h kit
utilizes a s o l i d rear p l e n u m w h i c h d i s c h a r g e s air f r o m t h e
floor dor a u n i f o r m u p w a r d airflow. T h e A r a b l d o p s l s a n d
I n c u b a t i o n kits; b a t h use a p e r f o r a t e d rear p l e n u m w h i c h
MedPhann Iowa, LLC
( O N V I K U N IVIUDLL A i o i K ;
r / M il || A i r L ! ' l A l i ( /il J IAiv:l:.i::
PG KIT A R KIT TC KIT I N KIT

C o r t r o l System CMP4010
Exterior Dimensions
H e i g h t (in. / m m ) 79 / 2005
W i d t h On. / mm.) i,\ / 1 0 4 0
D e p t h (in. / m m ) 32.5/825
D o o r s w i n g r a d i u s (m. / m m ) 3 9 . 2 5 / 1000
Interior Dimensions
H e i g h t (in. / m m ) 54.5/ i;s
W i d t h (in. / m m l 27 / 9 4 0
D e p t h (in. / m m ) 25 / 625
Environmental Control
T e m p (lights off) 4C - W'C
D
T e m p (lights on) 10 C-45C

T e m p Tolerance 1: 0 . 5 ' C
A d d i t i v e H u m i d i t y (lights o f l ) Resultant t o <m. RH l i m i t e d by +2SC d e wr p o i n t
A d d i t i v e H u m i d i t y (light* on) 75%
A d d i t i v e H u m i d i t y Tolerance i 6%
Light Intensity ( u m o i ; 2 5 * C I 700 BOO 225 125
Lighting
# of L i g h t c a n o p i e s . / Fixtures 1 canopy 2 canopies 4 canopies .'< fixtures II par shslf)
L a m p s per C a n o p y / Fixture 14 6 4 2 per fixlure
Airflow Direction Uniform Upward Uniform Horiiontal U n i f o r m Vertical Uniform Horizontal
Growth Envelope
Shelves 1 adjustable 2 adjustable 4 adjustable r\ a d j u s t a b l e
T o t a l G r o w t h A r e a (ft' / m d 6.13 / 0.57 1 1 . 3 / 1.05 22.6/2.1 22.6/2.1

G r o w t h H e i g h t (r,. / m m ) 42/1065 18/460 6 / 152 10/250
Growth Volume (fr /Litres) 5
2?.2/82*
Corstryrtior,
Back W a i l P l e n u m
solid w i t h
Conviron Unlfloor" perforated ^ÊEF" P e r f o r a t e d
Exterior Finish powder-coated steel

Interior Finish reflective w h i t e p o w d e r c o a t
O b s e r v a t i o n W i n d o w H e i g h t (In. / m m ) 35.25 / 5 9 5
O b s e r v a t i o n W i n d o w W i d t h (in. / m m ) 6/150
I n s t r u m e n t Port fin. / m m } 2/50
Refrigeration System CFC-free refrigerant
A l l - c o o l e d c o n d e n s i n g unit w i t h h o t - g a s b y p a s s - c o n t i n u o u s o p e r a t i o n
W a t e r - c o o l e d ' c o n d e n s i n g unit a v a i l a b l e - c o n s u l t f a c t o r y
Electrical Service 6 0 H z - *2i0-iS-6OHz-2
SCHz - 230-10-S0Hz-2
LED L i g h t i n g Yes Yes N/A N/A
H i g h - L i g h t (light i n t e n s i t y umoi) 1100- N/A 400 200
A d d i t i o n a l Tier N/A Yes N/A N/A
Low Temperature
W a t e r C o o l e d C o n d e n s i n g Unit
CO., BP C o n t r o l S y s t e m Yes
Phenolic C o a t e d R e f r i g e r a t i o n C o i l Yes
4 " Exhaust Colls? Yes
f
R e ^ u ; K mD-jTic^lion to powr supply. Plr^M ccnsult Lido.7. Sp-Bdiic-sUcrs rnrjy vary depending on region.
MedPhann Iowa, LLC
LO : R o N M O D P L A'fOOO
OONTROtrWH.
POWER SWITCH FAN FEfrD COMTRCX.
ARVENT^,
(FORPOOM-V)
OBSERVATION
meow' 11
ifBTRAIENT
PORT '
TO
<rOO(1Q40nill) 32 tST OD (B25mrJ
FRONT VIEW SIDE VIEW
POWER SUPPLY - CENTRAL ALARM COM/ACT

VOTER SUPPLY " - CC*L#CATICW PORT
5
GOMDEKSATE PLW
PLAN VIEW
NOTES:
1. REOURES MMMUM OF ? (5)rrm) FROM REAR OF CHAMBER TO BKX WAL. '0REOUREB SKHTmni)
VVTIHEXBALBT COLLAR)
1 LENGTH AND MOTH D S 6 I O N 3 W (Enml HEIGHT OflEMsiON 4 f (2Srm).
DO NOT SCALE THE DRASMNQ.
1 PQ KTT1REOUREEfcWMUMOF 4* (Iffimr,! SPACE BETWEEN C A B ^ T S .
A1000 M I J LTI - A P P L f C A T 10 N CHAMBER

DATE ISSUED: 1 2 / 0 3 / 1 4
D R A W I N G N0.2J1tS.
@ Msnsg-Emonl Slalom Ceriîod to ISO 9001 '.WAV.cDnvfrort . c o m | s n f c l i c c r ^ v - D r i . c o i r i

r \
MedPhami Iowa, LLC
mmi
I O N V I R O N
The Conviron Growth House''" offers the large growth capacity of a research greenhouse
with the tight temperature, light and humidity controls of a reach-tn chamber.
Ideal for large scale plant propagation studies r e q u i r i n g a growth area anywhere
2 2
I r o m 300 ft t o 2000 ft or above, the Conviron Growth House" can be configured t o
fit a designated area inside your existing facility or installed outdoors as an adjacent
or stand-alone structure.
Liqhttnq
Various lighting configurations are available. For example, units can bs designed with a High Intensity
Discharge (HID) lighting and support system similar to that used in a high-performance research
greenhouse. Thin enables units to achieve light level intensities similar to those of Conviron's standard
walk-in rooms. Other lighting systems, features end options can be designed to your specifications.
CurfHertJaL.... sfu77
MedPhann Iowa, L L C
0OMO3
c
"7h f- Cony iron Growth Houb^' ulHtu , tht-
exceptional growth CdtjBUiy of * grênhnuie-
with precise errvimn/ne/tt^l controls ycu firW in a
1
teach-in growth chamber, '
Airflow
Using en innovative design, a top-down airfiow pattern uniformly disperses conditioned air from the top
of each plenum and returns the air through conditioning coils located at the bottom of the chamber area.
Filtered and adjustable fresh air intake and exhaust openings enable researchers to manage exchange air to
the chamber
Refncje ratio n
Cooling for the Conviron Growth House is provided by a self-contained water-cooled condensing unit with
hot gas bypass for continuous compressor operation. An electronic modulating valve provides tight temperature
control while ensuring quiet operation. Pressure transducers monitor the status of the refrigeration system.
Alternative refrigeration methods ere available depending on site-specific and/or user defined requirements.
Information on heat rejection and other refrigeration options are available upon request.
Experiment Protection
User programmable alarms track the unit's operation versus user-defined set points. This- allows for
exceptionally accurate monitoring Without the need for
adjustment every time the set point is redefined. Backup
"high/low" alarms, provide a further level of protection
v.'hile visual and audible notification is provided when any
alarm is activated. Contacto for connection to a building
management system are also included.
irrigation, Fertigation rand Phenotypmg

To maximize floor space and reduce plant handling and
maintenance associated with Serge scale plant growth
experiments, units can be equipped with a plant conveyor
system and outfitted with automated irrigation and
fertigation capability. For highly specialized phenotyptng
applications, imaging and high throughput screening
systemic can also be integrated.
C 6 N V I R O N
Confidential s*at??
M50QQ4
interior fnr.iaiic
The Conviron Growth House offers g

compelling alternative for scaling up research
experiments compared to 'what has historically
required a greenhouse or multiple controlled
environment rooms, installed indoors,, the
Conviron Growth House can make use of
available space and integrate seamlessly into
the research facriity. Available *n many size
1
configurations, the Conviron Growth House**'
ensures available space within your facility is fully
utilized - maximizing your growth area.
Cv^fhssd '/i^'-v of CcnvtrcT> Omyrth Hc^:e^

Ice-iling no: i h o ^ n )
CorfWeitlal tut>?
MedPharm Iowa, LLC
Should ..pace be a In 11 tdiion at your facility, the

Conviron Growth House can be constructed at a
suitable location outdoors - adjacent, near your lab
or on a rooftop.
Constructed with bonded paneling, the interior

i ft* of the growth house is not visually exposed as it is
\
with a greenhouse and therefore light pollution is
eliminated and the security of the facility and the
experiment is enhanced.
?vt\ v ?'.'.' c{ 'C'crv7i"c~ Gnj'.\lf. H c ^ : * installed &d:csrT: to

lifting leb
III ' h 'I,
CooOdntlat_... W 7 ?
0OXO6
Key Product A t t r i b u t e s
Exceptionally large growth area
Precise and repeatable environmental control including Temperature, Light and Humidity
Customizable options include lighting, refrigeration, additive CO,,, irrigation, fertigation, and
construction method
Optional construction for outdoor use
Integration with plant conveyor and high throughput plant phenotyping systems
CortMaitM_._ *\a!??
OOD0O7
Oisi'omizfibie Dimension;,
The length, width and height of a Conviron Growth House" are fully customizable. A typical plan view is
shown be?ow.
f e r f o i" m a n c e L) a t a
Sample Sizes Temperature Range Light Intensity Relative Humidity

(If) C
( 'C) {~1rn from lamp) {%)
300
600 15-35 lights on up to 1100 umoles/nvVs. "fC
1200 12-35 lights off 25C
20CO
'Designs in excess of 3000 ft? also available.
ConrM6fitlal._... raR?
S E C T I O N 3 . 0 2 , P A R T C , S U B P A R T 10: Q U A L I T Y A S S U R A N C E AND C O N T R O L
a. Describe the elements of the quality control program, consistent with proposed
administrative rule 154.26, including the qualifications of staff involved in sampling,
laboratory testing, and determining product purity and stability. Include the experience
and credentials of any person employed by the applicant who has expertise in laboratory
testing and stability testing, including the person's name and position.
MedPhami Iowa has developed its quality control program through a number of standard
operating procedures that employees w i l l be required to follow. References to those procedures
area included throughout this Section 3.02, Part C , Subpart 10. This program, among other things,
assess the chemical and microbiological composition of medical cannabidiol; prescribes the
sampling protocols MedPharm Iowa w i l l utilize; describes quality testing procedures, both in-
house and with the laboratory; and provides MedPharm Iowa's recall and market withdrawal
procedures.
MedPharm Iowa w i l l staff its team with a Quality Assurance Manager and a Quality
Control Manager. Although these positions have not yet been filled, job descriptions are included
in Section 3.02, Part C , Subpart 12b. These team members w i l l be trained and supported by
Kemin, which has extensive experience in quality control programs and training. Kemin's quality
consulting team is led by Elizabeth Nelson, Esq. ("Ms. Nelson").
Ms. Nelson, the Vice President and General Counsel of Kemin, has spent her career i n
applied transactional and regulatory work for public and private enterprises. She has supported the
botanical aspects of Kemin's business with legal advice encompassing regulatory compliance,
organizational structure, tax considerations and otlier aspects of maintaining a secure and
compliant organization. Her experience supports the regulatory and current good manufacturing
practices of medical cannabidiol to ensure that a consistent high-quality product is produced in
MedPharm Iowa's facility.

Please see below for more information with respect to how MedPharm Iowa intends to
comply with proposed administrative subrales 154.26(2); 154.26(4); 154.26(5); 154.26(7); and
154.26(8).
b. Describe medical cannabidiol sampling procedures consistent with proposed
administrative subrule 154.26(2), including:
(1) Sampling protocols;

(2) Documentation;
(3) Labeling; and
(4) Retention of results.
A l l documentation relating to test results, assessment, and destruction of medical
cannabidiol w i l l be maintained for at least five (5) years.

c. Name the laboratory that will be used to conduct testing consistent with proposed
administrative rule 154.26. Provide evidence that the laboratory is or will be accredited
to Standard ISO/IEC 17025 by an ISO-approved accrediting body, has a controlled
substance registration certificate from the Drug Enforcement Administration of the US
Department of Justice, and a certificate of registration from the Iowa Board of
Pharmacy.
MedPharm Iowa w i l l utilize the state hygienic laboratory at the University of Iowa for all
testing required to be performed by a laboratory pursuant to Applicable Law. According to publicly
available information from the laboratory, it holds a controlled substance registration certificate
from the United States Department of Justice and a certificate of registration from the Iowa Board
( of Pharmacy, and the laboratory also lists the following registrations: A I H A - L A P , LLC ISO 17025
Accredited - Ankeny (Lab ID: 101048), Coralville (Lab ID: 102530).
d. Describe the testing procedures consistent with administrative subrule 154.26(4),
including expected frequency and volume of testing; the type of testing that will be
requested; protocols for samples that fail to meet acceptance criteria; and procedures for
documenting test results, assessments, and destruction offailed product lots.
MedPhann Iowa has detailed its process for meeting proposed administrative subrule
154.26(4) below in Section 3.02, Part C , Subpart l i e . please see that Section, including the
standard operating procedures noted, for more information.

e. Describe how the stability testing procedures detailed in proposed administrative subrule
154.26(4) will be met. Include a description of.
(1) Procedures for stability testing of each product type and determination of storage
conditions;
(2) Plans to involve dispensaries in shelf life studies;
(3) Intervals for testing; and

i (4) Timeline for the development of the stability testing program.
/ Describe the procedures for reserving samples from each lot consistent with proposed

Describe the process to collect, review, analyze and determine actions needed when
information on adverse events from patients using the medical cannabidiol is discovered.
Describe recall and market withdrawal procedures consistent with proposed

administrative subrule 154.26(8). Include a description of:
(1) The factors that would make a recall or market withdrawal necessary;
(2) The personnel who would be responsible for overseeing the recall or market
withdrawal; and
(3) How affected parties would be notified, including a projected timeline for the
notifications.
The Product Action Procedures address the factors that make a recall or market withdrawal
necessary. As further described in the Product Action Procedures, MedPharm Iowa w i l l rely on
the Code of Federal Regulations to establish the type of product action that may be necessary; the
type may be a stock recovery, a market withdrawal, or a recall. I n addition, the Product Action
Procedures note that MedPhann Iowa w i l l utilize the classification system defined in the Code o f
Federal Regulations at 21 CFR 7.3(m) to indicate the relative degree of health hazard that is
presented by a product that is to be recalled:
Class I : A situation in which there is a reasonable probability that the use of, or
exposure to, a violative product w i l l cause serious adverse health consequences or
death, such as inclusion of a toxic or incorrect level of an ingredient, an adulterant or a
critical defect (i.e. high levels of metal shavings, glass particles or undeclared
allergens).
Class I I : A situation in which the use of, or exposure to a violative product may cause
temporary or medically reversible adverse health consequences or where the
probability of serious adverse health consequences is remote, such as product efficacy
failure, inclusion of an incorrect ingredient, an adulterant or a serious defect (i.e. low
levels of metal shavings, glass particles, unapproved food additive, undeclared wheat,
etc.).
Class Ul: A situation in which the use of, or exposure to a violative product is not likely
to cause adverse health consequences such as mislabeling, incorrect level o f
ingredients, separation of liquid products, minor product efficacy concerns, etc.

MedPhann Iowa, LLC j 210
( Part C , Subpart 10//.

Exhibit A
i
CONFIDENTIAL pursuant to Iowa Code Sec. 22.7(3} & (6)
Part C , Subpart 10//.

Exhibit B

M e d P h a r m Iowa Product Name: Softgel

CERTIFICATE OF ANALYSIS Product Number:
1. Potency Testing
Limits mg/g
Characteristics Test Method Results
Min. Max.
THC External Lab
THCA External Lab
Total T H C 1
Calculated 1
ND 10
CBD External Lab
CBDA External Lab
Total C B D 2
Calculated 2
.85 1.15
CBG External Lab ND ND
CBN External Lab ND ND
1
THC= M delta-9 THC+ (0.877 .v M delta-9 THCA).
2
CBD = M CBD + (0 .877 x M CBDA)
2. Solvent Action Items
Chemical
Action Level
Solvent Abstract Services Results
(CAS) Registry (mm)
1,4-Dioxaue 123-91-1 380
2-Bntanol 78-92-2 5000
2-Ethoxyethanol 110-80-5 160
2-Propanol (IPA) 67-63-0 5000
Acetone 67-64-1 5000
Acetonitrile 75-05-8 410
Benzene 71-43-2 2
Butanes See 3
50004
Cvtmene 98-82-8 70
Cyclohexaue 110-82-7 3880
Dichloromethaue 75-09-2 600
Ethyl acetate 141-78-6 5000
Ethyl ether 60-29-7 5000
Ethylene glycol 107-21-1 620
Ethylene Oxide 75-21-8 50
Heptane 142-82-5 5000
Hexanes See 5
290
M e d P h a r m Iowa Product Name: Softge

CERTIFICATE OF ANALYSIS Product Number:
Isopropyl acetate 108-21-4 5000

Methanol 67-56-1 3000
Pentanes See6 5000
Propane 74-98-6 50007
Tetrahydrofuian 109-99-9 720
Toluene 108-88-3 890
Xylenes See8 21709
3
T o l a l butanes should be calculated as s u m o f n- butane ( C A S # 1 0 6 - 9 7 - 8 ) and iso-butane ( C A S / / 7 5 - 2 8 - 5 )
! L i m i t based o n s i m i l a r i t y to pentanes
5
T o t al hexanes should be calculated as s u m o f n - hexane ( C A S # 11 0 - 5 4 - 3 ) , 2-methylpentane ( C A S # 107-
6
83-5), 3-methylpenlane (CAS#96-14-0),2,2-dimetliylbutane (CAS#75-83-2),2,3-dimethylbutane(CAS# 79-29-8) Total
pentanes s h o u l d be c a l c u l a t e d as s u m o f n - pentane (CASH 1 0 9 - 6 6 - 0 ) , i s o -pentane ( C A S # 7 8 - 7 8 - 4 ) , and neo-pentane
(CAS# 463-82-1)
7 L i m i t based o n s i m i l a r i t y l o pentanes
s
T o t a l x y l e n e s are 1, 2 - d i m e t h y l b e n zene ( C A S # 9 5 - 4 7 - 6 ) , 1 , 3 - d i n i e t h y l b e n z e n e ( C A S # 10 8 - 3 8 - 3 ) , a n d 1,4-
d i m e t h y l b e n z e n e (CASH 106-42-3).
9 T l i e a c t i o n l i m i t f o r xylenes is based o n c o m b i n e d t o x i c i t y o f die xylenes listed i n footnote 8 p l u s e t h y l benzene ( C A S # 1 0 0 -
4 1 - 4 ) , w h i c h is not a x y l e n e . E t h y l benzene and x y l e n e s should be measured and reported separately, but the s u m o f
xylenes and e t h y l benzene should be calculated f o r c o m p a r i s o n against the action l i m i t f o r xylenes
3. Analyte Action Items
Chemical
Analyte Abstract Services Action Level ppm Results
(CAS) Registry
Abamectin 71751-41-2 0.5
Acephate 30560-19-1 0.4
Acequinocyl 57960-19-7 2
Acetamiprid 135410-20-7 0.2
Aldicarb 116-06-3 0.4
Azoxystrobin 131860-33-8 0.2
Bifenazate 149877-41-8 0.2
Bifenthriu 82657-04-3 0.2
Boscalid 188425-85-6 0.4
Carbary! 63-25-2 0.2
Carbofiiran 1563-66-2 0.2
Clilorantraniliprole 500008-45-7 0.2
Chlorfenapyr 122453-73-0 1
Clilorpyrifos 2921-88-2 0.2
Clofentezine 74115-24-5 0.2
M e d P h a r m Iowa Product Name: Softgc

CERTIFICATE OF ANALYSIS Product Number: yy i
C^rflntlii in 68359-37-5 1
Cypermethi in 52315-07-8 1
Darninozide 1596-84-5 1
D D W (Dichloivos) 62-73-7 1
Diazinon 333-41-5 0.2
Diniellioate 60-51-5 0.2
Efhoprophos 13194-48-4 0.2
Elofenprox 80844-07-1 0.4
Etoxazole 153233-91-1 0.2
Feiioxycarb 72490-01-8 0.2
Fenpyroxiniale 134098-61-6 0.4
Fipronil 120068-37-3 0.4
Flonicamid 158062-67-0 1
Fludioxonil 131341-86-1 0.4
Hexythiazox 78587-05-0 1
Imazalil 35554.44.O 0.2
Irnidacloprid 138261-41-3 0.4
Kresoxim-niethyl 143390-89-0 0.4
Malarhion 121-75-5 0.2
Metalaxyl 57837-19-1 0.2
Methiocarb 2032-65-7 0.2
Methomyl 16752-77-5 0.4
Methyl parathion 298-00-0 0.2
MGK-264 113-48-4 0.2
Myclobutanil 88671-89-0 0.2
Naled 300-76-5 0.5
Oxamyl 23135-22-0 1
Paclobutrazol 76738-62-0 0.4
Permetlirins 1 52645-53-1 0.2
Phosniet 732-11-6 0.2
Piperonyl butoxide 51-03-6 2
Prallethrin 23031-36-9 0.2
2 Pyrethrins shovtld be measured as tlie cumulative residues of pyrethrin 1, cineria I, and jasmolin I (CAS numbers
121-21-1, 25402-06-6. and 4466-14-2
respectively).
M e d P h a r m Iowa Product Name: Softge

CERTIFICATE OF ANALYSIS Product Number: uut
4. Metals Action Items
Action Level for Action Level for

Action Level
Suppositories, Topical and
for A l l Inhaled
Sublingual Products, Transdermal
Heavy Metal Medical Results
and Other Medical
Cannabis
Manufactured Cannabis
Goods (ugig)
Products (iigig) Goods (|.igig)
Cadmium 0.5 0.2 5.0
Lead 0.5 0.5 10.0
Arsenic 1.5 0.2 3.0
Mercury 3.0 0.1 1.0
5. Microbial Action Items
Microbial Action Level Method of Analysis Results

Shiga toxin-prodcing
N D in 1 gram USP
Escherichia coli (STEC)
Salmonella spp N D hi 1 grain uso
Aspergillusfiimigatus N D in 1 gram F D A -BAM
Aspergillus jlavus N D in 1 gram FDA-BAM
Aspergillus niger N D in 1 grain FDA-BAM
Aspergillus terrens N D in 1 gram FDA-BAM
Confirmatory steps must be conducted on all presumptive positive results.
Quality Analyst Date


Exhibit A
[Please see the following page.]

MP! R E T U R N E D G O O D S AUTHORIZATION RGA No
Originated by
Customer Name Contact Customer #
u Ship to No Phone Date
Original order #
Street Address
o
C2 State Zip Collect freight authorized? Y N

CO
rH City
Country Replacement order # Y N
CD
Reason for return Credit? Y N
Credit #
QC Analyst Signature Date:
QC Investigation:
OA Signature Date:
Disposition: (check one) Rejected: Slate for disposal
CUSTOMER SUPPORT RECEIVING INVENTORY

Units Actual
Auth for Original Units Lot/ Whse
Return Part N u m b e r Lot/Serial No. Rcvd. Part No. R c v d . S e r i a l No. Location Date Disposition
Returned via Date Received: Received by:
PRINTED C O P I E S A R E UNCONTROLLED AND A R E ONLY Page 1 of 1

VALID IF THE VERSION IS THE SAMF - MASTER ELECTRONIC DOCUMENT " '. Date:
CONFIDENTIAL AND PF IETARY INFORMATION F avel: 1
S E C T I O N 3 . 0 2 , P A R T C , S U B P A R T 1 1 : S U P P L Y AND I N V E N T O R Y
a. Describe the procedures for ensuring a reliable and ongoing supply of medical
cannabidiol to the dispensaries consistent with proposed administrative rule 154.27.
Include a description of:

MedPharm Iowa appreciates the need for a reliable and ongoing supply of medical
consulting team has many years of experience in ensuring reliable and ongoing product supply.
Many of these features are layered throughout MedPhami Iowa's entire operation. I n addition,
please also find below a response to each specific question posed by the Department.
(1) Inventory controls and procedures to prevent and detect diversion, theft, or loss in a
timely manner;
Please also review the inventory management procedures described in this Section 3.02,
P a r t C , Subpart 11, including SOP MPI-llaOOl Inventory Management (included in Section3.02,
Part D.: Operating Documents).

(2) The process for any employee to report the suspected or confirmed diversion of
Cannabis plants at any point in the manufacturing process;

MedPhann Iowa considers the protection of Cannabis plants, partially-manufactured
goods, and finished medical cannabidiol products paramount to its success as a medical
cannabidiol manufacturer in Iowa. Accordingly, in addition to the other policies and procedures
meant to protect its inventory that are described herein, MedPharm Iowa has established a
whistleblower policy for its employees and consultants, pursuant to which any employee or
consultant may submit a complaint, including without limitation regarding the suspected or
confirmed diversion of Cannabis plants. As part of its contractual duties with MedPharm Iowa,
Kemin would be responsible for compliance with and enforcement of with MedPharm Iowa's
whistleblower policy. A copy of this policy is attached hereto and incorporated herein as Part C ,
Subpart 1 lflf.(2), Exhibit A.

(3) Systems for maintaining a real-time record of the inventory of plant material and
medical cannabidiol should the Department's secure sales and inventory tracking
system not be available;
Regardless of whether the Department's secure sales and inventory system is operational,
MedPhann Iowa w i l l utihze its Tracking System to maintain a real-time record of the inventory of
plant material and medical camiabidiol. The functions of the Tracking System with respect to
maintaining a real-time record of inventory are described above. The Tracking System w i l l either
provide a report that MedPhann Iowa w i l l then provide to the Department, i f the Department's
system is not operational, or it w i l l integrate with the Department's secure sales and inventory
system to provide the same information, in the event the Department's system is operational.
(4) The personnel who will conduct inventory and the schedule for the inventory.
b. Describe the procedures for inventory of medical cannabidiol waste and plant material
waste consistent with proposed administrative subrule 154.27(4), including the
personnel involved and the schedule for the inventory.

Describe procedures for inventory reconciliation consistent with proposed administrative
subrule 154.27(5), including the personnel involved and the schedule for the inventory
reconciliation.
Part C , Subpart 11<I.(2)

Exhibit A
MEDPHARM IOWA - WHISTLEBLOWER POLICY
Procedures for the Submission of Complaints or Concerns Regarding Food Safety Matters
or Cannabis Plant or Medical Cannabidiol Compliance and Diversions (the "Policy").
MedPharm Iowa, LLC (the "Company") is committed to producing products that are safe,
effective and compliant with all applicable state, and local laws and regulations. Every employee
and consultant must be vigilant in maintaining food safety, botanical security, and personal safety
in the acquisition and use of raw materials, the method of manufacture and packaging o f the
Company's products, the storage of finished products and the shipment of products to the
Company's customers. Preventing botanicals and products from diversion is one of the Company's
guiding principles in doing business with medical cannabis. Producing safe products that are
effective for patient use is part of the Company's first valueintegrity with colleagues, our
customers, our suppliers, the patients we serve, and ourselves in all we do. For these reasons, the
Company must maintain a workplace where Company staff members can investigate and respond
to all complaints concerning allegedly questionable food safety activities and diversion activities,
and a workplace where employees and consultants can raise these concerns free of any
discrimination, retaliation or harassment.
It is this Company's policy to encourage employees and consultants to report to the
Company's management (on an anonymous basis, i f employees and consultants so desire)
concerns when they reasonably believe that:
a) questionable food safety activities have occurred or are occurring;
b) botanicals, propagates, oil, other raw material, finished goods or other inappropriate
activity has led to the theft or diversion of these items; or
c) any activity has occurred or is occurring that might lead to the theft or diversion of
botanicals, propagates, leaf tissue, oil, other raw material, or finished goods.
A l l reports w i l l be taken seriously and w i l l be promptly investigated. The specific nature
of the investigation undertaken in any case depends on the nature and gravity of the conduct or
circumstances reported, and the quantity and quality of the information provided.
( Any employee or consultant may submit a good faith complaint regarding the matters listed
above or other matters as described in this Policy to the management of the Company without fear
of retaliation of any kind. The Company is committed to achieving compliance with all applicable
state and local laws and regulations regarding food safety and medical cannabis.
The Company's "Consulting Internal Auditor" will oversee treatment of concerns in this
area. In order to facilitate the reporting and managing of complaints, the Company's Consulting
Internal Auditor has established the following procedures for the (1) receipt, retention and
treatment of complaints regarding food safety and medical cannabis compliance and diversion
prevention; and (2) the confidential (to the extent described below), anonymous submission by
employees and consultants of complaints or concerns regarding allegedly questionable food safety
or medical cannabis compliance or diversion issues.
1. Receipt of Employee Complaints: The Company has designated the Consulting Internal
Auditor as the person responsible for administering this Policy. Information can be
sent to auditor@Kemin.com to initiate a complaint. Employees and consultants with

concerns regarding food safety or medical cannabis compliance or diversion may report
their concerns or complaints regarding these items to the Consulting Internal Auditor
through email.
2. Scope of Matters Covered by These Procedures: These procedures relate to employee
and consultant complaints relating to any questionable food safety items and medical
cannabis compliance or diversion, including, without limitation, the following:
Practices which could lead to spoilage or growth of harmful bacteria;
Use of allegedly harmful additives;
Storage in facilities infested with flies, rodents or other vermin;
Failure by the Company to follow its market withdrawal or recall procedures for
food or medical cannabis products that it discovers are contaminated as defined
by relevant law;
e The use of hannful chemical lubricants in processing and packaging; or
Diversion of plants, propagates, finished products, intermediates or waste
material.
3. Reporting Questionable Matters: The confidentiality and anonymity of persons making
complaints or expressing concerns will be maintained to the fullest extent possible,
consistent with the need to investigate. The Consulting Internal Auditor encourages
employees and consultants to supply contact information with the submission to
facilitate clarification and any assistance with a possible investigation. To assist the
Consulting Internal Auditor in reviewing and, i f necessary, investigating a complaint

or concerns, the employee or consultant should provide as much factual, rather than
speculative, infonnation as possible. To the extent possible, the employee or consultant
should include the following infonnation in the submission:
The alleged event, matter or issue that is the subject of the complaint or concern;
The name of each person believed to be involved;
I f the complaint or concern involves a specific event or events, the approximate
date(s) and location(s) of each event; and
Any additional information, documentation or other evidence which supports the
complaint or concern.
4. Treatment of Complaints: Upon receipt of a complaint, the Manager w i l l direct the
Consulting Internal Auditor to
determine whether the complaint pertains to food safety matters or medical
cannabis compliance or diversions; and
when possible, acknowledge receipt of the complaint to the sender.
Complaints relating to food safety matters or medical cannabis compliance or
diversions w i l l be reviewed under the direction of Manager and oversight by the
Consulting Internal Auditor or such other persons as the Manager and Consulting
Internal Auditor determines to be appropriate. The Manager and Consulting Internal
Auditor may enlist employees and consultants of the Company and/or outside legal,
scientific, regulatory or other advisors as they determine to be appropriate.
A l l complaints under this Policy w i l l be promptly and thoroughly investigated, and all
information disclosed during the investigation w i l l remain confidential, to the extent consistent
with conducting the investigation and taking any appropriate remedial action, in accordance with
applicable law.
A l l employees, consultants, and supervisors have a duty to cooperate in the investigation
of reports under this Policy, and to be free of discrimination, retaliation or harassment allegedly
resulting from the reporting or investigation of such matters. In addition, an employee shall be
subject to disciplinary action, including the termination of his or her employment, i f the employee
fails to cooperate in an investigation or deliberately provides false infonnation during an
investigation. Likewise, a consultant w i l l have a contractual obligation to cooperate in the
investigation.
If, after its investigation, the Company determines that a violation of this Policy has
occureed, the Company w i l l take appropriate remedial action commensurate with the nature and
severity o f the offense, when and as wananted in the judgment of the Manager and Consulting
Internal Auditor. This action may include disciplinary action against the accused party, including
termination or termination of a contract. Reasonable steps w i l l also be taken to prevent any further
violations of relevant policy.
Discrimination, Retaliation or Harassment

The Company w i l l not discharge, demote, suspend, threaten, harass or in any manner
discriminate against any employee in the tenns and conditions of employment based upon any
lawful actions of such employee with respect to good faith reporting of complaints regarding food
safety matters or medical cannabis compliance or diversions or otherwise as specified in Section

402 o f the Food Safety and Modernization Act of 2010 or HF 524 An act relating to medical
cannabidiol and prescription drugs, including the establishment of the medical cannabidiol act,
the federal scheduling of a cannabidiol investigational product, and the exchange ofprescription
drug information, providing for civil and criminal penalties and fees, and including effective date
provisions and the relevant regulations.

The Company also strictly prohibits any discrimination, retaliation or harassment against
any person who participates in an investigation of complaints about allegedly questionable food
safety matters or medical cannabis compliance or diversions.

Any complaint that any managers, supervisors, employees, or consultants are involved in
discrimination, retaliation or harassment related to the reporting or investigation of allegedly
questionable food safety matters or medical cannabis compliance or diversions shall be promptly
and thoroughly investigated in accordance with the Company's investigation procedures. I f a
complaint of discrimination, retaliation or harassment is substantiated, appropriate disciplinary
action, including discharge, w i l l be taken.
Reporting and Retention of Complaints and Investigations

At the direction of the Manager, the Consulting Internal Auditor w i l l maintain a log o f all
complaints, tracking their receipt, investigation and resolution and shall prepare a periodic
summary report thereof for the Manager and the Board of Directors.
A l l documents related to the reporting, investigation and enforcement of this Policy,
because of a report of allegedly questionable food safety matters or medical cannabis compliance
or diversions, or of the discrimination, retaliation or harassment o f an employee that made such a
report, shall be kept in accordance with the Company's record retention policy and applicable law.
Modification
The Board of Directors of the Company can modify this Policy unilaterally at any time
without notice. Modification may be necessary, among other reasons, to maintain compliance with
local, state and federal regulations and/or accommodate organizational changes within the
Company.
S E C T I O N 3.02, P A R T C , S U B P A R T 12: O W N E R S H I P AND F I N A N C I A L S T R U C T U R E
a. Describe the applicant manufacturer's business structure, for example, hut not limited
to, sole proprietorship, limited partnership, or C-corporation.

MedPharm Iowa is organized as a limited liability company under the laws of the State o f
Iowa. Its Certificate of Organization is attached hereto and incoiporated herein as Part C , Subpart
12a., Exhibit A. As noted above, MedPharm Iowa was issued a Certificate of Existence on October
11, 2017 by the Iowa Secretary of State. This Certificate of Existence is attached hereto and
incoiporated herein as Part C , Subpart 12a., Exhibit B. As single member, manager managed
limited liability company, MedPharm Iowa has elected to rely on the Iowa Code Chapter 489 in
lieu of an operating agreement.

As noted in Section 3.02, Part C , Subpart la., MedPharm Iowa w i l l enter into a services
agreement with Kemin and a license agreement with MedPharm Holdings. Forms of documents
are attached hereto and incoiporated herein as Part C , Subpart 12a., Exhibit C and Exhibit D,
respectively.
b. Provide current organizational charts that include position descriptions and the names
of persons holding each position, to the extent such positions have been filled.
MedPharm Iowa has developed the organizational chart shown below in Figure 126.(1).
Figure 126.(1) - MedPharm Iowa organizational chart.
Med Pharm
With respect to position descriptions, please see the descriptions described in Part C ,
Subpart 12b., Exhibit A. Candidates for these positions are currently being identified, but unless
and until a license is issued to MedPharm Iowa by the Department and each candidate passes the
Department's background investigation, no offers of employment w i l l be made.

c. Provide the resume of each person listed on the organizational chart setting out the
employee's particular skills, education, experience or significant accomplishments that
are relevant to the position.
As noted above, candidates for MedPharm Iowa's positions are currently being identified,
but unless and until a license is issued to MedPharm Iowa by the Department and each candidate
passes the Department's background investigation, no offers of employment w i l l be made. Please
review Part C , Subpart 12Z>., Exhibit A with respect to the job descriptions for each position.
d. Provide copies of all compensation agreements with investors, board members, directors,
owners, officers, and other management. For purposes of this RFP, a compensation
agreement includes any agreement that provides, or will provide, a benefit to the
recipient whether in the form of salary, wages, commissions, fees, stock options, interest,
bonuses or otherwise.
Dr. Nelson w i l l take no compensation unless and until MedPharm Iowa is profitable. Thus,
there are no compensation agreements to disclose.
e. Provide a list of any criminal history and civil litigation (as a plaintiff or defendant) for
all individuals identified in items b, c, and d above.
A list of criminal history and civil litigation for Dr. Nelson is noted below in Figure 12e.(l).
This list excludes minor traffic matters per the Department's instructions.
Figure I2e.(l) - Criminal history and civil litigation table.
Case ID Title Name Role Matter
05251 LACV039720 NELSON V . D U N N NELSON, Plaintiff Property

CHRISTOPHER E Damage
05771 ESPR049829 K A R E N 0 NELSON NELSON, Executor Estate

TESTATE 7/29/2002 CHRISTOPHER E
05771 CDCDN00842 NELSON, NELSON, Oblige Child

CHRISTOPHER E - M A U R A STICK Support
NELSON, M A U R A Record
STICK
* NELSON V. NELSON, Respondent Divorce

NELSON M A U R A STICK
Divorce from early 1990's not found in the online records but disclosed for clarity
f. Describe the nature, type, terms, covenants, and priorities of all outstanding bonds,
loans, mortgages, trust deeds, pledges, lines of credit, notes, debentures, or other forms
of indebtedness issued or executed, or to be issued or executed, in connection with the
opening or operating of the proposed manufacturer.
Currently, MedPhann Iowa has neither obtained financing of any kind from any
institutional or other lender nor plans to do so in the future. Instead, MedPharm Iowa's owner w i l l
be responsible for fully funding operations.
g. Provide audited financial statements for the previous three (3) fiscal years, which shall
include, but not be limited to, an income statement, balance sheet, statement of retained
earnings or owners' equity, statement of cash flows, and all notes to such statements and
related financial schedules, prepared in accordance with generally accepted accounting
principles, along with the accompanying independent auditor's report.
h. Provide a list of owners, their ownership percentage and financial investment for all
investors.
MedPhann Iowa is owned and controlled by its sole member and manager, Dr. Nelson. Dr.
Nelson owns one hundred percent (100%) of MedPharm Iowa and w i l l invest funds sufficient to
fully operate the business.

/. Describe future financial investments and commitments per owner or investor and
potential owners or investors.
(1) Provide the amount of future financial investment and the timeline the commitment
is valid for.
(2) Each commitment should be accompanied by a letter certified by a Certified Public
Accountant (CPA) verifying that the commitment by each owner (or potential owner)
does not exceed 50% of their personal net worth.

If such commitment exceeds 50% of an owner or potential owner's personal net
worth, indicate the percentage of that person's net worth that the commitment
represents.
Dr. Nelson w i l l provide funds sufficient to fully operate MedPhann Iowa's
business, and there is cunently no time at which this commitment expires.


Exhibit A
'1X91)1 .C-^'KKC
M K f f l ' H A R M I O W A , 1,1 ,C
NYFiVlASTKK L A W
7 0 0 W A I .NI..T ST JM (Mi
DES .MOINHS, IA MlllW
>,(r!f;ORIGUEZ
No: WCU3884S
^ , Dvxv. 09/1 S'Û 17
Wr.H-C-554002
MBIH'HAKM IOWA. LLC
A C K N O W L K D C i t ' M L N T O l ' 1 X ) C 1 J M I '(NT I ' l l ,F,D
"Ihe .Secretary' of Hints acknowledges reueiru. ol'lho following document:
C ;;rl i fi f.-slc yf Organization
The document was filoc. on Sep IX 2017 11:11PVL lis bi: ufjfcudvs tia of Sep 18 2017 11:11 PM.
i lie oaioiurt of $50.00 was rccirival in full payment of die filing fee.
C E R T T F I f ' A IT: O F U K U A M Z A T I O N O F
MEDPHARM I O W A , L L C
T O TJ-TH SKORETARY OH STATE

OF THE ST ATT. OT IOWA:
Pursiinr! to Sctdcin 2(11 of the Revised Uniform funded J lability Company Act, 1lie
1
uutersigiitxJ, uutiny yrgwn'zer, delivers for filing the following c^riificali: of<w|_iJz!it .Pii:
r
1, The naiiu of the limited liability company k Mcdl'barra Iowa, LLC (the
"Compuny").
2. The address of the indial cgistciw oftfee ol'tlK Company ix 2100 Mainy Sircat, Des
Vloines, torn 50317 aid the name nftha Company's iuitieiregisteiedagenl al .such
address is Dr. Christopher B. Ntflsani.
Daltil Ihis J Nth day of September 2017.
F LEO
IOWA
SECRETARY OF SI ATE
0^-/9 -/f-
W0113884(3

Exhibit B
10/110017 CartfeafaaJSSimdng
IOWA SECRETARY O F STATE

PAUL D. P A T E
CERTIFICATE OF EXISTENCE
Certificate VaBdatiaa
Tlie following certificate was issued by the Iowa Secretary of Stale
Certificate ID; CS140S10 Validation Date; 10/11/2017
Date: 1011/2017
Name: MEDPHARM IOWA, L L C (489DLC - 554002)

Date of Iticorporatioti: 9/18/2017
Duration; PERPETUAL
I, Paul D, Pate, Secretary of State of"the State of Iowa, custodian of the records of incorporations, certify the
following for the limited liability company named on this certificate:
a, The entity is in existence and duly incorporated under the laws of Iowa,
b, All fees, taxes and penalties required under the Revised Uniform Limited Liability Company Act and other
laws due the Secretary of State have been paid,
c, The most recent biennial report required has been filed with the Secretary of State.
d, The Secretary of State has not administratively dissolved the limited liability company,
e, The Secretary of State has not filed either a statement of dissolution or statement of termination.
Paul D. Pate, Iowa Sccrctaiy of Stale
t
Exhibit C
SERVICES AGREEMENT
CONFIDENTIAL pursuant to Iowa Code Sec, 22.7(3) & (6)

Exhibit D
LICENSE AGREEMENT
IN W I T N E S S W H E R E O F , the parties hereto have caused this Agreement to be executed effective

as of the Effective Date.
MEDPHARM HOLDINGS, [LLC]
By:_
Name:.
Title:
MEDPHARM IOWA, LLC
By:_
Name:
Title:
SCHEDULE 1
LICENSE FEE
( Part C , Subpart 12b.
Exhibit A
MedPharm Iowa is an At W i l l Employer. This document is not meant to be an offer, contract,

or promise of future or continued employment. For more information, contact Human Resources.
M E D P H A R M I O W A I S AN E Q U A L O P P O R T U N I T Y E M P L O Y E R .
M P I Manager
JOB DESCRIPTION
POSITION: M P I Manager
FLSA STATUS: Exempt
S U M M A R Y : M P I Manager is responsible leading and providing strategic leadership for
MedPhann Iowa's, working with their team to establish long-range goals, implementing
strategies, and develop and grow the business. The incumbent directs and controls resources to
ensure all aspects of the business are adequately equipped to achieve its targeted growth targets
/ and business objectives. The MPI Manager assumes full P&L responsibilities, is responsible for
MedPhami Iowa business development, identifying new customers and new products, and
developing marketing strategies. The most important role is to provide overall leadership and to
nurture, motivate, and lead people in the organization.

M I N I M U M E D U C A T I O N (including licenses, certifications, designations, etc.):
Undergraduate degree from an accredited university or college in business, science, or
other field and at least 10 years of previous executive management experience in business
management with previous experience in more than one of the following areas is
required: sales, finance, marketing, research and development, or manufacturing is
required.
A PhD or M B A or other advanced technical degree as well as previous experience in
managing to specific profit/loss objectives of a business unit is strongly desired.
ESSENTIAL FUNCTIONS:
This position w i l l formulate and execute major policies, programs and objectives to
promote and ensure the company's continuing success and growth.
I
Must execute the strategic and tactical operational growth plans for the company, with
particular emphasis on continued expansion into new products and markets.
Must take a leadership role in formulating and articulating the company's vision and
mission and achieve maximum efficiency and profit objectives through the efforts of a
strong management team.
Responsible for developing management personnel and implement effective succession
plans as well as foster an achievement-oriented culture based on continuous learning
principles where employees are motivated and rewarded for both individual and team
contributions.
Oversees all functional areas of the company and must be action oriented with the ability
to build upon foundation o f the current organization as well as craft and execute the
company's continued growth strategy.
Decision-making must be fast, thoughtful and timely with unwavering ability to embrace
progressive change.
The incumbent w i l l be required to help forecast the future concerning various business
opportunities and lead fonnation of additional strategic partnerships.
They must continue to reinforce a sense of urgency with time-to-market first-mover
advantage and ensure timely delivery of future products.
e The M P I Manager w i l l provide the energy and guidance necessary to motivate staff to
excel throughout the organization and ensure effective communication while promoting a
sense of participation and involvement.
The M P I Manager must be passionate and emotionally involved in MedPhann Iowa's
objective to provide safe economical nutrition.
They w i l l serve as the primary interface with external constituents.
The M P I Manager must be a risk taker and an entrepreneur in order to grow the business.
OTHER FUNCTIONS:
This position is responsible for coordinating, drafting and implementing the strategic
plan, evaluating business processes, approving budgets, directing and managing all
aspects of a business including but not limited to personnel, sales, research and
development efforts, marketing, customer service, operations, technology

implementation, new business opportunities all with an attitude of entrepreneurial spirit
in a dynamic environment.
ESSENTIAL SKILLS & EXPERIENCES:

Must have a solid understanding and adherence to the Servant Leadership philosophy
Strong Communication skills coupled with effective presentation skills and the ability to
deliver insightful messages to external and internal audiences is critical.

It is paramount that the incumbent has a high level of ethical standards and professional
integrity and maintain an ethical work environment for all employees.
This position requires the willingness to travel.

P H Y S I C A L E F F O R T N E E D E D : Must be able to walk, talk, sit, stand, twist and bend. Must
be able to lift 25 lbs.

T Y P I C A L N U M B E R O F D I R E C T R E P O R T S : Up to 12
{Positions with direct reports require people leadership and the ability to effectively direct,
coach, and develop others.)
W O R K E N V I R O N M E N T : Normal Office Environment with frequent exposure to
plant/manufacturing environment. See Posting Supplement for additional information.
E N V I R O N M E N T A L C O N D I T I O N S : Conditions typical of office and plant/manufacturing
environment
Grow Supervisor
JOB DESCRIPTION
POSITION: Grow Supervisor
F L S A STATUS: Exempt
S U M M A R Y : The Grow Supervisor (Associate Scientist) plays a pivotal role in developing and
executing breeding, selection, and optimization strategies to increase the production of specific
phytochemical molecules in specialty crop plants.

PhD or Masters in plant genetics, plant breeding, botany or horticulture.
Practical experience in creating genetic variation via crossing and/or mutagenesis in
conventional or alternative crop species.
E S S E N T I A L FUNCTIONS:
( Develop breeding, selection and optimization strategies to increase the production
of target phytochemical molecules in alternative crop species of interest
Execute the breeding program for target crops
Generate test hybrids or advanced clonal lines, evaluate and collect phenotype
data. Analyze data and perform statistical analyses.
Conduct initial field testing of selected lines and hybrids. Provide input on field
scale-up of selected lines.
Set-up and execute an in-house marker-assisted breeding program for rapid
development of improved breeding lines.
Take a lead role in writing internal white paper and peer reviewed publications,
patent applications.
Conduct literature searches on relevant topics.
High energy level, strong self-motivation and a high degree of problem-solving skills.
A passion for the plant sciences and working with plants.
( A passion for scientific investigation and creative thinking.
Excellent written and oral communication skills with a minimal English proficiency level
of Intermediate High as defined in the ACTFL Proficiency Guidelines.
PHYSICAL EFFORT NEEDED:
High level, must be able to lift >50 pounds, be on feet all day, work in heat and cold
enviromnents with a high degree o f flexibility.
T Y P I C A L N U M B E R O F D I R E C T R E P O R T S : 0-1
W O R K E N V I R O N M E N T : Inside growing environments, moving daily between office, shop,
equipment cabs
ENVIRONMENTAL CONDITIONS:
Exposed to dust, dirt, mud, high temperatures, high humidity, high decibel sounds, petroleum
fuels and solvents
PERSONAL P R O T E C T I V E EQUIPMENT:
Safety toed shoes, Safety glasses, dust masks, ear protection, various types of gloves and
spraying PPE.
( Grow Assistant
JOB DESCRIPTION
POSITION: Grower
FLSA STATUS: Exempt
S U M M A R Y : The Grower w i l l play a pivotal role in assisting with day to day greenhouse
environmental control, plant wellbeing and health, rapid scale up o f select plant lines of interest
as well as furthering the breeding program using conventional lab breeding techniques. In
addition, the Grower w i l l oversee the day to day laboratory functions for the Des Moines based
team including micro-propagation and tissue culture. The incumbent w i l l be an active member
of the Breeding and Selection section of the specialty crops team and w i l l report to the Grow
Supervisor.
A B.S or M.S. degree in Plant Science or related field with a general knowledge in
chemistry, horticulture and biology
A minimum of 3 years of practical experience in a plant biology laboratory or research
I greenhouse.
Rapidly multiply select lines of plant species of interest in the lab via in vitro propagation
in Micropropagation lab and in the growth chambers.
Develop new, modify, or utilize existing micro-propagation protocols to ensure adequate
numbers of plants are generated each year.
Develop cryopreservation techniques for each species of interest.
Develop SOPs for new or improved micro-propagation protocols as well as write white
papers.
Understand the basic chemistry and laboratory skills to make plant growth media
effectively and efficiently.
Develop the necessary skills to operate the plant growth chamber to control
environmental conditions for growing in vitro plants.
Execute in vitro mutagenesis program for target plant species.
Manage and operate facilities including all aspects of the Micropropagation lab, growth
/ chambers, fume hood, general lab area and freeze dryers.

Oversee daily growth chambers maintenance including watering, fertilizing, and general
plant health.
Adopt safe working standards in the lab and greenhouse including safe disposal of
hazardous waste.
Purchase and maintain inventory o f supplies for the growth chambers and lab
Able to trouble-shoot and operate essential machinery in the growth chambers and lab for
day to day functions.
Be on call 24/7 to monitor growth chamber alarm systems.
Provide tours and demonstrations of the growth chambers and laboratory to customers
and government officials.
ESSENTIAL S K I L L S & EXPERIENCES:
A working knowledge and familiarity with various lab equipment including but not
limited to pH meter, autoclave, freeze dryer, and growth chambers control systems.
Excellent communication and networking skills with proficiency in the English language.
A passion for crop production and working with novel plant species.
A passion for scientific investigation and creative thinking.
Maintain state of Iowa Department of Agriculture and Land Stewardship Pesticide
Applicators license with 3G Endorsement
A B CDL with airbrake endorsement as well as DOT issued medical card would be
preferred
PHYSICAL EFFORT NEEDED:
High level, must be able to lift >50 pounds, be on feet all day, work in heat and cold
environments with a high degree o f flexibility.
A D D I T I O N A L D E S I R E D / T Y P I C A L S K I L L S , E X P E R I E N C E S , AND F U N C T I O N S :
W O R K E N V I R O N M E N T : Inside growing environments, moving daily between office, shop,
equipment cabs
ENVIRONMENTAL CONDITIONS:
Exposed to dust, dirt, mud, high temperatures, high humidity, high decibel sounds, petroleum
fuels and solvents

PERSONAL P R O T E C T I V E EQUIPMENT:
Safety toed shoes, Safety glasses, dust masks, ear protection, various types of gloves and
spraying PPE.
Extraction / Formulation
JOB DESCRIPTION
POSITION: Extraction/Formulation
FLSA STATUS: Non-Exempt
S U M M A R Y : The primaiy purpose of this position is to operate all equipment to produce the
foil line of MedPhami Iowa products while maintaining all manufacturing performance and
quality standards. This includes assembling and preparing the necessary and correct ingredients
and raw materials, measuring and blending materials and operating equipment i n the
manufacturing process. Some packaging of bulk and finished products and preparing for
shipping and receiving of freight and materials w i l l occur. It is expected that the employee w i l l
take careful considerations when performing their job. They are expected to follow instructions,
specific procedures and protocols, and adhere to the required measures to ensure the highest
quality of product and safe work environment.

Bachelor's Degree with 0-3 years of applicable experience
High School diploma, or equivalent, with 7-10 years of applicable experience
CDL is a plus.
Responsible for assembling and preparing raw materials and correct ingredients,
including measuring and blending, for manufacturing/blending/grinding of product
line(s).
Operate and monitor all equipment by reading and following equipment monitoring
systems, Standard Operating Procedures (SOPs), instructions, specific procedures and
protocols, process flow charts, and adhering to the required measures, including safety
procedures and protocols.
Utilize computer system for creating manufacturing orders and inventory control.
Responsible for area/equipment assembly, tear-down, cleaning/sanitation, and
reassembly.
Responsible for performing initial quality control/analysis on both raw materials and
finished product, (i.e. determine product consistency and ensure quality in finished
product through variety of assessments such as, moisture content, consistency &
appearance, texture, pigment strength, etc.)
Label and package bulk and finished products and prepare for shipping and receiving, as
applicable.
Ensures that the final product meets all required production standards.
Accomplish all GMP required procedures within established timelines.
Maintain and ensure all proper sanitation duties and process documentation is complete
Must use of extreme care and caution when handling and operating all materials (raw and
manufactured) and equipment, of which are of high value.
May train employees, as applicable.
Assist with providing proactive solutions for equipment maintenance and perfonnance
issues
O T H E R FUNCTIONS:
Work with other departments such as Quality, Auditing, Maintenance, Inventoiy, and
Research and Development.
Exercise decision-making latitude in relation to the day to day typical responsibilities and
processes described in SOPs. (Non-typicalprocedures in which products are not
consistent with specifications are referred to the supervisor for decision.)
Perfonn rework when needed.
Ability to read and follow Standard Operating Procedures, solves basic problems, and
utilize cognitive reasoning and ability to use fonnulas to calculate proper mixtures.
Strong safety values.
Must be reliable and have good attendance.
Mechanical aptitude.
High level of accountability for one's work.
Excellent communication skills.
e Time management and prioritization skills are needed.

Ability to use hand tools for normal preventative equipment maintenance and cleaning.
Ability to inspect raw materials and finished goods.
Detailed-oriented.
Must be able to see, read and write numbers and letters.
Must be able to perform basic math and accurately measure/weigh.
Familiarity with Lockout-Tagout and PPE (Personal Protective Equipment).
Understanding of SDS sheets.
Ability to perform daily tasks with minimal supervision.
Perform computer entry and complete required documentation.
Must have basic problem-solving skills.
Operate support equipment used in manufacturing or maintaining equipment.

P H Y S I C A L EFFORT N E E D E D : Constant standing and balancing. Frequent: walking,
bending, squatting, lateral reaching, twisting and bilateral handling. Must be able to regularly lift
and carry 55 lbs. Occasional: Stair climbing, crouching, reaching and lifting overhead. Must be
able to sit and stand for long periods of time. Must also be able to grab, push and pull with
abrupt force.
Previous chemical/product mixing or blending experience.
Computer skills, creating own MO's, M3 knowledge and training.
Packaging/production and PLC experience.
Basic chemistry knowledge.

T Y P I C A L N U M B E R O F D I R E C T R E P O R T S : No Direct Reports
W O R K E N V I R O N M E N T : Office and laboratory
E N V I R O N M E N T A L C O N D I T I O N S : Typical office conditions - not substantially exposed to
adverse environmental conditions. However, occasional work in growth chambers may be
required.
The nature of a chemical processing plant, and the fact that maintenance comes into play when
machines/equipment/processes are not working properly, results i n exposure to many different
chemicals, requiring the need for personal protective equipment. Some hazards are liquid
chemical in nature and others are air-bome, depending upon the project. Assembling and
starting up of equipment subjects the position to hazards that are both physically demanding and
fatiguing. Working in wet areas due to sanitation and wash downs may be required. Working in
dusty and/or caustic conditions due to materials being used may be possible. Materials (raw or
unfinished) may stain skin and clothing and emit a strong order. Extreme caution should be used
when working with materials. Noise levels require hearing protection in some areas. Protective
clothing and safety equipment is provided and required to wear.

PERSONAL P R O T E C T I V E EQUIPMENT: Safety glasses, thermal gloves, aprons, face
shield, ear protection, and other protection are all provided. Other related GMP, quality, and
other job-
specific PPE safety attire w i l l be required to be worn as well, (safety-toed shoes, hair/beard net,
gloves, lab coats, respirator, unifomis, etc.)
Packaging / Delivery
JOB DESCRIPTION
POSITION: Packaging / Delivery
F L S A STATUS: Non-Exempt
S U M M A R Y : The primary puipose of this position is to produce the f u l l line of MedPharm
Iowa products while maintain all good manufacturing standards and ensuring that the quality of
finished products is correct. These duties include but are not limited to product packaging,
labeling, palletizing, bagging/container sealing, and inventory, sanitation of equipment and
utensils, quality control functions and delivery. Employees are expected to follow instructions,
specific procedures and protocols, and adhere to the required measures to ensure the highest
quality of product and safe work environment.
High School diploma, or equivalent, with 3+ years of industrial experience
Associates Degree with 1-2 years of industrial experience
CDL license required
Responsible for being subject matter expert on business area.

Assist with providing proactive solutions for equipment maintenance and perfonnance
issues
Responsible for properly labeling, filling, and sealing, using both automating and manual
packaging equipment.
Ensures that the final product meets all required standards.
Responsible for adhering to all safety procedures and protocols.
Operate sanitation equipment, manufacturing equipment, support equipment.
Utilize computer system for completing manufacturing orders and inventoiy control.
Package finished products and prepare for shipping and receiving.
Ability to inspect in process materials and finished goods.
Responsible for collecting samples and entering in computer system
Accomplish all GMP required procedures within established timelines.
Maintain sanitation schedule, as applicable.
Must follow designated driving routes i f delivering product
Must adhere to all safety and logging requirements when delivering and picking up goods
and cash.
Work with other departments such as Quality, Auditing, Maintenance, Inventory, and
Research and Development.
Performs rework when needed.
Must complete required training.
Must be familiar with operator interface screens
Ability to read and follow standard operating procedures.
Strong safety values.
Must be reliable and have good attendance.
Basic problem-solving skills.
Mechanical aptitude.
Excellent team communication skills.
Detailed-oriented.
Ability to key/enter data into computer system.
Good math skills and ability to accurately measure/weigh.
Must be read, write and speak in English.

P H Y S I C A L E F F O R T N E E D E D : Constant standing and balancing. Frequent: walking,
bending, squatting, lateral reaching, twisting and bilateral handling. Must be able to regularly lift
and can-y 55 lbs. Occasional: Stair climbing, crouching, reaching and lifting overhead. Must be
able to sit and stand for long periods of time. Must also be able to grab, push and pull with
abrapt force. May need to work in wet areas due to sanitation and wash downs, dusty and/or
acidic conditions due to materials being used.

Previous manufacturing/production background (packaging line experience.)
Chemical/product mixing or blending experience.
Basic chemistry knowledge.

W O R K E N V I R O N M E N T : Office and laboratory
E N V I R O N M E N T A L CONDITIONS: Typical office conditions - not substantially exposed to
adverse environmental conditions. However, occasional work in growth chambers may be
required. The nature of a chemical processing plant results in exposure to many different
chemicals, acids, and bases, and their potential reactions, requiring the need for personal
protective equipment. Working in incomplete environments, assembling and starting up o f
equipment subjects the person to hazards that are both physically demanding and fatiguing.
Working in dusty and/or caustic conditions due to materials being used may be possible. Noise
levels require hearing protection i n some areas. Some hazards are liquid chemical in nature and
others are air-borne, depending upon the project.

shield, ear protection, respirator and other protection are all provided. Other related GMP,
quality, and other job-specific PPE safety attire w i l l be required to be worn as well. Some
equipment need may be but, not limited to; safety-toed shoes, hair/beard net, gloves, lab coats,
respirator, and uniforms.
Customer Service / Delivery

JOB DESCRIPTION
POSITION: Customer Services Representative
F L S A STATUS: Non-Exempt
S U M M A R Y : The Customer Service Representative is responsible for maintaining our
customers' account needs. The incumbent works very closely with packaging & Delivery
High school diploma or equivalent with 2-5 years of experience.
Bachelor's Degree with 0-3 years o f experience preferred.
Experience in Sales, Customer Service, and/or accounting preferred.
Previous experience working with logistics preferred.
Responsible for creating, handling, and maintaining customer satisfaction for MedPhami
Iowa's customers.
Responsible for accurate order entry and fulfilling product shipments.
Responsible for updating and maintaining product price list.
Responsible for sales.
Monitor inventoiy levels at designated customer locations to assist in maintaining
sufficient inventory levels.

Responsible for daily communication with the Production, Logistics, and Quality Control
Teams to coordinate domestic deliveries.
Responsible for reviewing Accounts Receivable reports and informing customers on past
due account status.

Generate invoices and accrue for rebates, commissions, and other applicable discounts
and withholdings.
Responsible for recording and rectifying customer complaints, with supervision.
Responsible for the return goods authorization with approval.
Must follow all regulatory standards.

Assist other team members as needed.
Other duties as assigned.

Must understand freight (domestic).
Must be able to multi-task, adjust priorities, and have excellent time management skills.
Must be an effective team player, detail-oriented and well organized.
Must possess a high sense of urgency to meet time-sensitive deadlines.
Ability to work productively in a fast-paced, high-pressure environment.
Excellent listening skills and ability to accurately document customer interactions.
Excellent written and oral communication and interpersonal skills to present ideas
effectively with customers, peers, and all levels of management.
Must be able to see and read numbers.
Must have strong analytical and problem-solving skills.
Must be able to accurately enter data and have strong mathematic skills.
Must be fluent in English, multilingual a plus
Proficient in MS Office programs (i.e. Word, PowerPoint, and Excel).
Experience with ERP systems is a plus.
P H Y S I C A L E F F O R T N E E D E D : Must be able to sit/stand for long periods of time. Extensive
keyboarding and computer usage. Must be able to bend and lift up to 25 lbs. on occasion.
T Y P I C A L N U M B E R O F D I R E C T R E P O R T S : No Direct Reports
W O R K E N V I R O N M E N T : Normal Office Conditions.
E N V I R O N M E N T A L C O N D I T I O N S : Some exposure to manufacturing environment.
Quality Assurance Manager
JOB DESCRIPTION
POSITION: QA Manager 2
S U M M A R Y : The principle puipose of this position is to play a critical role in the strategic
development of quality plan. It is the responsibility of the Incumbent to have knowledge o f Q A
(and possibly QC) systems and knowledge of manufacturing process and products. They are
responsible for overall quality system. Evaluates, reviews and approves external audits for
suppliers. The Incumbent must also be able to critically evaluate existing procedures and
documentation in multiple business departments for compliance to standards/requirements.
Bachelor Degree with 7 or more years of experience or Master's Degree with 5-7 years of
experience.
ESSENTI A L FUNCTIONS:
Identify strategic marketing opportunities.
Plan organize, and oversee the activities of the quality department.
Planning and budgeting, project management.
Coordinate training for all quality assurance programs.
Responsible for planning and managing the Quality department budgets.
The daily planning, organization, and planning of projects and their completion are also
under this positions direction.
OTHER FUNCTIONS:
Work with other departments such as, but not limited to Operations Personnel and
Management.
Must also represent company to external visitors (inspectors, customers, etc.).
Familiar with regulatory and International regulatory affairs.
program development skills
Skills or experience related to Quality Management Systems.
Excellent interpersonal communication skills.
Ability to communicate science to a wide audience.
Ability to communicate the need to balance quality issues with production schedule needs
to operations personnel.
Demonstrate leadership skills.
Effective management of several projects.

P H Y S I C A L E F F O R T N E E D E D : Walk/climb during audits, moderate to extensive travel
required. Extensive computer use.

T Y P I C A L N U M B E R O F D I R E C T R E P O R T S : Up to 2
(Positions with direct reports require people leadership and the ability to effectively direct,

other job- specific PPE safety attire w i l l be required to be worn as well, (safety-toed shoes,
hair/beard net, gloves, lab coats, respirator, uniforms, etc.)
Quality Control Manager

JOB DESCRIPTION
POSITION: QC Manager
S U M M A R Y : The principle purpose of the QC Manager is strategic development o f QC plan.
Responsible for effective planning, budgeting, and project management for the QC Department.
Knowledge of all QC systems and knowledge of manufacturing process and products. Trouble
shoot and provide solutions to problems related to base business, including but not limited to
rework solutions, process solutions or other solutions affecting the quality of the base business.
Responsible for overall quality system for the testing and reporting of finished products and raw
materials.
Bachelor Degree with 7 or more years of experience or Master's Degree with 5-7 years of
experience.
Approve disposition of nonconforming product i f appropriate.
Plan, organize, and oversee the activities of the quality control department.
Coordinate training for all quality control programs.
Effective communication including to support the resolution of customer complaints.
Work with other departments.
Responsible for accommodating shipment dates in-spite of delays (e.g. late Raw Material
arrivals and operational delays).
Ability to mentor and manage employees.
Ability to think intuitively.
Ability to plan and prioritize projects.
Excellent written and oral communication skills.

Ability to interact well with others in a team environment.

P H Y S I C A L E F F O R T NEEDED: Normal Office environment to include extensive computer
usage.
T Y P I C A L N U M B E R O F D I R E C T R E P O R T S : Minimum of 2.
(Positions with direct reports require people leadership and the ability to effectively direct,
other job-specific PPE safety attire w i l l be required to be worn as well, (safety-toed shoes,
hair/beard net, gloves, lab coats, respirator, uniforms, etc.)
Marketing / Education
JOB DESCRIPTION
POSITION: Marketing / Education Specialist
S U M M A R Y : The Marketing Specialist oversees marketing projects, events and trade show
activities from conception and development to completion, negotiates contracts, and detennines
ROI on various events, and ensures objectives are accomplished within prescribed time frame
and parameters. The role fulfills significant project management needs in the areas of
marketing, communications, and/or public relations. They are responsible for researching,
developing, implementing and measuring tactics related to departmental projects, with additional
responsibility for personnel direction, oversight, and development. The position is a "hands-on"
role, involved i n day-to-day operations.

Bachelor's Degree, preferably in Marketing, Communications, Journalism, or Public

Relations (specific background is dependent upon position focus) with 5-7 years of
corporate experience;
e Additional related experience may substitute.

Actively involved in strategic plan development and execution.

Developing ROI and reviewing the ROI success and analysis with strategic
recommendations for future and present to leadership.
Significant contributor to maximize MedPharm Iowa's marketing, communications,
and/or public relations efforts and to execute specific assignments within the strategic
plan which help to drive market share and industry growth.
Responsible for shaping communication strategy for the business.
Manage internal and external materials and communications which increases marketing
effectiveness and help build and create brand and/or product awareness.
Manage marketing, public relations, and communication efforts, and develop advertising
and literature, ensuring maintenance of a consistent corporate image throughout all
promotional materials, communications, and events.
Develop coimnunications plans for coiporate initiatives, including writing content and
the execution of press releases, employee communications and external coiporate website
material, bulletins, sales/marketing materials and other collateral, presentations,
tradeshow materials, articles and trade publications, news releases/announcements,
and/or blogs.
Act as overall project manager, tracking projects from conception to conclusion. This
involves developing and managing projects, including budgets and strategies, special
events, timelines, media and editorial activities.
Execute related projects such as advertising and promotion activities, coimnunications,
PR strategies including, but not limited to, print, point-of-sale, online,
electronic/interactive media, and direct mail.
Research, identify, recommend, and implement new marketing-related technologies and
strategies which drive future initiatives.
Develop internal and external presentations.
Manage public relations efforts including proofreading, creative, promotional materials,
and outreach activities.
Work with marketing leadership collaboratively to create, manage, and implement cross-
organizational, integrated marketing strategies such as product launches and promotional
product plans.
Must be able to execute responsibilities with regular autonomy and little direction.
Conduct market research and analysis to determine market share and other relevant
business environment indicators of current and future products; conduct market

forecasting, marketing trends and implications; monitor competitive environment
including competitor products and product reviews.
Coordinate communication plans with outsourced agencies, including promotional
activities, print/media, sale, and mail activities.
Work with media sources including video, audio, print, and digital.
Manage domestic and, likely, international tradeshows.
OTHER FUNCTIONS:
Provide ongoing improvements to increase department's value to MedPhaim Iowa.
Participate on cross-functional teams leading to the launch of meaningful new products.
Work with outside agencies and vendors and negotiate contracts with vendors.
Occasionally attend shows to represent MedPhaim Iowa to customers and other
audiences.
Assist in the creative development for layouts and designs of logos, advertising,
marketing collateral and other published material in print and online.
Prepare marketing activity reports.
Participate in the Product Innovation Process to help drive products through the process
to launch.
Develop and implement various forms of interactive media, including but not limited to
website enhancements & implementation, program development and execution, Internet
Ratings & Reviews, social networking/online communities, search engine marketing.
May also discover and evaluate competitive information, organize and maintain key
databases.
The position has a variety of budget management responsibilities, and has dotted-line
personnel supervisory/management responsibilities.
Direct decisions on policies, personnel decisions, salaries, and budget responsibility.
Other job-related duties as assigned.

Minimum of 3 years of previous coiporate or agency experience in
marketing/advertising, communications, and/or PR. Experience in one of the life
sciences is also preferred.
Excellent organizational skills and project management skills with the ability to set
priorities and handle multiple projects efficiently to meet deadlines.
Must have a solid understanding and adherence to the Servant Leadership philosophy.
Must have experience managing and developing a team.
A reliable, flexible, self-starter with strong initiative and the ability to maintain a
professional demeanor while working under pressure as there is a high level of
accountability for one's work.
High attention to detail, high accuracy, and analytical abilities.
Energetic and business-minded with the ability to provide marketing leadership, set
priorities, delegate responsibilities, and meet timetables.
Experience as an effective marketing manager, project team player, leader and motivator;
and the ability to present ideas effectively and communicate well with customers,
vendors, peers and all levels of management.
Demonstrated achievement of meeting marketing objectives.
Strong marketing, leadership, and interpersonal skills with the ability to work effectively
in a diverse team environment.
Excellent verbal and written communication skills, problem-solving skills, and critical-
thinking skills.
Solid financial skills with the ability to analytically evaluate and understand budget costs.
Advanced PC knowledge with MS Office and/or Graphics software desired.
Must have a marketing mentality combined with marketing training and experience as it
relates to marketing products in the industry, with the ability to gather key information
and translate into an exceptional promotional piece.
A high degree of personal motivation, a desire to make an immediate contribution, and
possession of a distinct sense of urgency.
The position requires the ability to gather information and take the initiative to make
decisions when deadlines occur.

Ability to develop and maintain effective strategic relationships with key partners
including external agencies, freelancers, media, and technology companies. The role is
responsible for building relationships with major trade publication editors to position
MedPharm Iowa as an advisor and content source for technical and industiy issues.
Must have at least 4 years of hands-on experience of various fonns of interactive media,
including but not limited to content management tools, website enhancements &
implementation, program development and execution, Internet Ratings & Reviews, social
networking/online communities, search engine marketing along with a deep

understanding of the latest online marketing technologies, techniques and best practices.
International experience desired.
Ability to adapt to a changing work environment and stay on top of latest online
technologies, techniques and best practices.

P H Y S I C A L E F F O R T N E E D E D : Sitting, typing, concentration, and utilizing computer for
prolonged periods of time. Driving/Flying to locations for tradeshows and/or sales/marketing
meetings. Extensive use of telephone/email communication, and verbal communication. Lifting
(generally up to 50 lbs.) periodically is required in this job for set-up/tear-down of tradeshow
booth, as well as standing and walking, climbing stairs, pushing, reaching, twisting, bending and
crawling on hands and knees is needed.

T Y P I C A L N U M B E R O F D I R E C T R E P O R T S : up to 3
W O R K E N V I R O N M E N T : Normal Office Conditions.
E N V I R O N M E N T A L C O N D I T I O N S : Typical office conditions - not substantially exposed to
adverse environmental conditions. However, occasional work in rented storage warehouse space
may be needed (i.e. to organize and prepare tradeshow display materials for use). Work outside
of traditional work hours, such as overnight and weekends, is likely.

Consultants
A number consultants w i l l lend their expertise to MedPharm Iowa through consulting
agreements. The lead consultant's expertise are summarized below.
Anita Norian
Anita Norian is President of Kemin's human nutrition and health division providing a line of
high quality science based ingredients with healthful benefits for the dietary supplement and
functional foods and beverage markets globally. In August of 2011, Anita was promoted to
Group President of Kemin Industries' venture business units, the company's new and developing
businesses. In addition to managing three venture businesses, Anita provided strategic oversight
for all Kemin businesses as well as managed worldwide marketing, engineering and audit
functions. Prior to joining Kemin as worldwide Vice President in October 2010, Anita worked
for Pioneer Hi-Bred in Des Moines providing guidance for strategic business and marketing
initiatives and established a competitive intelligence process that resulted in a significant refocus
of Pioneer's strategy. Before Pioneer, Anita coordinated business strategy, investor and
stockholder relations for the ag and nutrition business at DuPont. A Certified Public Accountant,
Anita started her career in public accounting with McGladrey and Pullen. Anita holds a Bachelor
of Science in accounting and transportation and logistics and a Master's in Business

Administration. She lives in Des Moines, Iowa with her 19-year-old daughter. She serves on the
Grand View College Board of Trustees and is a member of Young President's Organization.
John Greaves
Dr. John A. Greaves is the worldwide vice president, specialty crops at Kemin Industries, Inc., i n
Des Moines, Iowa. Kemin is a privately held international life science company providing
innovative molecular solutions to the food ingredient, human nutraceutical, personal care &
household, pet food, animal feed, veterinary and pharmaceutical industries worldwide. In his
cun ent role, John coordinates a global team of plant breeders, horticulturalists, analytical
chemists, research agronomists and field agronomists; and reports directly to Kemin's CEO.
Research, breeding and crop scale-up programs are i n the USA, China and India using plants to
produce key target molecules such as antioxidants, antimicrobials, surfactants; and functional
carotenoids and proteins using conventional and marker-assisted plant breeding. Kemin's
molecular farming operations in the USA includes over 1500 field acres and just under 2 acres
under glass; and over 20,000 acres internationally. John has been with Kemin for 15 years and
was previously manager of trait breeding at ICIVGarst Seed Company. John has held multiple
executive leadership positions at Kemin including Vice President, Research & Development for
Kemin Industries and Kemin Biotechnology; and business unit president for Kemin Agri-Foods.
John also served as president & CEO of Hy-Line International for three years. John is a native of
Lancaster in the northwest of England. He graduated with a B.Sc (Honors) degree in 1984
(Agricultural Botany), and a Ph.D. degree in 1987 (Plant Physiology), both from the University
of Wales in the United Kingdom. John is a 1998/99 gi aduate of the Iowa Association of Business
and Industry's "Leadership Iowa" program and was also recognized as a member of the Des
Moines Business Record's "Forty under 40" class of 2001/2002." John also served as the Chair
of the Governor's Life Science Advisory Committee for Iowa and is past Chair of the ISU Plant
Sciences Institute external board of advisors. John still serves on the board of advisors of ISU's
Plant Sciences Institute and the Greater Des Moines Botanic Garden; and is an independent
director on the board of Chromatin, Inc. He has received several honors including the Iowa "Da
Vinci Award;" the Governor's Volunteer Award (2001 and 2002) and the Iowa Futures Award
for service to education. He is an inventor on 12 U.S. and international issued patents and 6
pending patents. John lives with his wife and family in Ankeny, Iowa.
Nick TeBockhorst
Nick TeBockhorst, Plant Production Associate at Kemin Industries Specialty Crop Improvement
Program. Under this role, Nick oversees the day to day functions of the Des Moines Greenhouse
Complex, outdoor nursery, and the micro-propagation lab. Daily duties include leading the team
in plant care such as watering and fertilizing, routine pest monitoring, clonal line scale up and
acreage expansion of Kemin's Specialty Crops. Prior to working at Kemin, Nick attended the
University of Northern Iowa where he obtained his Bachelors of Science in Biology with an
emphasis in plant science. During college, multiple work experiences included commercial
greenhouse production, nursery production, native seed harvesting, and an internship at a
botanical center.
Alissa Jourdan
Alissa Jourdan joined Kemin in February 2001. Her initial role was to lead the Molecular
Biology team i n the execution of research projects. She is cunently the Worldwide Coordinator
of Research and Development and the Director of the Discovery Research group. Discovery
Research is a diverse scientific team responsible for biochemistry, molecular biology,
fermentation, and chemistry based research. The group's role is to perforin high risk research for
the Kemin business units on a worldwide basis. As Worldwide Research and Development
Coordinator Alissa is responsible for the Research and Development portion of the world wide
strategic plan, organizing and leading the annual worldwide Kemin Scientific meeting, strategic
communication between the Research and Development groups, organizing and leading R & D
Director meetings, and executing any special projects on a worldwide basis. Before joining
Kemin, Alissa completed a 2-year post-doc at the USDA National Animal Disease Center in
Ames, IA. Her research involved designing, optimizing, and validating fluorogenic PCR assays
for the rapid detection and quantitation of foodborne pathogens in production animals. Alissa
received her B.S. from Iowa State University and her Ph.D. from the University of Iowa; both
degiees are in Microbiology. Alissa's graduate thesis work involved dissection of the mechanism
of transcriptional regulation 1-carbon metabolism in E. coli, concentrating on the gcv-specific
regulatory protein GcvA. Alissa is also active in the community on behalf of Kemin, working
with the SEMI project, is a member of the SEMI Advisory committee, is an Executive member
of the Board of the Iowa Biotechnology Association, Board member of Inspire 21 Foundation,
participated in development of the Iowa Core Curriculum, initiated an annual biotech program
with East and Dowling High Schools and Kemin, Habitat for Humanity, and works with Drake's
DUCURS program.
Kenny Erdoes
Kenny is Vice President Worldwide Engineering. Kenny has over 15 years of experience leading
R & D , process design, technology development, process optimization, and production operations
in the specialty chemical, oleochemical, renewable, and oil & gas sectors. Kenny's engineering
team is responsible for the design, development, optimization, construction, and support of
Kemin's manufacturing processes worldwide. Kenny has a B.S. in Chemical Engineering.
Scott Karolchvk MS, RPh, F I A C P
Scott is cunently the Director of Formulations for MedPharm M x . Scott is an accomplished
product development leader with extensive experience in pharmaceutical formulation design,
compounded preparation research, and business management. Formulated Imprimis
Pharmaceutical's 'GoDropless' injection and 'LessDrops'. Proactive and tenacious in applying
knowledge to project initiatives, utilizing communication across divisions to influence and drive
project teams with a particular focus on successful delivery of new formulations, clinical trial
supplies, regulatory submissions and commercial deliverables. Scott has a BS Phannacy, and
University of Iowa 1990 and MS Phannaceutics, University of Iowa 1995. He was also the
owner of Phannacy Creations Compounding Pharmacy -leader in sterile admixtures, 2000-2015.
Stacy D i l l
Stacy D i l l , Global Marketing Director of the Human Nutrition and Health at Kemin Industries,
provides high quality science-based ingredients with healthful benefits for the dietaiy
supplement and functional foods and beverage markets globally. In January of 2016 Stacy
joined Kemin bringing over 20 years of marketing experience to the team. Stacy manages
strategic business and marketing initiatives globally. Prior to joining Kemin, Stacy worked for
Natrol, a leading vitamin/supplement manufacturer providing results-driven marketing plans for
4 distinct brands and 100+ products. Overseeing brand identity life cycle including product
messaging, positioning, pricing, packaging and promotion. Before Natrol, Stacy open and built
the southern California market for Pretzel Crisps implementing grassroots marketing strategies
and securing promotional partnership to justify a national product rollout and ultimately a
lucrative sale of the company. Stacy holds a Bachelor of Arts in communications and public
relations.
L i b b y Nelson
Libby Nelson is cwrently Vice President and General Counsel for privately held Kemin Industries,
Inc. headquartered in Des Moines, Iowa. She is a 1977 graduate o f Washington University i n St.
Louis and a 1980 graduate of Drake Law School. She has been general counsel with Kemin since
late 2001. Currently she is guiding legal, regulatory and intellectual property projects for Kemin
and its affiliated companies. She is intimately familiar with quality systems and requirements.
Ted Dyer
Prior to joining Kemin, Ted has a broad-based background i n EHS that includes aerospace
manufacturing, biofuels, rubber, chemicals and non-clinical toxicology. He has a degree in
chemistry and a Masters of Environmental Management from the University of Maryland
University College. Ted is also a Certified Hazardous Materials Manager and an OSHA
Authorized Instructor. Ted and his wife, both natives of Colorado, now make their home in
Ankeny, Iowa, where they intend to live permanently. He is an active outdoorsman and enjoys
music, art and literature.

Kemin H R Team
Kemin HR, under the direction of Alex Castillo, w i l l provide all HR functions to MedPharm
Iowa. Alex joined Kemin in October 2016 as the W W VP of Human Resources. Previously, Alex
worked in HR for HON Industr ies, General Electric, and Rockwell Collins. In his most recent
assignment, Alex served as the Chief Human Resources Officer at A T I Physical Therapy in
Chicago, IL. Alex grew up near Iowa City, Iowa, and attended St. Ambrose University to study
International Business and Economics. He holds an M B A from the Kellogg School of
Management at Northwestern University.
Kemin Finance Team
Kemin Finance, under the direction of Tammi Guldenpfennig, w i l l provide all finance functions
to MedPharm Iowa. This w i l l include accounting, tax and audit services. Tammi joined Kemin in
February 1990 and is the Sr VP, W W Finance and CFO. Prior to working at Kemin she worked
for K P M G for 5 years. Tammi holds a Bachelor's of Science in Accounting degree from U N I .
She also earned an M B A from Drake University with an emphasis on HR in 1999. Tammi's
hobbies include hiking and exercising as well as spending time at the lake with her family and
two granddaughters.
Kemin Legal Team
The Kemin legal team is led by Libby Nelson, w i l l provide legal services to MedPharm Iowa.
Libby is currently Vice President and General Counsel for privately held Kemin Industries, Inc.
headquartered in Des Moines, Iowa. She is a 1977 graduate of Washington University in St. Louis
and a 1980 graduate of Drake Law School. She has been general counsel with Kemin since late
2001. Cunently she is guiding legal, regulatory and intellectual property projects for Kemin and
its affiliated companies. She is intimately familiar with quality systems and requirements.
Kemin I T Team
The Kemin IT team, led by Joe Blackford, w i l l provide IT support and services to MedPharm
Iowa. This service includes selection and integration of the seed to sale tracking system. Joe
started his career at Kemin 2003. During his 14-year tenure he has been directly involved in
numerous projects and support efforts across all business units. Prior to his director role, Joe held
the position of NSCA IT Support Manager where he leads his team in supporting the IT needs
for North, South, and Central America. Joe has proven himself to be a valuable asset to Kemin
capable of filling the role of W W I T Director.
Security Contractor
MedPhami Iowa has elected to utilize U.S. Security Associates for security services. U.S.
Security Associates was established as Advance Security Engineering in 1955 in Atlanta,
Georgia, to provide security guard services. Over the next five decades, USA has expanded its
operations to 160 cities in 45 states, and now employs over 50,000 people. In 1996, we changed
our name to U.S. Security Associates to better accommodate our growing stature and national
service coverage.
S E C T I O N 3.02, P A R T P.: O P E R A T I N G D O C U M E N T S
Procedures for the oversight of the manufacturer, including descriptions of operational and
management practices regarding the forms and quantities of medical cannabidiol products that
are produced at the manufacturing facility.
MedPharm Iowa proposes to manufacture (using SOP MPI-9g002) and offer for sale the
following fonnulations and quantities of medical cannabidiol during the first year of operation:
1. Tincture - concentrated solution.
Oil dosed by a dropper
Alcohol dilutions of Cannabis extracts, containing surfactants to enhance
absorption
Excipients: ethanol, M C T oil, caprylic/capric triglycerides
CBD)
i i . Balanced THC/CBD - THC 3% and CBD 3% (delivers lOmg THC and
lOmg CBD)
iii. Low THC - THC 0.3% and CBD 3% (delivers l m g THC and lOmg CBD)
dropper)
2. Nano Tincture (emulsion) - alcohol-free, enhanced absorption oral suspension,
concentrated.
Oil, dosed by a dropper
Nanosuspensions are colloidal dispersions of nano-sized particles stabilized by
surfactants. As a delivery system, nanosuspensions enhance the therapeutic
efficacy o f the dose.
Excipients: caprylic /capric triglycerides, veegum, acacia

CBD)
lOmg CBD)
dropper)
Soft Gels - enhanced absoiption. concentrated
Available: 30 capsules per bottle
Formulated to achieve enhanced bioavailability and immediate release.
Excipients: phosphatidylcholine, coconut oil, capiylic/capric triglycerides
Available in three varieties:
CBD)
i i . Balanced THC/CBD - THC 3% and CBD 3% (delivers lOmg THC and
lOmgCBD)
Transdermal Liposome Cream: targeted for pain.
Liposomal creams/ointments/salves, utilizing L.E.A.F.
Available in a 30gm and 60gm metered dose applicator manufactured by Topi-
CLICK.
Excipients: acrylates copolymer, butyrospermum parkii (shea butter),
caprylic/capric triglycerides, carthamus tinctorius

i. Elevated CBD - 10% CBD and 1% THC (delivers lOOmg CBD and l m g
THC per gram)
Suppository - enhanced absorption.
Available i n both rectal and vaginal forms
1:1 ratio of THC/CBD, 1 gm suppository
Excipients: phosphatidyl choline, coconut oil, cetearyl alcohol

i. Balanced THC/CBD - 1% THC and 1% CBD (each suppository delivers
lOmg THC and lOmg CBD)

In the second and third year of operation, MedPharm Iowa would consider the following
formulations and quantities of medical cannabidiol, subject to revisions in Applicable Law and
information obtained during the first year of operation:

1. Sublingual Oral Strips - self-micro emulsifying; delivery system.
Emulsified, dissolvable strips, utilizing the saliva as the natural water source,
delivering Cannabis extracts. For oral use, these may be formulated as liquids or
solids. Solids would be packaged in capsules or tablets
Excipients: M C T oil, tween 80, PEG 400
2. Bio-Adhesive Strips.
Patch-like delivery system utilizing bio-adhesive strip technology, enhancing
mucosal absorption with micro-emulsion technology, resulting in a sustained
release effect of Cannabis extracts
Excipients: M C T oil, tween 80, carboxymethylcellulose
3. Inhalation - powdered inhalation and vaping.
The coating of standardized oil with an emulsion comprising a wax/lipid, an
emulsifying agent, and water. The emulsion can be spray dried to form a powder,
which can subsequently be dispersed in water and coated onto the surface of
medicaments to form a protective, enteric and/or controlled release of Cannabis-
containing granules, pellets and tablets.
Excipients: caprylic/capric triglycerides, veegum, poloxamer 407, beeswax
4. Bath Salts.
Powdered oil extract formulated with L.E.A.F., allowing Cannabis extracts and
essential oils to be absorbed full-body while taking a warm bath or soak.
Excipients: tween 80, poloxamer 407, veegum, M C T oil
i
MEDPHARM IOWA PROCEDURE NUMBER: MPI-9g002
STANDARD OPERATING PROCEDURES

REVISION NUMBER:
ORIGINATOR: ELIZABETH NELSON SUPERSEDES:
DATE: 10.21.17
SOP T I T L E : E X T R A C T MANUFACTURE PROCESS

management practices regarding the methods of planting, harvesting, drying, and storing
Cannabis.
MEDPHARM IOWA Procedure Number: MPI-9m001
Standard Operating Procedures Revision Number:
Originator: Nick TeBockhorst Supersedes:
Date: 10-15-17
SOP Title: The Methods of planting, han>esting,
diying, and storing Cannabis

MEDPHARM IOWA Procedure Number: MPI-9o002

Revision Number:
Originator: Anita Norian Supersedes:

Date: 10-19-17
SOP Title: Storage of Plant Material and Medical Page: 1 of 4
Cannabidiol Product

Revision Number:

Date: 10-19-17
Cannabidiol Product

STANDARD O P E R A T I N G P R O C E D U R E S
Revision Number:

Date: 10-19-17
Cannabidiol Product
CONFIDENTIAL AND PROPRIETARY INFORMATION ^

PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY VALID P
U
IF TfflS VERSION IS THE SAME AS ELECTRONIC DOCUMENT

Revision Number:

Date: 10-19-17
Cannabidiol Product
PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY VALID


Revision Number:
Originator: Alissa Jourdan Supersedes:
SOP Title: Method for grinding cannabis plant biomass for

extraction

S T A N D A R D O P E R A T I N G PROCEDURES
Revision Number:
Originator: Alissa Jourdau Supersedes:

SOP Title: Method for grinding cannabis plant biomass for
extraction

STANDARD O P E R A T I N G PROCEDURES
Revision Number:
SOP Title: Method for decarboxylating ground Cannabis

plant biomass for extr action
CONFIDENTIAL AND PRO

PRIETARY INFORMATION
M E D P H A R M IOWA Procedure Number: MPI-9m003

Revision Number:
SOP Title: Method for decarboxylating ground Cannabis

plant biomass for extraction
U
Co
CONFIDENTIAL AND PRO g

PRIETARY INFORMATION N
PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY VALID ^
IF THIS VERSION IS THE SAME AS ELECTRONIC DOCUMENT g
S E C T I O N 3.02, P A R T P . : O P E R A T I N G D O C U M E N T S
management practices regarding the estimated types and amounts of all crop inputs used in the
production of medical cannabidiol.
MEDPHARM IOWA Procedure Number: M P I -
Standard Operating Procedures 9h001
Revision Number:
Pate: 10-15-17
SOP Title: The estimated types and amounts of all crop
inputs used in the production of medical cannabidiol

MEDPHARM IOWA PROCEDURE NUMBER: MPI-9Q001

REVISION NUMBER:

DATE: 10.21.17
SOP TITLE: CHEMICAL HYGEINE PLAN
AND PROPRIETARY INFORMATION


REVISION NUMBER:

DATE: 10.21.17

REVISION NUMBER:

DATE: 10.21.17
REVISION NUMBER:

DATE: 10.21.17

REVISION NUMBER:

DATE: 10.21.17
PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY

V A L I D IF T H E V E R S I O N IS T H E S A M E A S M A S T E R E L E C T R O N I C D O C U M E N T C O N F I D E N T I A L Rev. Date: U
R e v
AND PROPRIETARY INFORMATION -
S E C T I O N 3.02. P A R T P.: O P E R A T I N G D O C U M E N T S
management practices regarding: the estimated types and amounts of medical cannabidiol
waste and plant material waste to be generated.
MEDPHARM IOWA Procedure Number: MPI-
Standard Operating Procedures 7b001
Revision Number:
Pate: 10-16-17
SOP Title: The estimated types and amounts of medical
cannabidiol waste and plant material to be generated

CD
a
05
r
o

S E C T I O N 3.02. P A R T P . : O P E R A T I N G D O C U M E N T S
management practices regarding the disposal methods for all waste materials.
Standard Operating Procedures 9m004
Revision Number:
Date: 10-16-17
The disposal methods of all waste materials
MedPharm Iowa, LLC j 319
management practices regarding employee training methods for the specific phases of
production and who (or what position) will be responsible for oversight of the training.
Please see the following pages.

Procedure Number: MPI-9a001

MEDPHARM IOWA
STANDARD O P E R A T I N G P R O C E D U R E S Revision Number:

Date: 10-18-17
SOP Title: Employee training methods for the specific
phases of production and who will be responsible for the
oversight training

MEDPHARM IOWA
STANDARD OPERATING PROCEDURES Revision Number:
Supersedes:
Originator: Nick TeBockhorst
n i t c in 18-17
Uml I " 1 i "
SOP Title: Employee training methods tor the specitic

oversight training

MEDPHARM IOWA
S T A N D A R D OPERATING P R O C E D U R E S Revision Number:
Supersedes:
ryitf 10-18-17
JL/alc i " **' * * - :
SOP Title: Employee training methods for the specdic
oversight training

MEDPHARM IOWA
STANDARD OPERATING P R O C E D U R E S Revision Number:
Supersedes:
r w . 10-18-17 .
uaie. lu-io LI
SOP Title: Employee training methods for the specific
oversight training
Si
t*4
CONFIDENTIAL AND PROPRIETARY I N F O ^ A T I O N
SXSSTTHE SAME AS ELECTRONIC DOCUMENT |

9m005
Standard Operating Procedures
Revision Number:
SOP Title: Method for extraction of Cannabis using

supercritical carbon dioxide

9m006
Revision Number:
SOP Title: Method for winterizatioii of a Cannabis

extract

9m007
Revision Number:
SOP Title: Method for concentrating cannabidiol oil

using short-path distillation
management practices regarding biosecurity measures used in the production and
manufacturing of medical cannabidiol.
MEDPHARM IOWA Procedure Number: MPI-9g001
Date: 10-15-17
SOP Title: Biosecurity measures used in the production
and manufacturing of medical cannabidiol

a
a.
63
r
n

Procedure Number: MPI-9o001

MEDPHARM IOWA
Revision Number:

Date: 10-19-17
SOP Title: Personal Hygiene Page: 1 of 5

Revision Number:

Date: 10-19-17
M E D P H A R M IOWA Procedure Number: MPI-9o001

Revision Number:

Date: 10-19-17
CONFIDENTIAL AND PROPRIETARY INFORMATION

IF THIS VERSION IS THE SAME AS ELECTRONIC DOCUMENT

Revision Number:

Date: 10-19-17

Revision Number:

Date: 10-19-17
management practices regarding strategies for identifying and reconciling discrepancies in
inventory of plant material or medical cannabidiol.
MedPharm Iowa Procedure Number: MP1-

Standard Operating Procedures llaOOl
Revision Number:
Originator: Joao Esteves Supersedes:

Date: 10.21.17
SOP Title: I N V E N T O R Y M A N A G E M E N T
management practices regarding sampling strategy and quality testing for labeling purposes
and shelf-life determination.
MEDPHARM IOWA Procedure Number: MPI-lObOOl
Date: 10-19-17
SOP Title: Sampling of Raw Materials and Finished
Products
MEDPHARM IOWA Procedure Number: MPI-lOdOOl
Date: 10-19-17
SOP Title: Sample Handling for QC Testing

CONFIDENTIAL pursuant tolowa Code Sec. 22.7(3) & (6)
i
S
o
so
r
r
o

MEDPHARM IOWA Procedure Number: MPI-lOeOOl
SOP Title: Method for determining shelf life stability
of a cannabidiol oil finished products.

CONFIDENTIAL pursuant to Iowa Code Sec, 22.7(3) & (6)

Revision Number:
SOP Title: Method for determining shelf life stability of a Page: 1 of 2
cannabidiol oil

STANDARD OPERATING P R O C E D U R E S
Revision Number:

SOP Title: Method for determining shelf life stability of a Page: 2 of 2
cannabidiol oil

Revision Number:
SOP Title: Method for determining homogeneity of a

cannabidiol oil

Revision Number:
SOP Title: Method for determining homogeneity of a

cannabidiol oil
MEDPHARM IOWA Procedure Number: MPI-lOaOOl

Revision Number:

Date: 10-19-17
SOP Title: Roles and Responsibilities of the Quality Unit
CONFIDENTIAL AND PROPRIETARY INFORMATION j

PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY VALID g
w

S T A N D A R D OPERATING PROCEDURES
Revision Number:

Date: 10-19-17

Revision Number:

Date: 10-19-17
MedPharrri Iowa, L L C | 365

Revision Number:

Date: 10-19-17

MEDPHARM IOWA Procedure Number: MPI-10a002

Revision Number:

Date: 10-19-17
SOP Title: Quality Monitoring and Measurement of
Product

Revision Number:

Date: 10-19-17
Product

Revision Number:

Date: 10-19-17
Product
MEDPHARM IOWA Procedure Number: MPI-10d002

Revision Number:

Date: 10-19-17
SOP Title: Out of Specification Laboratory Results

Revision Number:

Date: 10-19-17

Revision Number:

Date: 10-19-17

PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY VALID O
U
Revision Number:

Date: 10-19-17


Revision Number:

Date: 10-19-17

PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY VALID 5
U
MEDPHARM IOWA Procedure Number: MPI10d003

Revision Number:

Date: 10-19-17
SOP Title: Control of Nonconforming Raw Materials,
Work in Process, and Finished Goods

U
M E D P H A R M IOWA Procedure Number: MPI10d003

Revision Number:

Date: 10-19-17
MEDPHARM IOWA Procedure Number: MPI10d003

Revision Number:

Date: 10-19-17
z
3
S<

PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY VALID P
MEDPHARM IOWA Procedure Number: MPI-lOfOOl

Revision Number:

Date: 10-19-17
SOP Title: Retain Samples Storage, Handling and
Inventory Control

U
MEDPHARM IOWA Procedure Number: MPI-lOfOOl

Revision Number:

Date: 10-19-17
SOP Title: Retain Samples Storage, Handling and
Inventory Control

management practices regarding medical cannabidiol packaging and labeling procedures.
MEDPHARM IOWA PROCEDURE N U M B E R : MPI-5a001
REVISION NUMBER:
ORIGINATOR: E L I Z A B E T H NELSON SUPERSEDES:
D A T E : 10.21.17
SOP T I T L E : P A C K A G I N G A N D L A B E L I N G
management practices regarding procedures for mandatory (i.e., recall) and voluntary (i.e.,
market withdrawal) of medical cannabidiol.
Please see the following pages.

MEDPHARM IOWA PROCEDURE NUMBER: MP1-10H001
REVISION NUMBER:

DATE: 10.21.17
SOP TITLE: SERIOUS ADVERSE EVENT REPORTING
MEDPHARM IOWA PROCEDURE NUMBER: MPI-10H001
REVISION NUMBER:

DATE: 10.21.17
PRINTED COPIES ARE UNCONTROLLED AND A R E ONLY

V A L I D IF T H E V E R S I O N IS T H E S A M E A S M A S T E R E L E C T R O N I C D O C U M E N T C O N F I D E N T I A L Rev. Date:
AND PROPRIETARY INFORMATION Rev.
REVISION NUMBER:

DATE: 10.21.17
AND PROPRIETARY INFORMATION Rev. >
8
REVISION NUMBER:

DATE: 10.21.17

V A L I D IF T H E V E R S I O N IS T H E S A M E A S M A S T E R E L E C T R O N I C D O C U M E N T C O N F I D E N T I A L Rev. Date:
MEDPHARM IOWA PROCEDURE NUMBER: MPI-lOiOOl
REVISION NUMBER:

DATE: 10.21.17
SOP T I T L E : PRODUCT R E T R I E V A L - R E C A L L

VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFIDENTIAL Rev.
REVISION NUMBER:

DATE: 10.21.17
fx

VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFIDENTIAL
Rev. Date:
Rev.
s
REVISION NUMBER:

DATE: 10.21.17
faq

Rev. Date:
Rev.
I
REVISION NUMBER:

DATE: 10.21.17
SOP T I T L E : PRODUCT RETRIEV AL - R E C A L L

VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFIDENTIAL Rev. Date:
REVISION NUMBER:

DATE: 10.21.17
REVISION NUMBER:

DATE: 10.21.17

REVISION NUMBER:

DATE: 10.21.17

VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFIDENTIAL Rev.

REV ISION NUMBER:

DATE: 10.21.17
MEDPHARM IOWA PROCEDURE NUMBER: MPI lOiOOl

REVISION NUMBER:

DATE: 10.21.17

VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFrDENTTAL Rev. Dale.

REVISION NUMBER:

DATE: 10.21.17
SOP T I T L E : PRODUCT R E T R I E V A L - R E C A L L PAGE: 10 OF 11
CO


REVISION NUMBER:

DATE: 10.21.17
SOP T I T L E : PRODUCT RETRIEV AL - R E C A L L
PRINTED COPIES ARE UNCONTROLLED AND A R E ONLY o

MEDPHARM IOWA Procedure Number: MPl-10i()02
Originator: Elizabeth Nelson Supersedes:
Date: 10.21.17
Health Hazard Assessment

CONFIDENTIAL pursuant tolowa Code Sec. 22.7(3) & (6)
CONFIDENTIAL pursuant to Iowa Code Sea 22.7(3) & (6)
CONFIDENTIAL pursuant to-Iowa Code Sec. 22.7(3) & (6)
MEDPHARM IOWA PROCEDURE NUMBER: MPI-10i003
REVISION NUMBER:

DATE: 10.21.17
M A R K E T WITHDRAWAL REPORT

V A L I D IF T H E V E R S I O N IS T H E S A M E A S M A S T E R E L E C T R O N I C D O C U M E N T Rev. Date:
CONFIDENTIAL AND PROPRIETARY INFORMATION Rev. Level: 1
REVISION NUMBER:

DATE: 10.21.17
M A R K E T WITHDRAWAL REPORT
REVISION NUMBER:
DATE: 10.21.17
PRODUCT RECALL STATUS REPORT
REVISION NUMBER:
DATE: 10.21.17
PRODUCT RECALL STATUS REPORT
MEDPHARM IOWA PROCEDURE NUMBER: MPI-H005
REVISION NUMBER:

DATE: 10.21.17
PRODUCT WITHDRAWAL [RECALL! RESPONSE FORM

REVISION NUMBER:

DATE: 10.21.17
SOP TITLE: PRODUCT R E C A L L E F F E C T I V E N E S S CHECK
RESPONSE QUESTIONNAIRE
fx
C
a

8

REVISION NUMBER:

DATE: 10.21.17
SOP TITLE: PRODUCT R E C A L L E F F E C T I V E N E S S CHECK
RESPONSE QUESTIONNAIRE
MEDPHARM IOWA P R O C E D U R E N U M B E R : MPI-10i007

REVISION NUMBER:

D A T E : 10.21.17
PRODUCT RECALLAVITHDRAWAL SUMMARY FORM
REVISION NUMBER:

DATE: 10.21.17
SOP T I T L E : C O R R E C T I V E AND PREVENTATIVE ACTION
PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY Q

VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFIDENTIAL Rev. Date: V)
MEDPHARM IOWA PROCEDURE NUMBER: MPI-KH008
REVISION NUMBER:

DATE: 10.21.17

MEDPHARM IOWA PROCEDURE NUMBER: MPMOiOOS
REVISION NUMBER:

DATE: 10.21.17
SOP T I T L E : CORRECTIV E AND PREVENTATIVE ACTION
tx
to
a
a
3,
Mad

VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFIDENTIAL Rev. Date: 8
REVISION NUMBER:

DATE: 10.21.17
MEDPHARM IOWA PROCEDURE NUMBER: MPI-lOiOOS
REVISION NUMBER:

DATE: 10.21.17
REVISION NUMBER:

DATE: 10.21.17
PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY O

VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFIDENTIAL Rev. Date: U
REVISION NUMBER:

DATE: 10.21.17
Co
5
St
c
a
a,
-J
>
I
Rev. Date:
I
REVISION NUMBER:

DATE: 10.21.17

REVISION NUMBER:

DATE: 10.21.17
SOP T I T L E : C O R R E C T I V E AND P R E V E N T A T I V E ACTION
REVISION NUMBER:

DATE: 10.21.17
REVISION NUMBER:

DATE: 10.21.17
REVISION NUMBER:

DATE: 10.21.17
<-<
to
0
s

Rev. Date:
Rev.
I
REVISION NUMBER:

DATE: 10.21.17
k
PRINTED COPIES ARE UNCONTROLLED AND ARE ONLY O
VALID IF THE VERSION IS THE SAME AS MASTER ELECTRONIC DOCUMENT CONFIDENTIAL Rev. Date: O
management practices regarding plans for responding to a security breach at a manufacturing
facility or while medical cannabidiol is in transit to a dispensary.

management practices regarding a business continuity plan.
MedPharm Iowa is adequately prepared should it experience a loss of power or other event
that precludes manufacturing at its site for a period of time. First, MedPhaim Iowa's facility
includes a backup generator that w i l l power the grow rooms (among other systems) should a short-
term loss of power occur. In addition, MedPharm Iowa's production includes plans to begin
stocking inventory to equal three (3) months of demand, at minimum. This additional stock w i l l
be stored in fire-resistant safes attached to the floor of a secured room. MedPharm Iowa w i l l also
work with any other manufacturer licensed by the Iowa Department of Public Health to maintain
enough medical cannabidiol supply to the market in the event one manufacturer experiences a
catastrophic or total loss.

management practices regarding records relating to all transport activities.
MedPharm Iowa transportation employees w i l l fill out the manifest included below and
w i l l be responsible for logging all information into the Tracking System, as described in further
detail in Section 3.02, Part C , Subpart 6.
CARGO MANIFEST PAGE OF
NAME O F DRIVER DESTINATION(S)
NAME O F DRIVER V E H I C L E ID
R E P O R T TO: IF DELAYED CONTACT
DEPARTURE INTERMEDIATE S T O P S DESTINATION

PLACE ETD ETA PLACE ETD ETA PLA
CARGO CARGO RETURN ITEMS CARGO CARGO

C A R G O NAME
WEIGHT IN WEIGHT OUT WEIGHT IN WEIGHT OUT
1.
2.
3.
4.
5.
6.
7.
SIGNATURE O F AUTHORIZED R E P R E S E N T A T I V E DATE

management practices regarding handling, storage, application, and disposal of pesticides,
fertilizers, and other crop inputs.
Standard Operating Procedures 9h002
Revision Number:
Date: 10-15-17
SOP Title: Handling, storage, application, and

disposal of pesticides, fertilizers, and other crop inputs
management practices regarding oversight of all personnel and phases of manufacturing and
production of cannabidiol (including a table of organization).
MedPharm Iowa's table of organization is shown below. Job descriptions for each of these jobs
are described in Section 3.02, Part C , Subpart 12. I n addition, descriptions of the individual phases
of manufacturing and production of caimabidiol are discussed in Section 3.02, Part C , Subparts 2,
8, 9, 10,11, as well as other parts of MedPharm Iowa's response to the Department's RFP. Please
also review the standard operating procedures described in Section 3.02, Part D.
MED PHARM
FORMULATING THE M J 7 U 1 U OF C M l N A BIT,
Procedures to ensure accurate recordkeeping.
MedPhami Iowa's Tracking System w i l l be relied on to ensure accurate recordkeeping. Inventory
and audit procedures, such as the Inventory Management SOP below, w i l l enhance the accuracy
of the Tracking System. Please see Section 3.02, Part C , Subpart 8 for more information regarding
the Tracking System.
MedPharm Iowa Procedure Number: M P I -

Standard Operating Procedures llaOOl
Revision Number:
Originator: Joao Esteves Supersedes:

Date: 10.21.17
SOP Title: I N V E N T O R Y M A N A G E M E N T
Procedures for the implementation of appropriate security measures to deter and prevent the
theft of medical cannabidiol and unauthorized entrance into areas containing medical
cannabidiol
MedPharm Iowa described its security systems in Section 3.02, Part C , Subparts 2 and 3. Incident
planning is also discussed in Section 3.02, Part D. Please see those sections for more information.
MedPharm Iowa's security personnel w i l l receive detailed standing post orders for security
sweeps, equipment checks, and perimeter checks, with contact information for MedPhami Iowa's
safety team, local law enforcement, and emergency personnel. In addition, please see the Guide
for Handling and Transporting Cash below.
CONFIDENTIAL pursuant to Iowa Code Sec. 22.7(3} & (6)
(
(

MedPharmIA Manufacturer App Nov2017

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

MedPharmIA Manufacturer App Nov2017

Uploaded by

Copyright:

Available Formats

MedPharm Iowa, LLC | 1

Iowa Department of Public Health

Iowa Department of Public Health

Applicant Entity Information:

Legal Name include d/b/a MedPharm Iowa, LLC

Last Four Digits of the xx-xxx8360

I hereby affirm and certify that:

1. The information in this application is accurate, to the best of my knowledge.

Name - Printed: Christopher J L / l e l s o n , PhD, Manager

Title - Printed: Manager

Date: October 30, 2017

Iowa Department of Public Health

Statutory Requirements Certification Form

Applicant B u s i n e s s Name: MedPharm Iowa, LLC

Name of Person Completing Form: Christopher E. Nelson, PhD, Manager

3. I certify that the applicant manufacturer will participate in the Department's

a. Own or operate a medical cannabidiol manufacturing facility unless the

in proposed administrative subrule 154.22.

5. I certify that no owners of the applicant manufacturer business have been

6. I certify that no employees of an applicant manufacturer have been convicted of

8. I certify that all of the applicant manufacturer's manufacturing, cultivating,

12. I acknowledge that the applicant manufacturer is subject to reasonable

14. I acknowledge the Department may suspend or revoke a manufacturer license in

Name - Printed: Christopher E/Nelson, PhD, Manager

Date: October 30, 2017

Iowa Department of Public Health

Licensing/Regulatory Authority R e l e a s e Form

Applicant B u s i n e s s Name: MedPharm Iowa, LLC

Name of Person Completing Form: Christopher E. Nelson, PhD, Manager

c. State Agency or Authority Contact Name, Phone, and Email:

d. License, Authorization, or Registration Number:

Any denial, suspension, revocation or other sanction of the application, license,

Name - Printed: C h r i s t o p h e / t . Nelson, PhD, Manager

Date: October 30, 2017

Iowa Department of Public Health

Proper Zoning Form

Applicant B u s i n e s s Name: MedPharm Iowa, LLC

Name of Person Completing Form: Christopher E. Nelson, PhD, Manager

1. Business address of business applying for a manufacturer license:

1953 E. Market Street, Des Moines, Iowa 50317

2. Proposed physical address of manufacturing facility, including county name:

1953 E. Market Street, Des Moines, Polk County, Iowa 50317

6. Yes or No: The business has obtained a certificate of occupancy, or its

7. If the answer to question #6 is no, has one been requested?

As noted in the response to question #6 above, MedPharm Iowa's consultant

certificate of occupancy will only be issued after construction renovations to

No. Rezoning is not necessary.

Name - Printed: Christophers/Nelson, PhD, Manager

Date: October 30, 2017

The section below must be completed by an authorized representative of

Signature of Authorized Zoning Representative

Printed Name of Authorized Zoning Representative: EVUi A A P QF.UMPU=-.LAP

Signed before me on ^_ ^C/ lr)kdl? (date) by

Iowa Department of Public Health

Owner Certification Form

Applicant B u s i n e s s Name: MedPharm Iowa, LLC

Name of Person Completing Form: Christopher E. Nelson, PhD, Manager

Name - Printed: Christopher E. Nelson, PhD, Manager

Date: October 30, 2017

Name - Printed: Christopher^. Nelson, PhD, Manager

Date: October 30, 2017

(200) pages, as required.

a. Provide a brief summary of the applicant manufacturer's qualification, experience, and

industry knowledge relevant to the development and operation of a medical cannabidiol